data_5x34_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5x34 _Structure_validation_residue.Date_analyzed 2017-05-26 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 . . . . . 0 N--CA 1.44 -0.936 0 CA-C-O 121.085 0.469 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.7 p -65.65 163.27 16.68 Favored 'General case' 0 C--O 1.254 1.34 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.375 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -60.59 130.71 47.89 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.297 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 75.61 9.13 3.64 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.232 1.413 . . . . 0.0 112.331 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.95 172.05 32.0 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.471 HE21 ' HA2' ' A' ' 9' ' ' GLY . 48.8 tt0 -86.47 103.78 15.33 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.873 0.336 . . . . 0.0 110.702 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 3.6 p -67.12 -28.17 67.93 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.841 0.829 . . . . 0.0 109.428 174.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.471 ' HA2' HE21 ' A' ' 7' ' ' GLN . . . 108.98 134.22 7.04 Favored Glycine 0 N--CA 1.396 -3.991 0 C-N-CA 118.85 -1.643 . . . . 0.0 115.254 172.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.99 -155.94 29.04 Favored Glycine 0 N--CA 1.403 -3.506 0 N-CA-C 107.614 -2.195 . . . . 0.0 107.614 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.7 mt -57.11 128.03 17.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.71 -19.02 36.75 Favored Glycine 0 C--N 1.311 -0.844 0 C-N-CA 120.044 -1.074 . . . . 0.0 112.644 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.432 ' CG ' ' HA3' ' A' ' 9' ' ' GLY . 9.3 t80 -90.88 125.45 35.75 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -118.63 2.99 11.75 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -174.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.03 -128.68 5.97 Favored Glycine 0 C--N 1.311 -0.835 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.976 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -64.67 85.67 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.572 2.848 . . . . 0.0 113.027 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -90.12 -7.55 53.47 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 122.042 0.925 . . . . 0.0 109.72 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.14 131.28 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.2 m -92.85 158.05 16.06 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.086 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.52 141.19 32.08 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 123.801 0.688 . . . . 0.0 109.75 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 m -51.31 117.92 2.92 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.628 0.771 . . . . 0.0 111.859 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.92 -18.15 26.72 Favored Glycine 0 N--CA 1.431 -1.689 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.231 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.2 p -102.57 144.68 30.67 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.0 p -100.94 132.7 46.23 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.2 t -79.49 106.47 11.55 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.407 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.6 mt-30 -106.08 114.79 29.14 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.664 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.9 t -78.93 96.3 2.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.437 HD11 ' CE2' ' A' ' 32' ' ' TYR . 80.9 mt -77.15 -52.12 9.82 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.947 -175.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -115.79 162.31 26.05 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.57 -24.44 78.01 Favored 'Trans proline' 0 C--O 1.212 -0.791 0 CA-C-N 121.375 1.527 . . . . 0.0 112.099 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -108.87 -23.38 11.76 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.752 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.437 ' CE2' HD11 ' A' ' 28' ' ' LEU . 69.3 t80 -103.01 114.09 28.1 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.167 0.508 . . . . 0.0 111.457 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -126.88 134.26 50.53 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -120.24 151.25 39.43 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -176.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.1 m -92.76 106.17 18.19 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.407 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.9 mm? . . . . . 0 C--N 1.297 -1.681 0 CA-C-O 118.462 -0.78 . . . . 0.0 109.233 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 . . . . . 0 N--CA 1.43 -1.427 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 t -73.47 177.09 5.51 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-O 121.809 0.814 . . . . 0.0 110.947 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -64.12 131.8 48.55 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.374 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 76.06 9.79 3.25 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.916 1.286 . . . . 0.0 113.386 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.3 168.0 25.3 Favored Glycine 0 C--N 1.312 -0.786 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.565 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.0 tt0 -81.54 112.72 19.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 117.026 0.413 . . . . 0.0 110.353 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.646 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.3 p -72.87 -58.07 3.6 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.783 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.71 109.42 0.22 Allowed Glycine 0 N--CA 1.396 -3.98 0 C-N-CA 118.134 -1.984 . . . . 0.0 113.363 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.56 -157.53 17.31 Favored Glycine 0 N--CA 1.405 -3.406 0 N-CA-C 105.974 -2.851 . . . . 0.0 105.974 171.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.418 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 77.2 mt -65.67 126.1 24.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 117.665 0.732 . . . . 0.0 109.604 174.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.96 -13.16 60.69 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.907 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -90.37 111.96 23.38 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.8 p -109.98 6.83 23.44 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.97 -136.97 9.29 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.872 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -64.13 88.29 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.682 2.922 . . . . 0.0 112.996 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 24.4 p -84.21 -16.09 44.59 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.787 0.803 . . . . 0.0 110.5 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.3 t -82.4 129.84 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.74 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.0 m -88.18 168.92 12.34 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.002 0.43 . . . . 0.0 110.954 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.62 155.04 16.33 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.758 0.823 . . . . 0.0 110.709 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -64.52 111.53 2.74 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.245 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.51 6.47 27.08 Favored Glycine 0 N--CA 1.432 -1.578 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.056 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.7 p -125.1 152.19 44.71 Favored 'General case' 0 C--O 1.244 0.788 0 O-C-N 122.411 -0.464 . . . . 0.0 110.394 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.1 p -115.23 139.85 49.6 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.881 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.3 t -83.92 110.12 18.15 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -110.68 114.91 28.66 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -79.56 98.2 2.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.117 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.1 mt -78.52 -43.86 25.78 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.48 -174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -126.73 160.46 58.6 Favored Pre-proline 0 C--N 1.289 -2.033 0 N-CA-C 103.655 -2.72 . . . . 0.0 103.655 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.41 -29.43 84.37 Favored 'Trans proline' 0 C--O 1.225 -0.153 0 C-N-CA 121.752 1.635 . . . . 0.0 112.005 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 53.6 m-85 -104.36 -25.5 12.82 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.851 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -104.28 113.56 27.2 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 119.551 -0.859 . . . . 0.0 110.434 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 13.7 m -125.53 135.74 52.59 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 177.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -121.35 147.61 45.47 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.411 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.7 m -87.62 106.64 18.16 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.29 -2.003 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.98 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 . . . . . 0 N--CA 1.442 -0.847 0 CA-C-O 121.093 0.473 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 m -69.15 169.11 12.61 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.555 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.425 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 17.7 t-160 -59.62 132.25 53.39 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.509 0.723 . . . . 0.0 109.27 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 77.4 8.87 2.66 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.564 1.546 . . . . 0.0 112.247 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.87 169.0 29.33 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.0 tt0 -88.31 103.77 16.12 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.62 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.5 p -62.51 -47.86 82.09 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.246 0.546 . . . . 0.0 111.68 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.07 117.18 0.77 Allowed Glycine 0 N--CA 1.397 -3.904 0 C-N-CA 118.189 -1.958 . . . . 0.0 113.773 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.56 -157.39 18.78 Favored Glycine 0 N--CA 1.413 -2.873 0 N-CA-C 106.376 -2.69 . . . . 0.0 106.376 172.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.84 121.68 14.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 117.963 0.881 . . . . 0.0 109.597 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.96 -9.17 46.72 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.386 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -113.79 112.01 22.71 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.0 p -120.98 14.99 11.6 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 120.866 0.365 . . . . 0.0 111.877 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.41 -126.49 0.97 Allowed Glycine 0 C--O 1.241 0.588 0 C-N-CA 121.261 -0.495 . . . . 0.0 111.878 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.2 79.95 0.56 Allowed 'Trans proline' 0 C--O 1.217 -0.547 0 C-N-CA 122.939 2.426 . . . . 0.0 112.01 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 23.0 p -83.45 2.18 37.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 122.269 1.033 . . . . 0.0 110.787 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.2 t -101.42 131.86 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.62 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.8 m -90.31 162.08 15.34 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 123.358 0.411 . . . . 0.0 110.591 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.75 144.64 37.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.841 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.1 p -56.17 118.2 4.48 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 124.069 0.856 . . . . 0.0 111.416 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.03 -3.19 28.56 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.983 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.2 p -120.51 166.15 14.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 117.388 0.594 . . . . 0.0 110.281 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 34.4 p -120.89 146.04 47.02 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 122.202 0.201 . . . . 0.0 111.152 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.5 t -90.08 111.54 22.69 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -111.81 114.82 28.03 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -76.96 99.85 2.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 mt -82.53 -53.98 5.54 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.298 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -110.29 165.57 12.43 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.27 -26.23 64.2 Favored 'Trans proline' 0 C--O 1.221 -0.35 0 CA-C-N 121.445 1.552 . . . . 0.0 111.14 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -106.53 -25.29 11.9 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.432 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -103.62 113.26 26.64 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.631 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.4 m -123.54 139.31 54.14 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 176.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -127.61 150.57 49.67 Favored 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.597 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.7 m -90.01 106.42 18.46 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.299 -1.588 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 . . . . . 0 N--CA 1.445 -0.716 0 CA-C-O 121.246 0.546 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -74.22 171.95 12.67 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.459 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -62.32 132.86 54.05 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.365 0.666 . . . . 0.0 109.719 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 74.74 8.99 4.21 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.282 1.433 . . . . 0.0 112.406 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.25 169.56 33.36 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -89.09 105.61 17.9 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 117.134 0.467 . . . . 0.0 110.792 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.592 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 2.5 p -67.26 -31.5 71.87 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 121.587 0.708 . . . . 0.0 109.934 175.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.53 131.35 5.13 Favored Glycine 0 N--CA 1.396 -3.987 0 C-N-CA 118.922 -1.608 . . . . 0.0 115.866 172.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.6 -156.06 25.47 Favored Glycine 0 N--CA 1.408 -3.225 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.2 mt -56.31 127.4 15.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.17 -23.36 29.09 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.055 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -89.04 130.94 35.41 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.2 p -137.86 14.91 2.89 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.656 0.741 . . . . 0.0 111.234 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.8 -130.23 5.3 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.41 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.45 84.26 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.314 2.676 . . . . 0.0 112.267 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.3 p -88.25 2.32 52.59 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 122.252 1.025 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -105.88 127.25 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.592 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.9 m -87.76 153.02 21.68 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.84 154.4 15.09 Favored 'General case' 0 C--O 1.252 1.216 0 O-C-N 123.596 0.56 . . . . 0.0 111.236 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.2 m -49.4 116.39 1.71 Allowed 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.556 1.142 . . . . 0.0 112.035 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.89 -1.8 48.28 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.557 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.5 p -117.7 145.67 44.26 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 117.649 0.725 . . . . 0.0 110.212 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.5 p -106.25 138.64 42.07 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -79.4 113.81 17.83 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.415 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.6 mt-30 -113.73 114.76 26.81 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.49 100.14 2.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.3 mt -79.26 -53.2 7.18 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -175.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -116.85 160.3 37.32 Favored Pre-proline 0 C--N 1.29 -1.995 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.27 -29.89 91.48 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 121.484 1.456 . . . . 0.0 113.261 -174.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -106.58 -23.81 12.35 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 120.959 0.409 . . . . 0.0 110.488 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -103.12 113.49 27.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.217 0.532 . . . . 0.0 111.352 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.7 m -124.99 142.74 51.29 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -129.84 149.14 51.71 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.238 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 67.5 m -88.67 107.63 19.03 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.939 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.415 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.8 mm? . . . . . 0 C--N 1.303 -1.419 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 . . . . . 0 N--CA 1.436 -1.156 0 CA-C-O 121.144 0.497 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -81.77 169.85 16.42 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 124.088 0.955 . . . . 0.0 111.877 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -64.63 131.57 47.33 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 75.61 9.51 3.57 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.718 1.207 . . . . 0.0 112.741 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.03 167.57 26.7 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.429 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.9 tt0 -84.96 116.08 23.17 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.631 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.6 p -73.56 -55.2 6.61 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 123.8 0.688 . . . . 0.0 110.973 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 161.65 108.65 0.23 Allowed Glycine 0 N--CA 1.401 -3.673 0 C-N-CA 118.114 -1.993 . . . . 0.0 114.528 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.33 -158.33 29.0 Favored Glycine 0 N--CA 1.41 -3.043 0 N-CA-C 106.36 -2.696 . . . . 0.0 106.36 171.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.487 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 72.6 mt -65.3 117.07 5.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 118.074 0.937 . . . . 0.0 110.901 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.25 -14.79 23.16 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.573 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -92.27 125.57 36.99 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.6 p -119.76 -6.39 10.12 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.42 -131.2 1.81 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.762 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.53 79.98 0.1 Allowed 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 123.963 3.109 . . . . 0.0 112.669 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 5.2 p -85.35 -5.94 59.27 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.86 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.0 t -99.43 131.96 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.631 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 82.6 m -92.54 146.95 23.28 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 123.364 0.415 . . . . 0.0 110.092 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.53 154.05 6.95 Favored 'General case' 0 C--O 1.251 1.17 0 O-C-N 124.007 0.817 . . . . 0.0 110.865 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 m -50.82 126.86 16.97 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.865 0.866 . . . . 0.0 111.417 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.93 -16.54 57.29 Favored Glycine 0 N--CA 1.432 -1.585 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.565 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.8 p -110.22 142.41 41.83 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.432 0.616 . . . . 0.0 110.289 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.3 p -109.29 133.6 52.83 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.506 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.6 t -75.31 107.15 7.22 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -109.37 114.73 28.65 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.3 t -78.55 96.63 2.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.0 mt -75.7 -51.5 12.59 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.371 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -120.34 166.99 13.66 Favored Pre-proline 0 C--N 1.284 -2.258 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.57 -33.5 86.98 Favored 'Trans proline' 0 C--N 1.343 0.261 0 CA-C-N 121.399 1.535 . . . . 0.0 112.323 -175.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.487 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 21.9 m-85 -104.94 -23.78 12.93 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.44 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -102.23 113.5 26.85 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.376 0.607 . . . . 0.0 110.761 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.0 m -127.0 137.46 53.1 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -128.37 150.78 49.95 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.304 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 67.1 m -90.15 105.68 17.97 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.294 -1.833 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.945 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.195 0.522 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 p -70.39 169.81 13.19 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.004 0.922 . . . . 0.0 112.907 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -61.74 129.5 41.33 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.904 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 76.75 9.25 2.94 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.766 1.226 . . . . 0.0 112.765 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.05 164.21 28.46 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.3 tt0 -83.49 107.47 15.99 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.574 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.6 p -67.27 -51.04 57.82 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-O 121.183 0.516 . . . . 0.0 111.421 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.59 118.69 0.71 Allowed Glycine 0 N--CA 1.399 -3.794 0 C-N-CA 118.266 -1.921 . . . . 0.0 113.651 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.12 -158.09 18.34 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 105.691 -2.964 . . . . 0.0 105.691 171.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.63 119.97 15.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 117.919 0.86 . . . . 0.0 109.042 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.38 -6.27 28.39 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.014 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -113.9 132.27 55.98 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 p -141.33 20.82 2.23 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.88 -121.6 3.33 Favored Glycine 0 C--O 1.241 0.54 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -67.75 78.81 0.52 Allowed 'Trans proline' 0 N--CA 1.476 0.494 0 C-N-CA 123.697 2.931 . . . . 0.0 111.96 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.5 p -82.3 -16.66 48.57 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.55 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.8 t -89.14 133.0 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.495 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.1 m -87.39 159.1 18.84 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.12 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.63 160.61 8.89 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.931 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 m -62.82 128.9 38.07 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.625 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.17 5.41 59.43 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.492 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.4 p -128.55 164.88 21.85 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 117.33 0.565 . . . . 0.0 109.885 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.3 p -130.94 138.64 49.83 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 122.182 0.193 . . . . 0.0 110.845 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.459 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.2 t -78.23 114.38 17.06 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.559 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 40.4 mt-30 -115.94 115.81 26.84 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.922 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.1 t -77.7 99.79 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.2 mt -78.31 -50.6 11.5 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 122.042 0.925 . . . . 0.0 108.843 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -120.26 161.75 37.33 Favored Pre-proline 0 C--N 1.289 -2.057 0 N-CA-C 103.941 -2.615 . . . . 0.0 103.941 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.43 -28.66 88.12 Favored 'Trans proline' 0 N--CA 1.474 0.345 0 CA-C-N 120.896 1.356 . . . . 0.0 112.093 -175.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -105.01 -25.18 12.66 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.835 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -104.01 113.04 26.29 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.562 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -125.35 140.03 53.17 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -130.95 149.43 52.58 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.921 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.574 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.4 m -87.68 106.07 17.79 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.559 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.7 mm? . . . . . 0 C--N 1.289 -2.022 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 . . . . . 0 C--O 1.243 0.754 0 CA-C-O 121.518 0.675 . . . . 0.0 111.831 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 p -80.91 161.7 24.25 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 124.357 1.063 . . . . 0.0 111.426 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -62.06 131.59 50.09 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 77.69 9.68 2.37 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.717 1.207 . . . . 0.0 112.752 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.67 170.01 25.03 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.424 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.605 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.6 tt0 -81.56 109.18 15.76 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.604 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -71.44 -54.04 11.98 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 121.266 0.555 . . . . 0.0 111.353 177.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 163.12 116.47 0.38 Allowed Glycine 1 N--CA 1.394 -4.111 0 C-N-CA 118.101 -1.999 . . . . 0.0 113.835 -177.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.25 -158.2 18.19 Favored Glycine 0 N--CA 1.409 -3.149 0 N-CA-C 105.485 -3.046 . . . . 0.0 105.485 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.2 mt -66.38 121.05 14.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 117.891 0.845 . . . . 0.0 110.049 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.09 -20.06 29.08 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.295 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -80.03 129.32 34.4 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.7 p -135.4 18.53 3.37 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.56 -125.85 5.52 Favored Glycine 0 C--N 1.311 -0.807 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.513 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.79 85.78 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.242 2.628 . . . . 0.0 111.925 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 10.2 p -88.94 -8.04 54.92 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.573 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.91 137.05 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.524 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 90.6 m -87.71 163.14 16.68 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.147 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.87 153.43 10.98 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.967 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.7 m -57.71 114.57 2.34 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.506 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.53 4.43 56.04 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.814 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 81.3 p -113.83 143.82 44.04 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 117.486 0.643 . . . . 0.0 109.882 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.3 p -103.55 132.65 49.62 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.511 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 45.9 t -79.16 106.73 11.4 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -104.61 114.76 29.19 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.4 t -77.83 101.65 3.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.9 mt -81.53 -39.45 24.66 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.738 0.78 . . . . 0.0 109.503 -173.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -132.97 163.06 53.77 Favored Pre-proline 0 C--N 1.289 -2.058 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -60.88 -28.35 86.23 Favored 'Trans proline' 0 C--N 1.345 0.367 0 CA-C-N 120.986 1.388 . . . . 0.0 112.618 -175.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -108.84 -24.07 11.45 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.407 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -103.11 114.51 28.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.292 0.568 . . . . 0.0 111.442 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.3 m -124.62 146.91 48.82 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -131.44 147.19 52.53 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.079 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.3 m -89.57 106.47 18.48 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 C--N 1.297 -1.678 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.615 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 . . . . . 0 N--CA 1.438 -1.062 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 p -76.81 171.24 15.05 Favored 'General case' 0 C--O 1.251 1.151 0 CA-C-O 121.179 0.514 . . . . 0.0 111.952 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -63.46 129.74 41.46 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 75.19 9.43 3.84 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.62 1.568 . . . . 0.0 111.508 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.76 165.84 32.35 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -86.56 106.55 17.62 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.518 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 4.5 p -70.01 -27.09 64.4 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.834 0.825 . . . . 0.0 109.067 174.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.25 129.43 6.0 Favored Glycine 1 N--CA 1.394 -4.165 0 C-N-CA 119.245 -1.455 . . . . 0.0 115.41 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.8 -156.65 30.91 Favored Glycine 0 N--CA 1.407 -3.272 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 171.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.9 mt -59.78 125.43 15.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.54 -1.07 32.47 Favored Glycine 0 C--N 1.317 -0.525 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.386 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -113.62 119.94 39.2 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.4 p -115.81 9.52 15.1 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.76 -139.78 7.68 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.353 -0.693 . . . . 0.0 111.809 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.34 94.58 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.23 2.62 . . . . 0.0 112.083 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.0 p -92.76 -7.46 46.5 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.479 0.657 . . . . 0.0 111.378 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.5 t -100.77 135.58 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.9 m -90.71 161.8 15.19 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 120.719 0.295 . . . . 0.0 111.69 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.18 164.73 10.41 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.61 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.6 m -54.12 111.52 0.78 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 124.354 1.062 . . . . 0.0 112.764 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.07 -13.48 57.37 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.243 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 82.2 p -100.18 141.03 33.57 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 122.17 -0.606 . . . . 0.0 109.889 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.4 p -106.08 136.78 45.15 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.792 -0.186 . . . . 0.0 111.36 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.46 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.4 t -80.73 106.15 12.51 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -107.97 115.42 30.1 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.703 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.25 96.17 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.6 mt -77.55 -39.1 47.0 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.057 -173.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.4 HD21 ' HB3' ' A' ' 32' ' ' TYR . 29.7 m-80 -133.55 163.74 48.99 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -61.55 -29.31 84.35 Favored 'Trans proline' 0 C--O 1.235 0.373 0 CA-C-N 121.549 1.589 . . . . 0.0 112.941 -173.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -107.72 -23.5 12.08 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.85 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.4 ' HB3' HD21 ' A' ' 29' ' ' ASN . 70.3 t80 -103.15 113.83 27.63 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.054 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 m -125.34 141.27 52.17 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -131.75 150.38 52.17 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.018 -174.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.0 m -89.29 105.89 18.09 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.99 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--N 1.29 -1.984 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.413 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.46 ' NE2' ' HA3' ' A' ' 6' ' ' GLY . 26.0 tp60 . . . . . 0 N--CA 1.443 -0.777 0 CA-C-O 121.254 0.55 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 m -66.75 166.75 12.53 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.48 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -62.28 131.33 49.02 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.652 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 77.25 8.87 2.73 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.705 1.602 . . . . 0.0 112.482 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.46 ' HA3' ' NE2' ' A' ' 2' ' ' GLN . . . -91.85 170.59 33.56 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.5 tt0 -88.49 107.48 18.9 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.694 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.6 p -62.73 -56.91 13.26 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 121.016 0.436 . . . . 0.0 111.664 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.5 112.66 0.27 Allowed Glycine 0 N--CA 1.4 -3.725 0 C-N-CA 118.278 -1.915 . . . . 0.0 113.671 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.59 -167.28 20.13 Favored Glycine 0 N--CA 1.41 -3.038 0 N-CA-C 106.4 -2.68 . . . . 0.0 106.4 171.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.8 mt -59.76 111.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 117.823 0.812 . . . . 0.0 110.926 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.33 -5.02 26.69 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.753 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -98.49 127.94 44.63 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.0 p -124.59 -1.8 7.97 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.73 -135.64 2.81 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.042 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 39.5 Cg_exo -63.99 80.44 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.056 3.171 . . . . 0.0 112.386 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 9.2 p -76.8 -22.06 54.22 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.721 0.772 . . . . 0.0 110.726 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.08 129.15 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.694 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 87.6 m -87.13 161.5 18.06 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.889 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.76 157.79 14.16 Favored 'General case' 0 C--O 1.256 1.396 0 C-N-CA 123.765 0.826 . . . . 0.0 110.808 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.5 m -64.03 111.21 2.42 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.142 0.496 . . . . 0.0 110.406 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.31 0.32 33.14 Favored Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.903 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 79.2 p -116.81 139.48 50.55 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.283 -0.54 . . . . 0.0 109.605 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 24.8 p -102.04 136.04 42.57 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.056 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.5 t -81.89 109.95 16.72 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -109.89 114.6 28.28 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.41 98.88 3.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.9 mt -78.93 -53.27 7.22 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.855 0.836 . . . . 0.0 109.369 -173.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -115.77 167.04 10.86 Favored Pre-proline 0 C--N 1.283 -2.299 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -61.04 -32.14 91.72 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 CA-C-N 121.001 1.393 . . . . 0.0 112.278 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -105.68 -23.96 12.64 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.23 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -102.36 113.89 27.59 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.344 0.592 . . . . 0.0 111.477 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.6 m -124.64 153.0 42.92 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 176.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -140.83 149.4 41.96 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.536 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.539 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 68.9 m -91.67 106.07 18.2 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--N 1.3 -1.549 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.628 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.438 ' NE2' ' HA3' ' A' ' 6' ' ' GLY . 28.2 tp60 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.369 0.604 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 p -75.08 169.38 18.14 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.188 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -61.82 132.49 53.27 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.373 1.069 . . . . 0.0 109.244 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 74.52 8.84 4.38 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 125.077 1.351 . . . . 0.0 112.565 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.438 ' HA3' ' NE2' ' A' ' 2' ' ' GLN . . . -94.05 164.89 26.36 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 176.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.4 tt0 -84.58 101.13 11.88 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.6 p -63.23 -42.49 99.25 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.23 0.538 . . . . 0.0 111.053 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.59 123.61 2.08 Favored Glycine 1 N--CA 1.393 -4.199 0 C-N-CA 118.048 -2.025 . . . . 0.0 114.247 177.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.38 -157.81 17.75 Favored Glycine 0 N--CA 1.403 -3.565 0 N-CA-C 105.432 -3.067 . . . . 0.0 105.432 171.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.3 mt -62.67 130.92 27.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.88 -7.96 61.08 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.837 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -109.91 136.56 49.01 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.2 p -141.39 21.23 2.22 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.1 -126.38 5.07 Favored Glycine 0 C--N 1.307 -1.039 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.469 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -70.1 86.7 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.29 2.66 . . . . 0.0 111.537 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.9 p -82.54 -16.81 47.24 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.889 0.852 . . . . 0.0 110.917 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.78 135.36 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 67.3 m -93.07 162.17 14.14 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.62 138.97 51.52 Favored 'General case' 0 C--O 1.25 1.109 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.6 m -57.61 127.16 30.6 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.411 0.444 . . . . 0.0 110.731 -175.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.05 -16.54 27.66 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.214 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.6 p -115.91 144.89 43.43 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.8 p -103.66 136.86 42.58 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -175.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.551 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 38.4 t -81.1 107.1 13.62 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -104.42 114.51 28.79 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.554 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.0 t -80.01 100.59 4.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.5 mt -82.91 -51.33 7.71 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.254 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.49 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -112.35 161.64 25.2 Favored Pre-proline 0 C--N 1.292 -1.922 0 N-CA-C 102.102 -3.295 . . . . 0.0 102.102 174.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.02 -25.73 77.89 Favored 'Trans proline' 0 C--O 1.22 -0.412 0 CA-C-N 121.667 1.631 . . . . 0.0 111.326 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -104.26 -23.77 13.2 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.16 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -103.82 114.11 28.12 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.53 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.2 m -125.47 142.24 51.61 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -133.68 147.98 51.44 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.894 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.1 m -88.55 106.5 18.33 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.23 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.294 -1.826 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.519 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.449 ' NE2' ' HA3' ' A' ' 6' ' ' GLY . 28.0 tp60 . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 121.242 0.544 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 p -72.96 172.82 10.25 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 124.169 0.988 . . . . 0.0 112.655 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -67.52 130.41 42.95 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 77.13 9.18 2.74 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.37 1.468 . . . . 0.0 112.351 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.449 ' HA3' ' NE2' ' A' ' 2' ' ' GLN . . . -90.95 164.31 29.87 Favored Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 175.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -82.55 104.61 12.95 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.655 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.7 p -62.53 -55.18 29.84 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-O 121.099 0.476 . . . . 0.0 111.305 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.83 112.89 0.32 Allowed Glycine 1 N--CA 1.392 -4.285 0 C-N-CA 117.685 -2.198 . . . . 0.0 114.123 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.35 -158.14 22.91 Favored Glycine 0 N--CA 1.402 -3.604 0 N-CA-C 105.313 -3.115 . . . . 0.0 105.313 170.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.24 128.89 31.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 118.044 0.922 . . . . 0.0 108.628 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.91 -8.98 50.89 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.687 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -113.66 118.03 33.21 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 p -124.54 3.05 8.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.51 -119.69 0.84 Allowed Glycine 0 C--O 1.243 0.658 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.964 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 25.2 Cg_exo -67.96 78.5 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.662 2.908 . . . . 0.0 111.836 175.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.7 p -85.83 -22.66 27.5 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.455 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.89 131.94 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.613 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -85.68 153.11 22.57 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.291 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.94 148.64 20.6 Favored 'General case' 0 C--O 1.244 0.791 0 O-C-N 123.932 0.77 . . . . 0.0 110.717 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 m -55.11 116.82 3.0 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 122.979 0.512 . . . . 0.0 111.508 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.93 -5.7 29.08 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.287 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.2 p -119.27 154.52 33.33 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.6 p -116.73 142.09 47.36 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.977 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.5 t -83.06 112.04 19.43 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.513 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.5 mt-30 -109.74 114.37 27.89 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.7 t -81.93 105.83 12.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.8 mt -83.38 -53.89 5.39 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.943 -175.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -116.21 163.29 22.2 Favored Pre-proline 0 C--N 1.296 -1.737 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -58.37 -31.86 94.88 Favored 'Trans proline' 0 C--O 1.218 -0.503 0 C-N-CA 121.279 1.319 . . . . 0.0 112.04 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -102.69 -24.12 13.78 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.865 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -103.7 114.18 28.25 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 120.934 0.397 . . . . 0.0 111.904 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.8 m -129.22 147.52 51.07 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -136.62 147.65 47.04 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.14 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.645 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.6 m -87.25 106.74 18.12 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.197 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.513 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.6 mm? . . . . . 0 C--N 1.294 -1.816 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 . . . . . 0 C--O 1.245 0.826 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -73.76 166.17 23.79 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.953 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -60.41 133.81 56.46 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.74 0.816 . . . . 0.0 108.95 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 74.87 9.25 4.08 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.201 1.4 . . . . 0.0 112.04 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.17 170.43 28.81 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.175 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.7 tt0 -88.43 107.82 19.06 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.523 0.161 . . . . 0.0 110.574 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.582 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -69.08 -29.74 67.91 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 121.973 0.892 . . . . 0.0 109.024 173.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.23 126.97 4.19 Favored Glycine 1 N--CA 1.391 -4.36 0 C-N-CA 118.771 -1.681 . . . . 0.0 114.566 174.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.44 -156.25 32.13 Favored Glycine 0 N--CA 1.41 -3.037 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 171.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -58.08 129.75 20.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 117.566 0.683 . . . . 0.0 109.347 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.21 -22.34 31.38 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.687 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -103.05 112.02 24.65 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -118.58 11.41 12.86 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -175.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.23 -122.16 1.12 Allowed Glycine 0 C--O 1.245 0.804 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.849 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.8 78.65 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.051 3.167 . . . . 0.0 113.003 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.7 p -86.13 -16.81 36.78 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.081 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -90.58 133.8 31.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 86.1 m -92.97 157.55 16.27 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.388 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.13 158.9 18.62 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.784 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.5 m -55.1 121.11 8.05 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.303 0.641 . . . . 0.0 111.644 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.01 -16.96 45.67 Favored Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.427 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 59.2 p -106.88 143.11 35.44 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 122.248 -0.56 . . . . 0.0 110.976 -177.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.2 p -109.36 136.8 48.2 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.498 0.319 . . . . 0.0 111.567 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.427 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.0 t -79.93 108.68 13.7 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -113.19 117.36 31.69 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.338 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.76 106.91 7.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.2 mt -88.38 -41.73 12.64 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.193 0.997 . . . . 0.0 108.949 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.409 HD21 ' HB3' ' A' ' 32' ' ' TYR . 37.9 m-80 -127.71 161.16 56.92 Favored Pre-proline 0 C--N 1.286 -2.166 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 178.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -60.2 -31.63 93.36 Favored 'Trans proline' 0 CA--C 1.52 -0.217 0 CA-C-N 121.027 1.402 . . . . 0.0 112.051 -174.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -105.04 -23.46 12.95 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.295 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HB3' HD21 ' A' ' 29' ' ' ASN . 76.7 t80 -103.29 114.04 28.01 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.176 0.512 . . . . 0.0 111.421 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.2 m -125.57 138.82 53.96 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -124.01 149.96 45.43 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.315 -174.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.4 m -91.91 106.07 18.18 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.287 -2.134 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.638 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 . . . . . 0 N--CA 1.442 -0.87 0 CA-C-O 120.74 0.305 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 p -86.97 177.41 7.25 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 121.148 0.499 . . . . 0.0 111.596 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -62.92 132.41 51.99 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.048 0.539 . . . . 0.0 110.024 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 78.92 8.69 1.93 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.624 1.569 . . . . 0.0 113.218 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.47 173.54 32.67 Favored Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.877 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.0 tt0 -91.4 110.77 22.07 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.8 p -70.84 -33.28 70.5 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-O 121.76 0.79 . . . . 0.0 109.184 174.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.05 133.61 4.58 Favored Glycine 0 N--CA 1.398 -3.897 0 C-N-CA 118.469 -1.824 . . . . 0.0 115.397 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.31 -156.23 20.09 Favored Glycine 0 N--CA 1.402 -3.599 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.93 129.59 20.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.58 -6.72 55.35 Favored Glycine 0 C--N 1.307 -1.031 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.959 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -114.01 132.88 55.83 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.0 p -135.19 6.98 3.36 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.49 -123.14 2.03 Favored Glycine 0 C--O 1.246 0.865 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.273 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -65.27 79.21 0.22 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.709 2.94 . . . . 0.0 113.333 176.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.5 p -89.08 7.01 37.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 122.359 1.076 . . . . 0.0 109.384 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.9 t -106.24 116.92 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.112 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.444 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.1 m -83.44 149.69 26.51 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.14 151.25 12.63 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 123.932 0.77 . . . . 0.0 110.854 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -59.91 119.74 8.3 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.128 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.25 -9.98 28.87 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.784 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.7 p -118.49 146.18 44.71 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 122.197 -0.59 . . . . 0.0 110.491 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 34.4 p -107.08 140.94 39.1 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.135 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.447 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.0 t -85.42 107.26 17.32 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -107.89 114.64 28.73 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.49 96.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.404 HD11 ' CE1' ' A' ' 32' ' ' TYR . 87.6 mt -75.68 -53.22 8.9 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.468 0.707 . . . . 0.0 109.831 -174.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -112.06 162.66 20.28 Favored Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 172.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.67 -23.43 75.99 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 CA-C-N 120.935 1.37 . . . . 0.0 111.67 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -106.85 -24.72 11.96 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.979 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.404 ' CE1' HD11 ' A' ' 28' ' ' LEU . 74.7 t80 -103.67 113.8 27.59 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.971 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.9 m -126.68 135.35 51.04 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -124.76 150.34 46.36 Favored 'General case' 0 C--N 1.286 -2.169 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.199 -175.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 24' ' ' THR . 79.3 m -90.37 106.27 18.38 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.302 -1.494 0 CA-C-O 118.646 -0.692 . . . . 0.0 109.835 -178.867 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 121.15 0.5 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 p -79.56 170.85 15.96 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.857 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -62.84 134.88 56.92 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.116 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 74.16 9.31 4.58 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.28 1.432 . . . . 0.0 112.3 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.78 170.65 30.94 Favored Glycine 0 N--CA 1.431 -1.653 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.398 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.1 tt0 -87.18 107.25 18.39 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.5 p -68.26 -51.46 44.9 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 121.195 0.521 . . . . 0.0 110.814 177.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.48 121.2 0.69 Allowed Glycine 1 N--CA 1.393 -4.184 0 C-N-CA 118.203 -1.951 . . . . 0.0 114.061 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.9 -157.26 19.66 Favored Glycine 0 N--CA 1.408 -3.171 0 N-CA-C 106.183 -2.767 . . . . 0.0 106.183 171.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.5 mt -62.48 129.63 25.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 117.812 0.806 . . . . 0.0 108.938 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.53 -20.34 44.73 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.932 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -95.25 124.86 39.51 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.1 p -128.47 9.67 6.08 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.67 -124.06 3.75 Favored Glycine 0 C--O 1.248 0.993 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.945 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.95 75.44 0.43 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 124.054 3.169 . . . . 0.0 112.418 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.1 p -80.36 -11.87 59.65 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.99 0.9 . . . . 0.0 110.598 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.7 t -90.2 133.05 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.563 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.9 m -93.09 160.09 15.01 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 123.332 0.395 . . . . 0.0 110.503 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.67 147.13 28.47 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.259 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 m -53.39 117.01 2.75 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.581 0.752 . . . . 0.0 111.346 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.7 -8.15 34.17 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.234 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.3 p -113.59 146.87 39.04 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.228 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 32.6 p -106.58 137.24 44.94 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.557 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.487 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.7 t -83.8 113.08 20.67 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -116.59 116.05 26.87 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.261 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.38 99.44 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.7 mt -81.71 -48.05 12.17 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.667 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -122.24 166.84 15.63 Favored Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.16 -32.69 82.97 Favored 'Trans proline' 0 C--N 1.346 0.415 0 CA-C-N 121.495 1.57 . . . . 0.0 112.729 -175.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -105.62 -23.31 12.79 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.294 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -102.24 113.81 27.42 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.462 0.649 . . . . 0.0 111.412 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -126.49 140.7 52.26 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 177.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -128.43 147.33 50.65 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.769 -0.773 . . . . 0.0 110.535 -174.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 65.7 m -89.02 106.51 18.48 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.412 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.293 -1.869 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.646 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 . . . . . 0 N--CA 1.446 -0.656 0 CA-C-O 121.132 0.491 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -64.1 165.76 8.68 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 124.307 1.043 . . . . 0.0 111.985 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -61.58 131.01 48.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 74.76 9.27 4.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.93 1.292 . . . . 0.0 112.833 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.64 169.35 32.62 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -88.05 103.33 15.61 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.649 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.6 p -64.37 -26.06 68.3 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 121.806 0.813 . . . . 0.0 109.228 175.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.31 132.46 7.62 Favored Glycine 1 N--CA 1.39 -4.403 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.697 172.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.75 -155.84 29.97 Favored Glycine 0 N--CA 1.403 -3.508 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 172.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.41 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 66.0 mt -57.32 123.44 8.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.39 -12.14 26.01 Favored Glycine 0 C--N 1.302 -1.317 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.872 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -109.83 114.34 27.82 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 p -110.49 0.23 17.67 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.83 -134.67 1.5 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.732 -0.482 . . . . 0.0 112.869 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -63.55 79.19 0.14 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 123.401 2.734 . . . . 0.0 113.65 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 9.6 p -80.49 -14.28 58.4 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.202 1.001 . . . . 0.0 109.905 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.0 t -92.66 128.73 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.8 m -87.34 167.24 14.23 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.445 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.38 152.88 44.4 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.846 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.9 m -58.48 123.44 16.22 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.813 0.339 . . . . 0.0 110.561 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.09 -7.77 29.09 Favored Glycine 0 N--CA 1.433 -1.561 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.975 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.1 p -123.06 154.45 38.52 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.7 p -117.02 135.74 53.47 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.473 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.0 t -78.52 114.82 17.78 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -116.12 114.94 25.19 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.75 96.36 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 mt -78.31 -38.9 41.24 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.773 -173.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -134.46 167.85 20.75 Favored Pre-proline 0 C--N 1.291 -1.954 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -64.23 -32.96 61.7 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 CA-C-N 121.306 1.502 . . . . 0.0 112.435 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.41 ' HD1' ' O ' ' A' ' 11' ' ' ILE . 42.8 m-85 -106.5 -24.4 12.21 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.762 -176.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -102.02 117.42 34.76 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.43 0.633 . . . . 0.0 110.885 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.8 m -134.2 140.74 46.72 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -127.1 152.41 47.35 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.215 -173.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.649 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 84.6 m -92.55 106.36 18.36 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.292 -1.926 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.459 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 121.358 0.599 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 p -88.88 177.84 6.59 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 124.664 1.185 . . . . 0.0 110.855 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -72.06 133.8 45.46 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 74.76 9.43 4.13 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.439 1.096 . . . . 0.0 112.702 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.0 170.12 31.54 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -90.9 113.19 25.33 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.936 0.368 . . . . 0.0 110.056 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.62 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.8 p -72.56 -33.7 66.99 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.758 0.79 . . . . 0.0 109.166 174.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.6 130.38 4.03 Favored Glycine 0 N--CA 1.398 -3.859 0 C-N-CA 118.58 -1.771 . . . . 0.0 115.311 174.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.42 -155.73 25.6 Favored Glycine 0 N--CA 1.406 -3.323 0 N-CA-C 106.179 -2.768 . . . . 0.0 106.179 172.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.35 129.42 21.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.24 9.11 52.19 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.269 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -114.43 138.49 50.51 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.6 p -138.38 14.15 2.79 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.27 0.557 . . . . 0.0 112.478 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.91 -132.72 7.2 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -69.98 94.02 0.55 Allowed 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.01 2.473 . . . . 0.0 112.307 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.6 p -86.98 -13.96 43.06 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.49 0.662 . . . . 0.0 111.026 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.66 133.11 31.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.106 177.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.62 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.5 m -92.75 168.82 10.94 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.059 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.28 156.44 39.26 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.878 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 m -60.89 121.19 11.73 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.317 0.58 . . . . 0.0 110.738 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.32 -15.5 42.68 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 68.8 p -107.15 145.07 32.98 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 p -110.95 135.2 51.83 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 123.555 0.535 . . . . 0.0 110.572 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 47.9 t -80.11 108.01 13.36 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -110.28 117.76 34.5 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.649 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.1 t -77.78 96.09 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.3 mt -79.93 -36.57 36.13 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.316 1.055 . . . . 0.0 109.661 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.401 HD21 ' HB3' ' A' ' 32' ' ' TYR . 23.0 m-80 -135.8 162.4 57.14 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -60.39 -32.18 93.6 Favored 'Trans proline' 0 C--O 1.223 -0.26 0 CA-C-N 121.22 1.471 . . . . 0.0 112.966 -174.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -105.58 -24.02 12.66 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 120.975 0.417 . . . . 0.0 110.383 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.401 ' HB3' HD21 ' A' ' 29' ' ' ASN . 71.4 t80 -103.24 113.82 27.61 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.613 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.2 m -124.31 134.7 53.12 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -122.08 150.19 42.49 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.977 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.8 m -91.43 105.84 18.06 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.294 -1.835 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.493 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 . . . . . 0 N--CA 1.431 -1.397 0 CA-C-O 121.173 0.511 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 p -74.75 167.86 20.99 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 124.378 1.071 . . . . 0.0 112.068 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -65.3 130.98 45.3 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 77.16 9.16 2.73 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.196 1.398 . . . . 0.0 112.36 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.29 169.21 26.16 Favored Glycine 0 N--CA 1.431 -1.659 0 C-N-CA 119.85 -1.167 . . . . 0.0 110.449 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.3 tt0 -86.85 109.46 19.31 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 116.911 0.355 . . . . 0.0 110.368 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.564 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -71.45 -34.82 70.57 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-O 121.578 0.704 . . . . 0.0 109.57 174.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.32 133.75 4.44 Favored Glycine 0 N--CA 1.396 -3.976 0 C-N-CA 118.16 -1.972 . . . . 0.0 115.146 174.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.37 -156.26 23.59 Favored Glycine 0 N--CA 1.401 -3.671 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 173.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -56.97 131.7 20.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.92 -11.19 62.39 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.421 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -113.73 117.2 30.85 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 p -126.53 19.63 7.36 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.02 -128.49 1.88 Allowed Glycine 0 C--O 1.243 0.715 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -65.61 79.41 0.25 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.18 2.586 . . . . 0.0 112.867 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -85.3 -18.01 35.18 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.85 0.833 . . . . 0.0 109.907 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.92 129.4 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.3 m -91.66 168.47 11.46 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 120.762 0.315 . . . . 0.0 110.469 -178.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.79 145.46 52.48 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.2 t -52.26 124.66 13.73 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 123.716 0.635 . . . . 0.0 110.507 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.06 -26.66 16.48 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.858 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.2 p -97.61 140.73 31.59 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.994 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.4 p -100.52 133.8 44.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.278 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.446 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.2 t -81.01 107.01 13.46 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -108.77 116.98 33.01 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.8 t -75.02 103.26 2.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.0 mt -86.5 -48.07 8.71 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.666 -174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -118.58 165.02 17.76 Favored Pre-proline 0 C--N 1.288 -2.099 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -60.97 -29.4 87.92 Favored 'Trans proline' 0 C--O 1.218 -0.476 0 CA-C-N 121.421 1.543 . . . . 0.0 111.646 -175.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -105.7 -23.93 12.64 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.964 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -103.1 113.97 27.88 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.16 0.505 . . . . 0.0 111.16 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.1 m -125.11 137.97 54.17 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 176.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -122.98 149.07 44.78 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.948 -175.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.564 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.2 m -89.36 106.07 18.21 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.297 -1.715 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.32 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 . . . . . 0 N--CA 1.436 -1.162 0 CA-C-O 120.999 0.428 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -70.3 165.64 21.88 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.374 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.404 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 16.2 t-160 -66.07 131.13 45.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 75.94 8.88 3.49 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.126 1.37 . . . . 0.0 111.631 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.68 170.76 31.18 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.0 tt0 -88.71 106.81 18.59 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.602 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.9 p -65.38 -40.97 94.16 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-O 121.594 0.711 . . . . 0.0 109.44 174.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.2 119.91 2.35 Favored Glycine 1 N--CA 1.396 -4.032 0 C-N-CA 118.449 -1.834 . . . . 0.0 114.667 174.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.95 -156.76 33.04 Favored Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 106.39 -2.684 . . . . 0.0 106.39 170.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -58.06 132.81 22.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 117.244 0.522 . . . . 0.0 109.908 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.21 -17.62 55.51 Favored Glycine 0 C--O 1.245 0.798 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.462 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -93.43 127.81 39.22 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.6 p -129.29 15.35 6.14 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.037 0.446 . . . . 0.0 111.465 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.61 -137.57 5.47 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.76 91.54 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.915 2.41 . . . . 0.0 111.351 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 2.4 p -89.67 0.24 57.09 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.73 0.776 . . . . 0.0 111.293 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -106.45 128.81 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.5 m -79.82 155.74 27.72 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.515 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.5 159.43 18.59 Favored 'General case' 0 C--O 1.254 1.297 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.883 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 m -49.86 118.24 2.75 Favored 'General case' 0 C--O 1.247 0.933 0 C-N-CA 124.041 0.936 . . . . 0.0 112.157 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.32 -12.1 43.75 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.52 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 75.6 p -110.51 153.51 24.98 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 117.59 0.695 . . . . 0.0 111.846 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.9 p -112.02 139.88 47.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.35 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.404 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.8 t -84.41 107.06 16.46 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.496 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 75.6 mt-30 -103.67 115.01 29.7 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.1 t -81.35 101.28 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.51 HD11 ' CE1' ' A' ' 32' ' ' TYR . 86.2 mt -80.03 -52.31 7.98 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.822 0.82 . . . . 0.0 109.37 -176.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -118.94 167.7 11.28 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.72 -32.52 86.56 Favored 'Trans proline' 0 C--N 1.347 0.489 0 CA-C-N 120.92 1.364 . . . . 0.0 112.384 -176.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -105.66 -23.55 12.73 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 120.777 0.322 . . . . 0.0 110.76 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.51 ' CE1' HD11 ' A' ' 28' ' ' LEU . 63.3 t80 -101.51 114.21 28.02 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.546 0.689 . . . . 0.0 110.801 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.7 m -129.37 143.74 50.96 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -130.97 148.93 52.79 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.512 -174.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 81.7 m -88.86 106.67 18.54 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.876 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.496 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.8 mm? . . . . . 0 C--N 1.298 -1.653 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 . . . . . 0 N--CA 1.445 -0.688 0 CA-C-O 121.372 0.606 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 p -75.31 176.26 7.59 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.193 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -63.51 134.1 55.0 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.831 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 73.91 9.22 4.77 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 124.58 1.152 . . . . 0.0 112.503 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.97 170.16 31.62 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.4 tt0 -90.81 105.79 18.07 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 122.439 0.296 . . . . 0.0 110.548 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.2 p -64.7 -56.76 11.69 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 170.61 106.46 0.19 Allowed Glycine 0 N--CA 1.407 -3.269 0 C-N-CA 117.958 -2.068 . . . . 0.0 113.34 -175.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.21 -165.07 20.34 Favored Glycine 0 N--CA 1.417 -2.606 0 N-CA-C 105.963 -2.855 . . . . 0.0 105.963 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.4 mt -65.11 112.66 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 118.22 1.01 . . . . 0.0 110.337 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.5 -9.09 28.39 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.026 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.43 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 2.8 t80 -113.52 113.22 24.82 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.8 p -125.46 14.77 8.24 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.124 0.487 . . . . 0.0 112.095 -176.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.65 -124.18 0.7 Allowed Glycine 0 C--N 1.318 -0.452 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -66.19 80.98 0.29 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.59 2.86 . . . . 0.0 111.812 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.2 p -84.04 -12.53 55.02 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-O 121.892 0.854 . . . . 0.0 111.182 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.9 132.87 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.614 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.8 m -90.75 163.14 14.58 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.395 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.43 141.43 54.67 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.585 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -53.68 114.58 1.6 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 123.748 0.819 . . . . 0.0 110.732 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.15 -9.95 29.09 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.595 -0.73 . . . . 0.0 113.06 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.7 p -111.52 135.64 51.81 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.1 p -96.17 132.77 41.25 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.736 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.576 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.0 t -77.01 113.06 14.31 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -114.73 116.95 29.48 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.5 t -79.72 103.15 6.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.3 mt -81.75 -48.44 11.64 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.142 0.972 . . . . 0.0 109.472 -173.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -122.44 167.24 14.63 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 103.734 -2.691 . . . . 0.0 103.734 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.37 -34.69 53.83 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 CA-C-N 121.18 1.457 . . . . 0.0 111.94 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -100.51 -24.81 14.38 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.699 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -104.0 114.39 28.6 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.9 m -118.88 153.32 34.74 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 174.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -140.33 148.24 41.05 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 118.798 0.726 . . . . 0.0 110.55 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.42 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.3 m -91.81 106.62 18.61 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.385 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 . . . . . 0 N--CA 1.424 -1.754 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 p -72.62 166.67 22.29 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 123.558 0.743 . . . . 0.0 111.29 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.402 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 15.0 t-160 -63.03 132.93 53.63 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 76.56 9.39 3.03 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.74 1.216 . . . . 0.0 112.462 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.2 170.63 28.94 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.6 tt0 -85.8 114.1 22.48 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.878 0.339 . . . . 0.0 110.337 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.643 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.4 p -71.47 -54.29 11.11 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 123.618 0.574 . . . . 0.0 110.3 176.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.5 122.46 0.83 Allowed Glycine 1 N--CA 1.396 -4.029 0 C-N-CA 118.228 -1.939 . . . . 0.0 113.902 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.13 -157.71 19.53 Favored Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 105.572 -3.011 . . . . 0.0 105.572 173.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.13 126.03 20.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 118.009 0.904 . . . . 0.0 108.92 175.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.6 -17.13 39.92 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.582 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -89.41 127.41 35.82 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -124.18 -3.43 8.01 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.37 -135.24 2.16 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.1 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.35 92.62 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.373 2.715 . . . . 0.0 113.348 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.5 p -91.72 -5.97 52.74 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.284 0.564 . . . . 0.0 111.624 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.8 t -96.18 130.11 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.9 m -87.56 161.72 17.59 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.182 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.14 153.03 5.43 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 124.206 1.002 . . . . 0.0 110.684 176.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.2 m -51.23 111.19 0.53 Allowed 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 123.936 0.895 . . . . 0.0 111.741 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.49 -14.95 57.76 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.247 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 70.4 p -92.74 139.76 30.22 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.0 p -101.97 136.83 41.13 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -176.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.422 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.6 t -80.89 117.63 21.69 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -116.96 117.93 31.02 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.67 96.29 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.2 mt -76.76 -38.98 53.16 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.094 -175.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -131.27 160.56 66.55 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -59.62 -27.63 85.43 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 121.548 1.499 . . . . 0.0 111.332 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -106.55 -24.38 12.2 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.453 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -103.32 114.37 28.59 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.051 -0.659 . . . . 0.0 110.463 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.7 m -127.76 136.06 50.99 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -123.03 149.93 43.71 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.388 -173.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.569 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 79.2 m -90.05 106.79 18.71 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.578 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.298 -1.638 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.507 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.439 -0.997 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -86.45 123.65 31.91 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 118.514 0.597 . . . . 0.0 111.073 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.7 p -65.65 163.27 16.68 Favored 'General case' 0 C--O 1.254 1.34 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.375 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -60.59 130.71 47.89 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.297 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 75.61 9.13 3.64 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.232 1.413 . . . . 0.0 112.331 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.95 172.05 32.0 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.471 HE21 ' HA2' ' A' ' 9' ' ' GLY . 48.8 tt0 -86.47 103.78 15.33 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.873 0.336 . . . . 0.0 110.702 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 3.6 p -67.12 -28.17 67.93 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.841 0.829 . . . . 0.0 109.428 174.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.471 ' HA2' HE21 ' A' ' 7' ' ' GLN . . . 108.98 134.22 7.04 Favored Glycine 0 N--CA 1.396 -3.991 0 C-N-CA 118.85 -1.643 . . . . 0.0 115.254 172.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.99 -155.94 29.04 Favored Glycine 0 N--CA 1.403 -3.506 0 N-CA-C 107.614 -2.195 . . . . 0.0 107.614 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.7 mt -57.11 128.03 17.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.71 -19.02 36.75 Favored Glycine 0 C--N 1.311 -0.844 0 C-N-CA 120.044 -1.074 . . . . 0.0 112.644 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.432 ' CG ' ' HA3' ' A' ' 9' ' ' GLY . 9.3 t80 -90.88 125.45 35.75 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -118.63 2.99 11.75 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -174.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.03 -128.68 5.97 Favored Glycine 0 C--N 1.311 -0.835 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.976 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -64.67 85.67 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.572 2.848 . . . . 0.0 113.027 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -90.12 -7.55 53.47 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 122.042 0.925 . . . . 0.0 109.72 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.14 131.28 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.2 m -92.85 158.05 16.06 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.086 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.52 141.19 32.08 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 123.801 0.688 . . . . 0.0 109.75 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 m -51.31 117.92 2.92 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.628 0.771 . . . . 0.0 111.859 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.92 -18.15 26.72 Favored Glycine 0 N--CA 1.431 -1.689 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.231 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.2 p -102.57 144.68 30.67 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.0 p -100.94 132.7 46.23 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.2 t -79.49 106.47 11.55 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.407 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.6 mt-30 -106.08 114.79 29.14 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.664 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.9 t -78.93 96.3 2.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.437 HD11 ' CE2' ' A' ' 32' ' ' TYR . 80.9 mt -77.15 -52.12 9.82 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.947 -175.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -115.79 162.31 26.05 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.57 -24.44 78.01 Favored 'Trans proline' 0 C--O 1.212 -0.791 0 CA-C-N 121.375 1.527 . . . . 0.0 112.099 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -108.87 -23.38 11.76 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.752 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.437 ' CE2' HD11 ' A' ' 28' ' ' LEU . 69.3 t80 -103.01 114.09 28.1 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.167 0.508 . . . . 0.0 111.457 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -126.88 134.26 50.53 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -120.24 151.25 39.43 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -176.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.1 m -92.76 106.17 18.19 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.407 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.9 mm? . . . . . 0 C--N 1.297 -1.681 0 CA-C-O 118.462 -0.78 . . . . 0.0 109.233 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 N--CA 1.442 -0.874 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -90.62 128.03 36.47 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.356 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 t -73.47 177.09 5.51 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-O 121.809 0.814 . . . . 0.0 110.947 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -64.12 131.8 48.55 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.374 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 76.06 9.79 3.25 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.916 1.286 . . . . 0.0 113.386 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.3 168.0 25.3 Favored Glycine 0 C--N 1.312 -0.786 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.565 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.0 tt0 -81.54 112.72 19.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 117.026 0.413 . . . . 0.0 110.353 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.646 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.3 p -72.87 -58.07 3.6 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.783 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.71 109.42 0.22 Allowed Glycine 0 N--CA 1.396 -3.98 0 C-N-CA 118.134 -1.984 . . . . 0.0 113.363 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.56 -157.53 17.31 Favored Glycine 0 N--CA 1.405 -3.406 0 N-CA-C 105.974 -2.851 . . . . 0.0 105.974 171.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.418 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 77.2 mt -65.67 126.1 24.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 117.665 0.732 . . . . 0.0 109.604 174.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.96 -13.16 60.69 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.907 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -90.37 111.96 23.38 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.8 p -109.98 6.83 23.44 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.97 -136.97 9.29 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.872 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -64.13 88.29 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.682 2.922 . . . . 0.0 112.996 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 24.4 p -84.21 -16.09 44.59 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.787 0.803 . . . . 0.0 110.5 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.3 t -82.4 129.84 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.74 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.0 m -88.18 168.92 12.34 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.002 0.43 . . . . 0.0 110.954 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.62 155.04 16.33 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.758 0.823 . . . . 0.0 110.709 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -64.52 111.53 2.74 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.245 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.51 6.47 27.08 Favored Glycine 0 N--CA 1.432 -1.578 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.056 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.7 p -125.1 152.19 44.71 Favored 'General case' 0 C--O 1.244 0.788 0 O-C-N 122.411 -0.464 . . . . 0.0 110.394 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.1 p -115.23 139.85 49.6 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.881 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.3 t -83.92 110.12 18.15 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -110.68 114.91 28.66 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -79.56 98.2 2.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.117 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.1 mt -78.52 -43.86 25.78 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.48 -174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -126.73 160.46 58.6 Favored Pre-proline 0 C--N 1.289 -2.033 0 N-CA-C 103.655 -2.72 . . . . 0.0 103.655 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.41 -29.43 84.37 Favored 'Trans proline' 0 C--O 1.225 -0.153 0 C-N-CA 121.752 1.635 . . . . 0.0 112.005 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 53.6 m-85 -104.36 -25.5 12.82 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.851 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -104.28 113.56 27.2 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 119.551 -0.859 . . . . 0.0 110.434 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 13.7 m -125.53 135.74 52.59 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 177.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -121.35 147.61 45.47 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.411 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.7 m -87.62 106.64 18.16 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.29 -2.003 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.98 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.439 -1.014 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -93.57 117.91 30.69 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 121.796 -0.565 . . . . 0.0 110.451 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 m -69.15 169.11 12.61 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.555 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.425 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 17.7 t-160 -59.62 132.25 53.39 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.509 0.723 . . . . 0.0 109.27 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 77.4 8.87 2.66 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.564 1.546 . . . . 0.0 112.247 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.87 169.0 29.33 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.0 tt0 -88.31 103.77 16.12 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.62 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.5 p -62.51 -47.86 82.09 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.246 0.546 . . . . 0.0 111.68 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.07 117.18 0.77 Allowed Glycine 0 N--CA 1.397 -3.904 0 C-N-CA 118.189 -1.958 . . . . 0.0 113.773 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.56 -157.39 18.78 Favored Glycine 0 N--CA 1.413 -2.873 0 N-CA-C 106.376 -2.69 . . . . 0.0 106.376 172.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.84 121.68 14.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 117.963 0.881 . . . . 0.0 109.597 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.96 -9.17 46.72 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.386 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -113.79 112.01 22.71 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.0 p -120.98 14.99 11.6 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 120.866 0.365 . . . . 0.0 111.877 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.41 -126.49 0.97 Allowed Glycine 0 C--O 1.241 0.588 0 C-N-CA 121.261 -0.495 . . . . 0.0 111.878 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.2 79.95 0.56 Allowed 'Trans proline' 0 C--O 1.217 -0.547 0 C-N-CA 122.939 2.426 . . . . 0.0 112.01 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 23.0 p -83.45 2.18 37.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 122.269 1.033 . . . . 0.0 110.787 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.2 t -101.42 131.86 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.62 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.8 m -90.31 162.08 15.34 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 123.358 0.411 . . . . 0.0 110.591 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.75 144.64 37.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.841 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.1 p -56.17 118.2 4.48 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 124.069 0.856 . . . . 0.0 111.416 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.03 -3.19 28.56 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.983 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.2 p -120.51 166.15 14.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 117.388 0.594 . . . . 0.0 110.281 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 34.4 p -120.89 146.04 47.02 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 122.202 0.201 . . . . 0.0 111.152 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.5 t -90.08 111.54 22.69 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -111.81 114.82 28.03 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -76.96 99.85 2.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 mt -82.53 -53.98 5.54 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.298 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -110.29 165.57 12.43 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.27 -26.23 64.2 Favored 'Trans proline' 0 C--O 1.221 -0.35 0 CA-C-N 121.445 1.552 . . . . 0.0 111.14 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -106.53 -25.29 11.9 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.432 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -103.62 113.26 26.64 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.631 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.4 m -123.54 139.31 54.14 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 176.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -127.61 150.57 49.67 Favored 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.597 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.7 m -90.01 106.42 18.46 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.299 -1.588 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.433 -1.302 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -78.68 123.9 27.63 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.246 0.546 . . . . 0.0 111.7 -170.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -74.22 171.95 12.67 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.459 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -62.32 132.86 54.05 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.365 0.666 . . . . 0.0 109.719 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 74.74 8.99 4.21 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.282 1.433 . . . . 0.0 112.406 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.25 169.56 33.36 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -89.09 105.61 17.9 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 117.134 0.467 . . . . 0.0 110.792 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.592 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 2.5 p -67.26 -31.5 71.87 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 121.587 0.708 . . . . 0.0 109.934 175.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.53 131.35 5.13 Favored Glycine 0 N--CA 1.396 -3.987 0 C-N-CA 118.922 -1.608 . . . . 0.0 115.866 172.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.6 -156.06 25.47 Favored Glycine 0 N--CA 1.408 -3.225 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.2 mt -56.31 127.4 15.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.17 -23.36 29.09 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.055 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -89.04 130.94 35.41 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.2 p -137.86 14.91 2.89 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.656 0.741 . . . . 0.0 111.234 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.8 -130.23 5.3 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.41 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.45 84.26 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.314 2.676 . . . . 0.0 112.267 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.3 p -88.25 2.32 52.59 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 122.252 1.025 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -105.88 127.25 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.592 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.9 m -87.76 153.02 21.68 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.84 154.4 15.09 Favored 'General case' 0 C--O 1.252 1.216 0 O-C-N 123.596 0.56 . . . . 0.0 111.236 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.2 m -49.4 116.39 1.71 Allowed 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.556 1.142 . . . . 0.0 112.035 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.89 -1.8 48.28 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.557 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.5 p -117.7 145.67 44.26 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 117.649 0.725 . . . . 0.0 110.212 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.5 p -106.25 138.64 42.07 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -79.4 113.81 17.83 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.415 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.6 mt-30 -113.73 114.76 26.81 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.49 100.14 2.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.3 mt -79.26 -53.2 7.18 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -175.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -116.85 160.3 37.32 Favored Pre-proline 0 C--N 1.29 -1.995 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.27 -29.89 91.48 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 121.484 1.456 . . . . 0.0 113.261 -174.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -106.58 -23.81 12.35 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 120.959 0.409 . . . . 0.0 110.488 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -103.12 113.49 27.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.217 0.532 . . . . 0.0 111.352 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.7 m -124.99 142.74 51.29 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -129.84 149.14 51.71 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.238 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 67.5 m -88.67 107.63 19.03 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.939 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.415 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.8 mm? . . . . . 0 C--N 1.303 -1.419 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.438 -1.072 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -80.15 135.63 36.34 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.555 -175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -81.77 169.85 16.42 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 124.088 0.955 . . . . 0.0 111.877 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -64.63 131.57 47.33 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 75.61 9.51 3.57 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.718 1.207 . . . . 0.0 112.741 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.03 167.57 26.7 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.429 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.9 tt0 -84.96 116.08 23.17 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.631 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.6 p -73.56 -55.2 6.61 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 123.8 0.688 . . . . 0.0 110.973 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 161.65 108.65 0.23 Allowed Glycine 0 N--CA 1.401 -3.673 0 C-N-CA 118.114 -1.993 . . . . 0.0 114.528 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.33 -158.33 29.0 Favored Glycine 0 N--CA 1.41 -3.043 0 N-CA-C 106.36 -2.696 . . . . 0.0 106.36 171.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.487 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 72.6 mt -65.3 117.07 5.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 118.074 0.937 . . . . 0.0 110.901 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.25 -14.79 23.16 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.573 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -92.27 125.57 36.99 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.6 p -119.76 -6.39 10.12 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.42 -131.2 1.81 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.762 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.53 79.98 0.1 Allowed 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 123.963 3.109 . . . . 0.0 112.669 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 5.2 p -85.35 -5.94 59.27 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.86 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.0 t -99.43 131.96 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.631 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 82.6 m -92.54 146.95 23.28 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 123.364 0.415 . . . . 0.0 110.092 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.53 154.05 6.95 Favored 'General case' 0 C--O 1.251 1.17 0 O-C-N 124.007 0.817 . . . . 0.0 110.865 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 m -50.82 126.86 16.97 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.865 0.866 . . . . 0.0 111.417 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.93 -16.54 57.29 Favored Glycine 0 N--CA 1.432 -1.585 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.565 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.8 p -110.22 142.41 41.83 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.432 0.616 . . . . 0.0 110.289 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.3 p -109.29 133.6 52.83 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.6 t -75.31 107.15 7.22 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -109.37 114.73 28.65 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.3 t -78.55 96.63 2.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.0 mt -75.7 -51.5 12.59 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.371 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -120.34 166.99 13.66 Favored Pre-proline 0 C--N 1.284 -2.258 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.57 -33.5 86.98 Favored 'Trans proline' 0 C--N 1.343 0.261 0 CA-C-N 121.399 1.535 . . . . 0.0 112.323 -175.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.487 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 21.9 m-85 -104.94 -23.78 12.93 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.44 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -102.23 113.5 26.85 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.376 0.607 . . . . 0.0 110.761 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.0 m -127.0 137.46 53.1 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -128.37 150.78 49.95 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.304 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 67.1 m -90.15 105.68 17.97 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.294 -1.833 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.945 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.444 -0.747 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -81.79 128.07 33.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.195 0.522 . . . . 0.0 111.721 -172.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 p -70.39 169.81 13.19 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.004 0.922 . . . . 0.0 112.907 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -61.74 129.5 41.33 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.904 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 76.75 9.25 2.94 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.766 1.226 . . . . 0.0 112.765 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.05 164.21 28.46 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.3 tt0 -83.49 107.47 15.99 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.574 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.6 p -67.27 -51.04 57.82 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-O 121.183 0.516 . . . . 0.0 111.421 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.59 118.69 0.71 Allowed Glycine 0 N--CA 1.399 -3.794 0 C-N-CA 118.266 -1.921 . . . . 0.0 113.651 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.12 -158.09 18.34 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 105.691 -2.964 . . . . 0.0 105.691 171.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.63 119.97 15.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 117.919 0.86 . . . . 0.0 109.042 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.38 -6.27 28.39 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.014 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -113.9 132.27 55.98 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 p -141.33 20.82 2.23 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.88 -121.6 3.33 Favored Glycine 0 C--O 1.241 0.54 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -67.75 78.81 0.52 Allowed 'Trans proline' 0 N--CA 1.476 0.494 0 C-N-CA 123.697 2.931 . . . . 0.0 111.96 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.5 p -82.3 -16.66 48.57 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.55 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.8 t -89.14 133.0 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.495 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.1 m -87.39 159.1 18.84 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.12 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.63 160.61 8.89 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.931 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 m -62.82 128.9 38.07 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.625 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.17 5.41 59.43 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.492 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.4 p -128.55 164.88 21.85 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 117.33 0.565 . . . . 0.0 109.885 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.3 p -130.94 138.64 49.83 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 122.182 0.193 . . . . 0.0 110.845 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.459 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.2 t -78.23 114.38 17.06 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.559 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 40.4 mt-30 -115.94 115.81 26.84 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.922 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.1 t -77.7 99.79 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.2 mt -78.31 -50.6 11.5 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 122.042 0.925 . . . . 0.0 108.843 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -120.26 161.75 37.33 Favored Pre-proline 0 C--N 1.289 -2.057 0 N-CA-C 103.941 -2.615 . . . . 0.0 103.941 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.43 -28.66 88.12 Favored 'Trans proline' 0 N--CA 1.474 0.345 0 CA-C-N 120.896 1.356 . . . . 0.0 112.093 -175.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -105.01 -25.18 12.66 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.835 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -104.01 113.04 26.29 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.562 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -125.35 140.03 53.17 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -130.95 149.43 52.58 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.921 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.574 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.4 m -87.68 106.07 17.79 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.559 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.7 mm? . . . . . 0 C--N 1.289 -2.022 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -83.14 146.15 28.82 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.518 0.675 . . . . 0.0 111.831 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 p -80.91 161.7 24.25 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 124.357 1.063 . . . . 0.0 111.426 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -62.06 131.59 50.09 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 77.69 9.68 2.37 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.717 1.207 . . . . 0.0 112.752 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.67 170.01 25.03 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.424 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.605 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.6 tt0 -81.56 109.18 15.76 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.604 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -71.44 -54.04 11.98 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 121.266 0.555 . . . . 0.0 111.353 177.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 163.12 116.47 0.38 Allowed Glycine 1 N--CA 1.394 -4.111 0 C-N-CA 118.101 -1.999 . . . . 0.0 113.835 -177.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.25 -158.2 18.19 Favored Glycine 0 N--CA 1.409 -3.149 0 N-CA-C 105.485 -3.046 . . . . 0.0 105.485 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.2 mt -66.38 121.05 14.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 117.891 0.845 . . . . 0.0 110.049 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.09 -20.06 29.08 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.295 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -80.03 129.32 34.4 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.7 p -135.4 18.53 3.37 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.56 -125.85 5.52 Favored Glycine 0 C--N 1.311 -0.807 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.513 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.79 85.78 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.242 2.628 . . . . 0.0 111.925 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 10.2 p -88.94 -8.04 54.92 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.573 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.91 137.05 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.524 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 90.6 m -87.71 163.14 16.68 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.147 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.87 153.43 10.98 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.967 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.7 m -57.71 114.57 2.34 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.506 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.53 4.43 56.04 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.814 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 81.3 p -113.83 143.82 44.04 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 117.486 0.643 . . . . 0.0 109.882 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.3 p -103.55 132.65 49.62 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.511 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 45.9 t -79.16 106.73 11.4 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -104.61 114.76 29.19 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.4 t -77.83 101.65 3.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.9 mt -81.53 -39.45 24.66 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.738 0.78 . . . . 0.0 109.503 -173.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -132.97 163.06 53.77 Favored Pre-proline 0 C--N 1.289 -2.058 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -60.88 -28.35 86.23 Favored 'Trans proline' 0 C--N 1.345 0.367 0 CA-C-N 120.986 1.388 . . . . 0.0 112.618 -175.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -108.84 -24.07 11.45 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.407 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -103.11 114.51 28.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.292 0.568 . . . . 0.0 111.442 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.3 m -124.62 146.91 48.82 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -131.44 147.19 52.53 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.079 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.3 m -89.57 106.47 18.48 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 C--N 1.297 -1.678 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.615 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -99.11 143.38 29.44 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 p -76.81 171.24 15.05 Favored 'General case' 0 C--O 1.251 1.151 0 CA-C-O 121.179 0.514 . . . . 0.0 111.952 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -63.46 129.74 41.46 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 75.19 9.43 3.84 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.62 1.568 . . . . 0.0 111.508 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.76 165.84 32.35 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -86.56 106.55 17.62 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.518 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 4.5 p -70.01 -27.09 64.4 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.834 0.825 . . . . 0.0 109.067 174.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.25 129.43 6.0 Favored Glycine 1 N--CA 1.394 -4.165 0 C-N-CA 119.245 -1.455 . . . . 0.0 115.41 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.8 -156.65 30.91 Favored Glycine 0 N--CA 1.407 -3.272 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 171.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.9 mt -59.78 125.43 15.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.54 -1.07 32.47 Favored Glycine 0 C--N 1.317 -0.525 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.386 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -113.62 119.94 39.2 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.4 p -115.81 9.52 15.1 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.76 -139.78 7.68 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.353 -0.693 . . . . 0.0 111.809 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.34 94.58 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.23 2.62 . . . . 0.0 112.083 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.0 p -92.76 -7.46 46.5 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.479 0.657 . . . . 0.0 111.378 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.5 t -100.77 135.58 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.9 m -90.71 161.8 15.19 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 120.719 0.295 . . . . 0.0 111.69 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.18 164.73 10.41 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.61 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.6 m -54.12 111.52 0.78 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 124.354 1.062 . . . . 0.0 112.764 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.07 -13.48 57.37 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.243 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 82.2 p -100.18 141.03 33.57 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 122.17 -0.606 . . . . 0.0 109.889 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.4 p -106.08 136.78 45.15 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.792 -0.186 . . . . 0.0 111.36 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.46 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.4 t -80.73 106.15 12.51 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -107.97 115.42 30.1 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.703 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.25 96.17 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.6 mt -77.55 -39.1 47.0 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.057 -173.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.4 HD21 ' HB3' ' A' ' 32' ' ' TYR . 29.7 m-80 -133.55 163.74 48.99 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -61.55 -29.31 84.35 Favored 'Trans proline' 0 C--O 1.235 0.373 0 CA-C-N 121.549 1.589 . . . . 0.0 112.941 -173.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -107.72 -23.5 12.08 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.85 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.4 ' HB3' HD21 ' A' ' 29' ' ' ASN . 70.3 t80 -103.15 113.83 27.63 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.054 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 m -125.34 141.27 52.17 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -131.75 150.38 52.17 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.018 -174.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.0 m -89.29 105.89 18.09 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.99 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--N 1.29 -1.984 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.413 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.46 ' NE2' ' HA3' ' A' ' 6' ' ' GLY . 26.0 tp60 -81.39 121.76 26.64 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.254 0.55 . . . . 0.0 111.106 -175.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 m -66.75 166.75 12.53 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.48 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -62.28 131.33 49.02 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.652 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 77.25 8.87 2.73 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.705 1.602 . . . . 0.0 112.482 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.46 ' HA3' ' NE2' ' A' ' 2' ' ' GLN . . . -91.85 170.59 33.56 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.5 tt0 -88.49 107.48 18.9 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.694 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.6 p -62.73 -56.91 13.26 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 121.016 0.436 . . . . 0.0 111.664 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.5 112.66 0.27 Allowed Glycine 0 N--CA 1.4 -3.725 0 C-N-CA 118.278 -1.915 . . . . 0.0 113.671 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.59 -167.28 20.13 Favored Glycine 0 N--CA 1.41 -3.038 0 N-CA-C 106.4 -2.68 . . . . 0.0 106.4 171.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.8 mt -59.76 111.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 117.823 0.812 . . . . 0.0 110.926 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.33 -5.02 26.69 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.753 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -98.49 127.94 44.63 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.0 p -124.59 -1.8 7.97 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.73 -135.64 2.81 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.042 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 39.5 Cg_exo -63.99 80.44 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.056 3.171 . . . . 0.0 112.386 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 9.2 p -76.8 -22.06 54.22 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.721 0.772 . . . . 0.0 110.726 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.08 129.15 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.694 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 87.6 m -87.13 161.5 18.06 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.889 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.76 157.79 14.16 Favored 'General case' 0 C--O 1.256 1.396 0 C-N-CA 123.765 0.826 . . . . 0.0 110.808 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.5 m -64.03 111.21 2.42 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.142 0.496 . . . . 0.0 110.406 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.31 0.32 33.14 Favored Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.903 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 79.2 p -116.81 139.48 50.55 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.283 -0.54 . . . . 0.0 109.605 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 24.8 p -102.04 136.04 42.57 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.056 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.5 t -81.89 109.95 16.72 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -109.89 114.6 28.28 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.41 98.88 3.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.9 mt -78.93 -53.27 7.22 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.855 0.836 . . . . 0.0 109.369 -173.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -115.77 167.04 10.86 Favored Pre-proline 0 C--N 1.283 -2.299 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -61.04 -32.14 91.72 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 CA-C-N 121.001 1.393 . . . . 0.0 112.278 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -105.68 -23.96 12.64 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.23 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -102.36 113.89 27.59 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.344 0.592 . . . . 0.0 111.477 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.6 m -124.64 153.0 42.92 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 176.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -140.83 149.4 41.96 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.536 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.539 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 68.9 m -91.67 106.07 18.2 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--N 1.3 -1.549 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.628 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.436 -1.162 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' NE2' ' HA3' ' A' ' 6' ' ' GLY . 28.2 tp60 -86.35 130.29 34.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.369 0.604 . . . . 0.0 110.93 -176.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 p -75.08 169.38 18.14 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.188 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -61.82 132.49 53.27 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.373 1.069 . . . . 0.0 109.244 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 74.52 8.84 4.38 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 125.077 1.351 . . . . 0.0 112.565 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.438 ' HA3' ' NE2' ' A' ' 2' ' ' GLN . . . -94.05 164.89 26.36 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 176.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.4 tt0 -84.58 101.13 11.88 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.6 p -63.23 -42.49 99.25 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.23 0.538 . . . . 0.0 111.053 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.59 123.61 2.08 Favored Glycine 1 N--CA 1.393 -4.199 0 C-N-CA 118.048 -2.025 . . . . 0.0 114.247 177.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.38 -157.81 17.75 Favored Glycine 0 N--CA 1.403 -3.565 0 N-CA-C 105.432 -3.067 . . . . 0.0 105.432 171.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.3 mt -62.67 130.92 27.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.88 -7.96 61.08 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.837 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -109.91 136.56 49.01 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.2 p -141.39 21.23 2.22 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.1 -126.38 5.07 Favored Glycine 0 C--N 1.307 -1.039 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.469 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -70.1 86.7 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.29 2.66 . . . . 0.0 111.537 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.9 p -82.54 -16.81 47.24 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.889 0.852 . . . . 0.0 110.917 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.78 135.36 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 67.3 m -93.07 162.17 14.14 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.62 138.97 51.52 Favored 'General case' 0 C--O 1.25 1.109 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.6 m -57.61 127.16 30.6 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.411 0.444 . . . . 0.0 110.731 -175.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.05 -16.54 27.66 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.214 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.6 p -115.91 144.89 43.43 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.8 p -103.66 136.86 42.58 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -175.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.551 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 38.4 t -81.1 107.1 13.62 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -104.42 114.51 28.79 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.554 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.0 t -80.01 100.59 4.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.5 mt -82.91 -51.33 7.71 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.254 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.49 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -112.35 161.64 25.2 Favored Pre-proline 0 C--N 1.292 -1.922 0 N-CA-C 102.102 -3.295 . . . . 0.0 102.102 174.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.02 -25.73 77.89 Favored 'Trans proline' 0 C--O 1.22 -0.412 0 CA-C-N 121.667 1.631 . . . . 0.0 111.326 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -104.26 -23.77 13.2 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.16 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -103.82 114.11 28.12 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.53 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.2 m -125.47 142.24 51.61 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -133.68 147.98 51.44 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.894 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.1 m -88.55 106.5 18.33 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.23 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.294 -1.826 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.519 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.435 -1.197 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.449 ' NE2' ' HA3' ' A' ' 6' ' ' GLY . 28.0 tp60 -89.8 129.55 36.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.242 0.544 . . . . 0.0 111.145 -174.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 p -72.96 172.82 10.25 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 124.169 0.988 . . . . 0.0 112.655 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -67.52 130.41 42.95 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 77.13 9.18 2.74 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.37 1.468 . . . . 0.0 112.351 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.449 ' HA3' ' NE2' ' A' ' 2' ' ' GLN . . . -90.95 164.31 29.87 Favored Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 175.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -82.55 104.61 12.95 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.655 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.7 p -62.53 -55.18 29.84 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-O 121.099 0.476 . . . . 0.0 111.305 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.83 112.89 0.32 Allowed Glycine 1 N--CA 1.392 -4.285 0 C-N-CA 117.685 -2.198 . . . . 0.0 114.123 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.35 -158.14 22.91 Favored Glycine 0 N--CA 1.402 -3.604 0 N-CA-C 105.313 -3.115 . . . . 0.0 105.313 170.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.24 128.89 31.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 118.044 0.922 . . . . 0.0 108.628 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.91 -8.98 50.89 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.687 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -113.66 118.03 33.21 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 p -124.54 3.05 8.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.51 -119.69 0.84 Allowed Glycine 0 C--O 1.243 0.658 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.964 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 25.2 Cg_exo -67.96 78.5 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.662 2.908 . . . . 0.0 111.836 175.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.7 p -85.83 -22.66 27.5 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.455 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.89 131.94 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.613 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -85.68 153.11 22.57 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.291 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.94 148.64 20.6 Favored 'General case' 0 C--O 1.244 0.791 0 O-C-N 123.932 0.77 . . . . 0.0 110.717 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 m -55.11 116.82 3.0 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 122.979 0.512 . . . . 0.0 111.508 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.93 -5.7 29.08 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.287 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.2 p -119.27 154.52 33.33 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.6 p -116.73 142.09 47.36 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.977 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.5 t -83.06 112.04 19.43 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.513 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.5 mt-30 -109.74 114.37 27.89 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.7 t -81.93 105.83 12.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.8 mt -83.38 -53.89 5.39 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.943 -175.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -116.21 163.29 22.2 Favored Pre-proline 0 C--N 1.296 -1.737 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -58.37 -31.86 94.88 Favored 'Trans proline' 0 C--O 1.218 -0.503 0 C-N-CA 121.279 1.319 . . . . 0.0 112.04 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -102.69 -24.12 13.78 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.865 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -103.7 114.18 28.25 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 120.934 0.397 . . . . 0.0 111.904 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.8 m -129.22 147.52 51.07 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -136.62 147.65 47.04 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.14 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.645 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.6 m -87.25 106.74 18.12 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.197 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.513 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.6 mm? . . . . . 0 C--N 1.294 -1.816 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -103.75 134.36 47.19 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 118.656 0.662 . . . . 0.0 110.157 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -73.76 166.17 23.79 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.953 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -60.41 133.81 56.46 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.74 0.816 . . . . 0.0 108.95 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 74.87 9.25 4.08 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.201 1.4 . . . . 0.0 112.04 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.17 170.43 28.81 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.175 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.7 tt0 -88.43 107.82 19.06 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.523 0.161 . . . . 0.0 110.574 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.582 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -69.08 -29.74 67.91 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 121.973 0.892 . . . . 0.0 109.024 173.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.23 126.97 4.19 Favored Glycine 1 N--CA 1.391 -4.36 0 C-N-CA 118.771 -1.681 . . . . 0.0 114.566 174.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.44 -156.25 32.13 Favored Glycine 0 N--CA 1.41 -3.037 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 171.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -58.08 129.75 20.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 117.566 0.683 . . . . 0.0 109.347 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.21 -22.34 31.38 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.687 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -103.05 112.02 24.65 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -118.58 11.41 12.86 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -175.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.23 -122.16 1.12 Allowed Glycine 0 C--O 1.245 0.804 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.849 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.8 78.65 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.051 3.167 . . . . 0.0 113.003 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.7 p -86.13 -16.81 36.78 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.081 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -90.58 133.8 31.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 86.1 m -92.97 157.55 16.27 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.388 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.13 158.9 18.62 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.784 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.5 m -55.1 121.11 8.05 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.303 0.641 . . . . 0.0 111.644 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.01 -16.96 45.67 Favored Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.427 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 59.2 p -106.88 143.11 35.44 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 122.248 -0.56 . . . . 0.0 110.976 -177.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.2 p -109.36 136.8 48.2 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.498 0.319 . . . . 0.0 111.567 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.427 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.0 t -79.93 108.68 13.7 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -113.19 117.36 31.69 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.338 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.76 106.91 7.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.2 mt -88.38 -41.73 12.64 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.193 0.997 . . . . 0.0 108.949 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.409 HD21 ' HB3' ' A' ' 32' ' ' TYR . 37.9 m-80 -127.71 161.16 56.92 Favored Pre-proline 0 C--N 1.286 -2.166 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 178.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -60.2 -31.63 93.36 Favored 'Trans proline' 0 CA--C 1.52 -0.217 0 CA-C-N 121.027 1.402 . . . . 0.0 112.051 -174.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -105.04 -23.46 12.95 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.295 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HB3' HD21 ' A' ' 29' ' ' ASN . 76.7 t80 -103.29 114.04 28.01 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.176 0.512 . . . . 0.0 111.421 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.2 m -125.57 138.82 53.96 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -124.01 149.96 45.43 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.315 -174.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.4 m -91.91 106.07 18.18 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.287 -2.134 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.638 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.5 m . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -96.46 134.84 39.15 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 118.948 0.795 . . . . 0.0 110.786 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 p -86.97 177.41 7.25 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 121.148 0.499 . . . . 0.0 111.596 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -62.92 132.41 51.99 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.048 0.539 . . . . 0.0 110.024 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 78.92 8.69 1.93 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.624 1.569 . . . . 0.0 113.218 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.47 173.54 32.67 Favored Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.877 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.0 tt0 -91.4 110.77 22.07 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.8 p -70.84 -33.28 70.5 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-O 121.76 0.79 . . . . 0.0 109.184 174.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.05 133.61 4.58 Favored Glycine 0 N--CA 1.398 -3.897 0 C-N-CA 118.469 -1.824 . . . . 0.0 115.397 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.31 -156.23 20.09 Favored Glycine 0 N--CA 1.402 -3.599 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.93 129.59 20.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.58 -6.72 55.35 Favored Glycine 0 C--N 1.307 -1.031 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.959 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -114.01 132.88 55.83 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.0 p -135.19 6.98 3.36 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.49 -123.14 2.03 Favored Glycine 0 C--O 1.246 0.865 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.273 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -65.27 79.21 0.22 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.709 2.94 . . . . 0.0 113.333 176.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.5 p -89.08 7.01 37.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 122.359 1.076 . . . . 0.0 109.384 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.9 t -106.24 116.92 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.112 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.444 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.1 m -83.44 149.69 26.51 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.14 151.25 12.63 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 123.932 0.77 . . . . 0.0 110.854 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -59.91 119.74 8.3 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.128 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.25 -9.98 28.87 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.784 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.7 p -118.49 146.18 44.71 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 122.197 -0.59 . . . . 0.0 110.491 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 34.4 p -107.08 140.94 39.1 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.135 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.447 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.0 t -85.42 107.26 17.32 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -107.89 114.64 28.73 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.49 96.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.404 HD11 ' CE1' ' A' ' 32' ' ' TYR . 87.6 mt -75.68 -53.22 8.9 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.468 0.707 . . . . 0.0 109.831 -174.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -112.06 162.66 20.28 Favored Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 172.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.67 -23.43 75.99 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 CA-C-N 120.935 1.37 . . . . 0.0 111.67 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -106.85 -24.72 11.96 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.979 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' CE1' HD11 ' A' ' 28' ' ' LEU . 74.7 t80 -103.67 113.8 27.59 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.971 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.9 m -126.68 135.35 51.04 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -124.76 150.34 46.36 Favored 'General case' 0 C--N 1.286 -2.169 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.199 -175.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 24' ' ' THR . 79.3 m -90.37 106.27 18.38 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.302 -1.494 0 CA-C-O 118.646 -0.692 . . . . 0.0 109.835 -178.867 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.437 -1.09 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -84.34 138.36 32.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.15 0.5 . . . . 0.0 111.654 -175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 p -79.56 170.85 15.96 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.857 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -62.84 134.88 56.92 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.116 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 74.16 9.31 4.58 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.28 1.432 . . . . 0.0 112.3 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.78 170.65 30.94 Favored Glycine 0 N--CA 1.431 -1.653 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.398 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.1 tt0 -87.18 107.25 18.39 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.5 p -68.26 -51.46 44.9 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 121.195 0.521 . . . . 0.0 110.814 177.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.48 121.2 0.69 Allowed Glycine 1 N--CA 1.393 -4.184 0 C-N-CA 118.203 -1.951 . . . . 0.0 114.061 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.9 -157.26 19.66 Favored Glycine 0 N--CA 1.408 -3.171 0 N-CA-C 106.183 -2.767 . . . . 0.0 106.183 171.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.5 mt -62.48 129.63 25.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 117.812 0.806 . . . . 0.0 108.938 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.53 -20.34 44.73 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.932 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -95.25 124.86 39.51 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.1 p -128.47 9.67 6.08 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.67 -124.06 3.75 Favored Glycine 0 C--O 1.248 0.993 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.945 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.95 75.44 0.43 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 124.054 3.169 . . . . 0.0 112.418 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.1 p -80.36 -11.87 59.65 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.99 0.9 . . . . 0.0 110.598 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.7 t -90.2 133.05 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.563 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.9 m -93.09 160.09 15.01 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 123.332 0.395 . . . . 0.0 110.503 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.67 147.13 28.47 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.259 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 m -53.39 117.01 2.75 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.581 0.752 . . . . 0.0 111.346 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.7 -8.15 34.17 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.234 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.3 p -113.59 146.87 39.04 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.228 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 32.6 p -106.58 137.24 44.94 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.557 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.487 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.7 t -83.8 113.08 20.67 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -116.59 116.05 26.87 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.261 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.38 99.44 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.7 mt -81.71 -48.05 12.17 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.667 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -122.24 166.84 15.63 Favored Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.16 -32.69 82.97 Favored 'Trans proline' 0 C--N 1.346 0.415 0 CA-C-N 121.495 1.57 . . . . 0.0 112.729 -175.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -105.62 -23.31 12.79 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.294 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -102.24 113.81 27.42 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.462 0.649 . . . . 0.0 111.412 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -126.49 140.7 52.26 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 177.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -128.43 147.33 50.65 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.769 -0.773 . . . . 0.0 110.535 -174.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 65.7 m -89.02 106.51 18.48 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.412 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.293 -1.869 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.646 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 N--CA 1.442 -0.843 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -74.89 130.1 38.82 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.132 0.491 . . . . 0.0 110.582 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -64.1 165.76 8.68 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 124.307 1.043 . . . . 0.0 111.985 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -61.58 131.01 48.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 74.76 9.27 4.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.93 1.292 . . . . 0.0 112.833 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.64 169.35 32.62 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -88.05 103.33 15.61 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.649 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.6 p -64.37 -26.06 68.3 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 121.806 0.813 . . . . 0.0 109.228 175.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.31 132.46 7.62 Favored Glycine 1 N--CA 1.39 -4.403 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.697 172.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.75 -155.84 29.97 Favored Glycine 0 N--CA 1.403 -3.508 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 172.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.41 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 66.0 mt -57.32 123.44 8.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.39 -12.14 26.01 Favored Glycine 0 C--N 1.302 -1.317 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.872 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -109.83 114.34 27.82 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 p -110.49 0.23 17.67 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.83 -134.67 1.5 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.732 -0.482 . . . . 0.0 112.869 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -63.55 79.19 0.14 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 123.401 2.734 . . . . 0.0 113.65 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 9.6 p -80.49 -14.28 58.4 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.202 1.001 . . . . 0.0 109.905 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.0 t -92.66 128.73 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.8 m -87.34 167.24 14.23 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.445 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.38 152.88 44.4 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.846 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.9 m -58.48 123.44 16.22 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.813 0.339 . . . . 0.0 110.561 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.09 -7.77 29.09 Favored Glycine 0 N--CA 1.433 -1.561 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.975 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.1 p -123.06 154.45 38.52 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.7 p -117.02 135.74 53.47 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.473 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.0 t -78.52 114.82 17.78 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -116.12 114.94 25.19 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.75 96.36 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 mt -78.31 -38.9 41.24 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.773 -173.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -134.46 167.85 20.75 Favored Pre-proline 0 C--N 1.291 -1.954 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -64.23 -32.96 61.7 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 CA-C-N 121.306 1.502 . . . . 0.0 112.435 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.41 ' HD1' ' O ' ' A' ' 11' ' ' ILE . 42.8 m-85 -106.5 -24.4 12.21 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.762 -176.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -102.02 117.42 34.76 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.43 0.633 . . . . 0.0 110.885 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.8 m -134.2 140.74 46.72 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -127.1 152.41 47.35 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.215 -173.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.649 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 84.6 m -92.55 106.36 18.36 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.292 -1.926 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.459 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.429 -1.494 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -81.76 147.43 29.44 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.358 0.599 . . . . 0.0 112.158 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 p -88.88 177.84 6.59 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 124.664 1.185 . . . . 0.0 110.855 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -72.06 133.8 45.46 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 74.76 9.43 4.13 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.439 1.096 . . . . 0.0 112.702 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.0 170.12 31.54 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -90.9 113.19 25.33 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.936 0.368 . . . . 0.0 110.056 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.62 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.8 p -72.56 -33.7 66.99 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.758 0.79 . . . . 0.0 109.166 174.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.6 130.38 4.03 Favored Glycine 0 N--CA 1.398 -3.859 0 C-N-CA 118.58 -1.771 . . . . 0.0 115.311 174.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.42 -155.73 25.6 Favored Glycine 0 N--CA 1.406 -3.323 0 N-CA-C 106.179 -2.768 . . . . 0.0 106.179 172.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.35 129.42 21.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.24 9.11 52.19 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.269 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -114.43 138.49 50.51 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.6 p -138.38 14.15 2.79 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.27 0.557 . . . . 0.0 112.478 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.91 -132.72 7.2 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -69.98 94.02 0.55 Allowed 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.01 2.473 . . . . 0.0 112.307 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.6 p -86.98 -13.96 43.06 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.49 0.662 . . . . 0.0 111.026 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.66 133.11 31.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.106 177.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.62 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.5 m -92.75 168.82 10.94 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.059 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.28 156.44 39.26 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.878 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 m -60.89 121.19 11.73 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.317 0.58 . . . . 0.0 110.738 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.32 -15.5 42.68 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 68.8 p -107.15 145.07 32.98 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 p -110.95 135.2 51.83 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 123.555 0.535 . . . . 0.0 110.572 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 47.9 t -80.11 108.01 13.36 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -110.28 117.76 34.5 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.649 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.1 t -77.78 96.09 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.3 mt -79.93 -36.57 36.13 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.316 1.055 . . . . 0.0 109.661 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.401 HD21 ' HB3' ' A' ' 32' ' ' TYR . 23.0 m-80 -135.8 162.4 57.14 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -60.39 -32.18 93.6 Favored 'Trans proline' 0 C--O 1.223 -0.26 0 CA-C-N 121.22 1.471 . . . . 0.0 112.966 -174.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -105.58 -24.02 12.66 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 120.975 0.417 . . . . 0.0 110.383 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.401 ' HB3' HD21 ' A' ' 29' ' ' ASN . 71.4 t80 -103.24 113.82 27.61 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.613 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.2 m -124.31 134.7 53.12 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -122.08 150.19 42.49 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.977 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.8 m -91.43 105.84 18.06 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.294 -1.835 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.493 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.446 -0.625 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -88.98 139.31 30.58 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.173 0.511 . . . . 0.0 110.559 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 p -74.75 167.86 20.99 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 124.378 1.071 . . . . 0.0 112.068 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -65.3 130.98 45.3 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 77.16 9.16 2.73 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.196 1.398 . . . . 0.0 112.36 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.29 169.21 26.16 Favored Glycine 0 N--CA 1.431 -1.659 0 C-N-CA 119.85 -1.167 . . . . 0.0 110.449 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.3 tt0 -86.85 109.46 19.31 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 116.911 0.355 . . . . 0.0 110.368 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.564 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -71.45 -34.82 70.57 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-O 121.578 0.704 . . . . 0.0 109.57 174.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.32 133.75 4.44 Favored Glycine 0 N--CA 1.396 -3.976 0 C-N-CA 118.16 -1.972 . . . . 0.0 115.146 174.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.37 -156.26 23.59 Favored Glycine 0 N--CA 1.401 -3.671 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 173.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -56.97 131.7 20.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.92 -11.19 62.39 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.421 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -113.73 117.2 30.85 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 p -126.53 19.63 7.36 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.02 -128.49 1.88 Allowed Glycine 0 C--O 1.243 0.715 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -65.61 79.41 0.25 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.18 2.586 . . . . 0.0 112.867 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -85.3 -18.01 35.18 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.85 0.833 . . . . 0.0 109.907 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.92 129.4 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.3 m -91.66 168.47 11.46 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 120.762 0.315 . . . . 0.0 110.469 -178.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.79 145.46 52.48 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.2 t -52.26 124.66 13.73 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 123.716 0.635 . . . . 0.0 110.507 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.06 -26.66 16.48 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.858 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.2 p -97.61 140.73 31.59 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.994 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.4 p -100.52 133.8 44.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.278 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.446 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.2 t -81.01 107.01 13.46 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -108.77 116.98 33.01 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.8 t -75.02 103.26 2.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.0 mt -86.5 -48.07 8.71 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.666 -174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -118.58 165.02 17.76 Favored Pre-proline 0 C--N 1.288 -2.099 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -60.97 -29.4 87.92 Favored 'Trans proline' 0 C--O 1.218 -0.476 0 CA-C-N 121.421 1.543 . . . . 0.0 111.646 -175.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -105.7 -23.93 12.64 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.964 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -103.1 113.97 27.88 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.16 0.505 . . . . 0.0 111.16 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.1 m -125.11 137.97 54.17 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 176.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -122.98 149.07 44.78 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.948 -175.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.564 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.2 m -89.36 106.07 18.21 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.297 -1.715 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.32 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.436 -1.139 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -93.87 135.82 34.79 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 120.999 0.428 . . . . 0.0 110.551 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -70.3 165.64 21.88 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.374 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.404 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 16.2 t-160 -66.07 131.13 45.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 75.94 8.88 3.49 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.126 1.37 . . . . 0.0 111.631 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.68 170.76 31.18 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.0 tt0 -88.71 106.81 18.59 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.602 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.9 p -65.38 -40.97 94.16 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-O 121.594 0.711 . . . . 0.0 109.44 174.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.2 119.91 2.35 Favored Glycine 1 N--CA 1.396 -4.032 0 C-N-CA 118.449 -1.834 . . . . 0.0 114.667 174.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.95 -156.76 33.04 Favored Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 106.39 -2.684 . . . . 0.0 106.39 170.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -58.06 132.81 22.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 117.244 0.522 . . . . 0.0 109.908 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.21 -17.62 55.51 Favored Glycine 0 C--O 1.245 0.798 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.462 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -93.43 127.81 39.22 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.6 p -129.29 15.35 6.14 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.037 0.446 . . . . 0.0 111.465 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.61 -137.57 5.47 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.76 91.54 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.915 2.41 . . . . 0.0 111.351 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 2.4 p -89.67 0.24 57.09 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.73 0.776 . . . . 0.0 111.293 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -106.45 128.81 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.5 m -79.82 155.74 27.72 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.515 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.5 159.43 18.59 Favored 'General case' 0 C--O 1.254 1.297 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.883 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 m -49.86 118.24 2.75 Favored 'General case' 0 C--O 1.247 0.933 0 C-N-CA 124.041 0.936 . . . . 0.0 112.157 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.32 -12.1 43.75 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.52 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 75.6 p -110.51 153.51 24.98 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 117.59 0.695 . . . . 0.0 111.846 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.9 p -112.02 139.88 47.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.35 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.404 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.8 t -84.41 107.06 16.46 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.496 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 75.6 mt-30 -103.67 115.01 29.7 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.1 t -81.35 101.28 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.51 HD11 ' CE1' ' A' ' 32' ' ' TYR . 86.2 mt -80.03 -52.31 7.98 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.822 0.82 . . . . 0.0 109.37 -176.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -118.94 167.7 11.28 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.72 -32.52 86.56 Favored 'Trans proline' 0 C--N 1.347 0.489 0 CA-C-N 120.92 1.364 . . . . 0.0 112.384 -176.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -105.66 -23.55 12.73 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 120.777 0.322 . . . . 0.0 110.76 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' CE1' HD11 ' A' ' 28' ' ' LEU . 63.3 t80 -101.51 114.21 28.02 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.546 0.689 . . . . 0.0 110.801 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.7 m -129.37 143.74 50.96 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -130.97 148.93 52.79 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.512 -174.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 81.7 m -88.86 106.67 18.54 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.876 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.496 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.8 mm? . . . . . 0 C--N 1.298 -1.653 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.441 -0.904 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -74.26 126.73 31.26 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.372 0.606 . . . . 0.0 111.694 -170.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 p -75.31 176.26 7.59 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.193 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -63.51 134.1 55.0 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.831 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 73.91 9.22 4.77 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 124.58 1.152 . . . . 0.0 112.503 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.97 170.16 31.62 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.4 tt0 -90.81 105.79 18.07 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 122.439 0.296 . . . . 0.0 110.548 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.2 p -64.7 -56.76 11.69 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 170.61 106.46 0.19 Allowed Glycine 0 N--CA 1.407 -3.269 0 C-N-CA 117.958 -2.068 . . . . 0.0 113.34 -175.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.21 -165.07 20.34 Favored Glycine 0 N--CA 1.417 -2.606 0 N-CA-C 105.963 -2.855 . . . . 0.0 105.963 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.4 mt -65.11 112.66 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 118.22 1.01 . . . . 0.0 110.337 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.5 -9.09 28.39 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.026 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.43 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 2.8 t80 -113.52 113.22 24.82 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.8 p -125.46 14.77 8.24 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.124 0.487 . . . . 0.0 112.095 -176.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.65 -124.18 0.7 Allowed Glycine 0 C--N 1.318 -0.452 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -66.19 80.98 0.29 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.59 2.86 . . . . 0.0 111.812 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.2 p -84.04 -12.53 55.02 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-O 121.892 0.854 . . . . 0.0 111.182 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.9 132.87 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.614 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.8 m -90.75 163.14 14.58 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.395 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.43 141.43 54.67 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.585 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -53.68 114.58 1.6 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 123.748 0.819 . . . . 0.0 110.732 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.15 -9.95 29.09 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.595 -0.73 . . . . 0.0 113.06 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.7 p -111.52 135.64 51.81 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.1 p -96.17 132.77 41.25 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.736 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.576 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.0 t -77.01 113.06 14.31 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -114.73 116.95 29.48 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.5 t -79.72 103.15 6.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.3 mt -81.75 -48.44 11.64 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.142 0.972 . . . . 0.0 109.472 -173.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -122.44 167.24 14.63 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 103.734 -2.691 . . . . 0.0 103.734 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.37 -34.69 53.83 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 CA-C-N 121.18 1.457 . . . . 0.0 111.94 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -100.51 -24.81 14.38 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.699 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -104.0 114.39 28.6 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.9 m -118.88 153.32 34.74 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 174.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -140.33 148.24 41.05 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 118.798 0.726 . . . . 0.0 110.55 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.42 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.3 m -91.81 106.62 18.61 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.385 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.0 p . . . . . 0 N--CA 1.437 -1.096 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -105.28 141.52 36.65 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 p -72.62 166.67 22.29 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 123.558 0.743 . . . . 0.0 111.29 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.402 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 15.0 t-160 -63.03 132.93 53.63 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 76.56 9.39 3.03 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.74 1.216 . . . . 0.0 112.462 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.2 170.63 28.94 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.6 tt0 -85.8 114.1 22.48 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.878 0.339 . . . . 0.0 110.337 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.643 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.4 p -71.47 -54.29 11.11 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 123.618 0.574 . . . . 0.0 110.3 176.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.5 122.46 0.83 Allowed Glycine 1 N--CA 1.396 -4.029 0 C-N-CA 118.228 -1.939 . . . . 0.0 113.902 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.13 -157.71 19.53 Favored Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 105.572 -3.011 . . . . 0.0 105.572 173.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.13 126.03 20.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 118.009 0.904 . . . . 0.0 108.92 175.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.6 -17.13 39.92 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.582 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -89.41 127.41 35.82 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -124.18 -3.43 8.01 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.37 -135.24 2.16 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.1 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.35 92.62 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.373 2.715 . . . . 0.0 113.348 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.5 p -91.72 -5.97 52.74 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.284 0.564 . . . . 0.0 111.624 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.8 t -96.18 130.11 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.9 m -87.56 161.72 17.59 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.182 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.14 153.03 5.43 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 124.206 1.002 . . . . 0.0 110.684 176.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.2 m -51.23 111.19 0.53 Allowed 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 123.936 0.895 . . . . 0.0 111.741 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.49 -14.95 57.76 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.247 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 70.4 p -92.74 139.76 30.22 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.0 p -101.97 136.83 41.13 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -176.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.422 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.6 t -80.89 117.63 21.69 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -116.96 117.93 31.02 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.67 96.29 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.2 mt -76.76 -38.98 53.16 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.094 -175.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -131.27 160.56 66.55 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -59.62 -27.63 85.43 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 121.548 1.499 . . . . 0.0 111.332 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -106.55 -24.38 12.2 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.453 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -103.32 114.37 28.59 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.051 -0.659 . . . . 0.0 110.463 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.7 m -127.76 136.06 50.99 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -123.03 149.93 43.71 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.388 -173.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.569 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 79.2 m -90.05 106.79 18.71 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.578 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.298 -1.638 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.507 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 . . . . . 0 N--CA 1.44 -0.936 0 CA-C-O 121.085 0.469 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.7 p -65.65 163.27 16.68 Favored 'General case' 0 C--O 1.254 1.34 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.375 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -60.59 130.71 47.89 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.297 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 75.61 9.13 3.64 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.232 1.413 . . . . 0.0 112.331 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.95 172.05 32.0 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 33' ' ' SER . 7.7 tt0 -86.47 103.78 15.33 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.873 0.336 . . . . 0.0 110.702 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.574 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 3.6 p -67.12 -28.17 67.93 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.841 0.829 . . . . 0.0 109.428 174.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.463 ' HA3' ' CG ' ' A' ' 13' ' ' TYR . . . 108.98 134.22 7.04 Favored Glycine 0 N--CA 1.396 -3.991 0 C-N-CA 118.85 -1.643 . . . . 0.0 115.254 172.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.99 -155.94 29.04 Favored Glycine 0 N--CA 1.403 -3.506 0 N-CA-C 107.614 -2.195 . . . . 0.0 107.614 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.7 mt -57.11 128.03 17.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.71 -19.02 36.75 Favored Glycine 0 C--N 1.311 -0.844 0 C-N-CA 120.044 -1.074 . . . . 0.0 112.644 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.463 ' CG ' ' HA3' ' A' ' 9' ' ' GLY . 9.3 t80 -90.88 125.45 35.75 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -118.63 2.99 11.75 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -174.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.03 -128.68 5.97 Favored Glycine 0 C--N 1.311 -0.835 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.976 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -64.67 85.67 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.572 2.848 . . . . 0.0 113.027 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -90.12 -7.55 53.47 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 122.042 0.925 . . . . 0.0 109.72 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.14 131.28 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.574 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.2 m -92.85 158.05 16.06 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.086 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.52 141.19 32.08 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 123.801 0.688 . . . . 0.0 109.75 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 m -51.31 117.92 2.92 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.628 0.771 . . . . 0.0 111.859 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.92 -18.15 26.72 Favored Glycine 0 N--CA 1.431 -1.689 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.231 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 61.2 p -102.57 144.68 30.67 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.0 p -100.94 132.7 46.23 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.486 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.2 t -79.49 106.47 11.55 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.419 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.6 mt-30 -106.08 114.79 29.14 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.664 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.9 t -78.93 96.3 2.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.454 HD12 ' CE2' ' A' ' 32' ' ' TYR . 80.9 mt -77.15 -52.12 9.82 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.947 -175.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -115.79 162.31 26.05 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.57 -24.44 78.01 Favored 'Trans proline' 0 C--O 1.212 -0.791 0 CA-C-N 121.375 1.527 . . . . 0.0 112.099 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -108.87 -23.38 11.76 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.752 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.454 ' CE2' HD12 ' A' ' 28' ' ' LEU . 69.3 t80 -103.01 114.09 28.1 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.167 0.508 . . . . 0.0 111.457 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -126.88 134.26 50.53 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -120.24 151.25 39.43 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -176.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.1 m -92.76 106.17 18.19 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.419 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.9 mm? . . . . . 0 C--N 1.297 -1.681 0 CA-C-O 118.462 -0.78 . . . . 0.0 109.233 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 . . . . . 0 N--CA 1.43 -1.427 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 t -73.47 177.09 5.51 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-O 121.809 0.814 . . . . 0.0 110.947 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -64.12 131.8 48.55 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.374 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 76.06 9.79 3.25 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.916 1.286 . . . . 0.0 113.386 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.3 168.0 25.3 Favored Glycine 0 C--N 1.312 -0.786 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.573 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.0 tt0 -81.54 112.72 19.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 117.026 0.413 . . . . 0.0 110.353 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.699 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.3 p -72.87 -58.07 3.6 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.783 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.418 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 171.71 109.42 0.22 Allowed Glycine 0 N--CA 1.396 -3.98 0 C-N-CA 118.134 -1.984 . . . . 0.0 113.363 -176.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.56 -157.53 17.31 Favored Glycine 0 N--CA 1.405 -3.406 0 N-CA-C 105.974 -2.851 . . . . 0.0 105.974 171.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.418 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 77.2 mt -65.67 126.1 24.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 117.665 0.732 . . . . 0.0 109.604 174.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.96 -13.16 60.69 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.907 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -90.37 111.96 23.38 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.8 p -109.98 6.83 23.44 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.97 -136.97 9.29 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.872 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -64.13 88.29 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.682 2.922 . . . . 0.0 112.996 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 24.4 p -84.21 -16.09 44.59 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.787 0.803 . . . . 0.0 110.5 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.3 t -82.4 129.84 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.74 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.0 m -88.18 168.92 12.34 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.002 0.43 . . . . 0.0 110.954 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.62 155.04 16.33 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.758 0.823 . . . . 0.0 110.709 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -64.52 111.53 2.74 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.245 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.51 6.47 27.08 Favored Glycine 0 N--CA 1.432 -1.578 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.056 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 59.7 p -125.1 152.19 44.71 Favored 'General case' 0 C--O 1.244 0.788 0 O-C-N 122.411 -0.464 . . . . 0.0 110.394 177.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.1 p -115.23 139.85 49.6 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.881 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.3 t -83.92 110.12 18.15 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -110.68 114.91 28.66 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -79.56 98.2 2.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.117 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.1 mt -78.52 -43.86 25.78 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.48 -174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -126.73 160.46 58.6 Favored Pre-proline 0 C--N 1.289 -2.033 0 N-CA-C 103.655 -2.72 . . . . 0.0 103.655 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.41 -29.43 84.37 Favored 'Trans proline' 0 C--O 1.225 -0.153 0 C-N-CA 121.752 1.635 . . . . 0.0 112.005 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 53.6 m-85 -104.36 -25.5 12.82 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.851 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -104.28 113.56 27.2 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 119.551 -0.859 . . . . 0.0 110.434 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 13.7 m -125.53 135.74 52.59 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 177.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -121.35 147.61 45.47 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.411 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.699 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.7 m -87.62 106.64 18.16 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.29 -2.003 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.98 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 . . . . . 0 N--CA 1.442 -0.847 0 CA-C-O 121.093 0.473 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 m -69.15 169.11 12.61 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.555 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.424 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 17.7 t-160 -59.62 132.25 53.39 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.509 0.723 . . . . 0.0 109.27 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 77.4 8.87 2.66 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.564 1.546 . . . . 0.0 112.247 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.87 169.0 29.33 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.562 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.0 tt0 -88.31 103.77 16.12 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.604 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.5 p -62.51 -47.86 82.09 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.246 0.546 . . . . 0.0 111.68 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 151.07 117.18 0.77 Allowed Glycine 0 N--CA 1.397 -3.904 0 C-N-CA 118.189 -1.958 . . . . 0.0 113.773 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.56 -157.39 18.78 Favored Glycine 0 N--CA 1.413 -2.873 0 N-CA-C 106.376 -2.69 . . . . 0.0 106.376 172.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.84 121.68 14.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 117.963 0.881 . . . . 0.0 109.597 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.96 -9.17 46.72 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.386 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.445 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 2.7 t80 -113.79 112.01 22.71 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.0 p -120.98 14.99 11.6 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 120.866 0.365 . . . . 0.0 111.877 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.41 -126.49 0.97 Allowed Glycine 0 C--O 1.241 0.588 0 C-N-CA 121.261 -0.495 . . . . 0.0 111.878 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.2 79.95 0.56 Allowed 'Trans proline' 0 C--O 1.217 -0.547 0 C-N-CA 122.939 2.426 . . . . 0.0 112.01 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 23.0 p -83.45 2.18 37.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 122.269 1.033 . . . . 0.0 110.787 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.2 t -101.42 131.86 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.8 m -90.31 162.08 15.34 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 123.358 0.411 . . . . 0.0 110.591 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.75 144.64 37.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.841 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.1 p -56.17 118.2 4.48 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 124.069 0.856 . . . . 0.0 111.416 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.03 -3.19 28.56 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.983 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.2 p -120.51 166.15 14.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 117.388 0.594 . . . . 0.0 110.281 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 34.4 p -120.89 146.04 47.02 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 122.202 0.201 . . . . 0.0 111.152 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.5 t -90.08 111.54 22.69 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -111.81 114.82 28.03 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -76.96 99.85 2.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 mt -82.53 -53.98 5.54 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.298 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -110.29 165.57 12.43 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.27 -26.23 64.2 Favored 'Trans proline' 0 C--O 1.221 -0.35 0 CA-C-N 121.445 1.552 . . . . 0.0 111.14 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -106.53 -25.29 11.9 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.432 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -103.62 113.26 26.64 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.631 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.4 m -123.54 139.31 54.14 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 176.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -127.61 150.57 49.67 Favored 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.597 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.7 m -90.01 106.42 18.46 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.299 -1.588 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 . . . . . 0 N--CA 1.445 -0.716 0 CA-C-O 121.246 0.546 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -74.22 171.95 12.67 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.459 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -62.32 132.86 54.05 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.365 0.666 . . . . 0.0 109.719 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 74.74 8.99 4.21 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.282 1.433 . . . . 0.0 112.406 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.25 169.56 33.36 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -89.09 105.61 17.9 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 117.134 0.467 . . . . 0.0 110.792 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 2.5 p -67.26 -31.5 71.87 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 121.587 0.708 . . . . 0.0 109.934 175.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.53 131.35 5.13 Favored Glycine 0 N--CA 1.396 -3.987 0 C-N-CA 118.922 -1.608 . . . . 0.0 115.866 172.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.6 -156.06 25.47 Favored Glycine 0 N--CA 1.408 -3.225 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.2 mt -56.31 127.4 15.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.17 -23.36 29.09 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.055 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -89.04 130.94 35.41 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.2 p -137.86 14.91 2.89 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.656 0.741 . . . . 0.0 111.234 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.8 -130.23 5.3 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.41 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.45 84.26 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.314 2.676 . . . . 0.0 112.267 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.3 p -88.25 2.32 52.59 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 122.252 1.025 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -105.88 127.25 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.9 m -87.76 153.02 21.68 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.84 154.4 15.09 Favored 'General case' 0 C--O 1.252 1.216 0 O-C-N 123.596 0.56 . . . . 0.0 111.236 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.2 m -49.4 116.39 1.71 Allowed 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.556 1.142 . . . . 0.0 112.035 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.89 -1.8 48.28 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.557 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.5 p -117.7 145.67 44.26 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 117.649 0.725 . . . . 0.0 110.212 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.5 p -106.25 138.64 42.07 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -79.4 113.81 17.83 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.427 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.6 mt-30 -113.73 114.76 26.81 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.49 100.14 2.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.3 mt -79.26 -53.2 7.18 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -175.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -116.85 160.3 37.32 Favored Pre-proline 0 C--N 1.29 -1.995 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.27 -29.89 91.48 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 121.484 1.456 . . . . 0.0 113.261 -174.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -106.58 -23.81 12.35 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 120.959 0.409 . . . . 0.0 110.488 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -103.12 113.49 27.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.217 0.532 . . . . 0.0 111.352 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.7 m -124.99 142.74 51.29 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -129.84 149.14 51.71 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.238 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 67.5 m -88.67 107.63 19.03 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.939 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.427 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.8 mm? . . . . . 0 C--N 1.303 -1.419 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 . . . . . 0 N--CA 1.436 -1.156 0 CA-C-O 121.144 0.497 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -81.77 169.85 16.42 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 124.088 0.955 . . . . 0.0 111.877 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -64.63 131.57 47.33 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 75.61 9.51 3.57 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.718 1.207 . . . . 0.0 112.741 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.03 167.57 26.7 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.429 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.9 tt0 -84.96 116.08 23.17 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.617 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.6 p -73.56 -55.2 6.61 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 123.8 0.688 . . . . 0.0 110.973 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.411 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 161.65 108.65 0.23 Allowed Glycine 0 N--CA 1.401 -3.673 0 C-N-CA 118.114 -1.993 . . . . 0.0 114.528 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.33 -158.33 29.0 Favored Glycine 0 N--CA 1.41 -3.043 0 N-CA-C 106.36 -2.696 . . . . 0.0 106.36 171.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.495 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 72.6 mt -65.3 117.07 5.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 118.074 0.937 . . . . 0.0 110.901 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.25 -14.79 23.16 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.573 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -92.27 125.57 36.99 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.6 p -119.76 -6.39 10.12 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.42 -131.2 1.81 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.762 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.53 79.98 0.1 Allowed 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 123.963 3.109 . . . . 0.0 112.669 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 5.2 p -85.35 -5.94 59.27 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.86 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.0 t -99.43 131.96 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 82.6 m -92.54 146.95 23.28 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 123.364 0.415 . . . . 0.0 110.092 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.53 154.05 6.95 Favored 'General case' 0 C--O 1.251 1.17 0 O-C-N 124.007 0.817 . . . . 0.0 110.865 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 m -50.82 126.86 16.97 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.865 0.866 . . . . 0.0 111.417 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.93 -16.54 57.29 Favored Glycine 0 N--CA 1.432 -1.585 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.565 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.8 p -110.22 142.41 41.83 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.432 0.616 . . . . 0.0 110.289 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.3 p -109.29 133.6 52.83 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.507 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.6 t -75.31 107.15 7.22 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -109.37 114.73 28.65 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.3 t -78.55 96.63 2.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.0 mt -75.7 -51.5 12.59 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.371 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -120.34 166.99 13.66 Favored Pre-proline 0 C--N 1.284 -2.258 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.57 -33.5 86.98 Favored 'Trans proline' 0 C--N 1.343 0.261 0 CA-C-N 121.399 1.535 . . . . 0.0 112.323 -175.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.495 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 21.9 m-85 -104.94 -23.78 12.93 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.44 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -102.23 113.5 26.85 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.376 0.607 . . . . 0.0 110.761 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.0 m -127.0 137.46 53.1 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -128.37 150.78 49.95 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.304 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.556 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 67.1 m -90.15 105.68 17.97 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.294 -1.833 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.945 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.195 0.522 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 p -70.39 169.81 13.19 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.004 0.922 . . . . 0.0 112.907 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -61.74 129.5 41.33 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.904 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 76.75 9.25 2.94 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.766 1.226 . . . . 0.0 112.765 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.05 164.21 28.46 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.3 tt0 -83.49 107.47 15.99 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.627 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.6 p -67.27 -51.04 57.82 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-O 121.183 0.516 . . . . 0.0 111.421 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.59 118.69 0.71 Allowed Glycine 0 N--CA 1.399 -3.794 0 C-N-CA 118.266 -1.921 . . . . 0.0 113.651 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.12 -158.09 18.34 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 105.691 -2.964 . . . . 0.0 105.691 171.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.63 119.97 15.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 117.919 0.86 . . . . 0.0 109.042 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.38 -6.27 28.39 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.014 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -113.9 132.27 55.98 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 p -141.33 20.82 2.23 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.88 -121.6 3.33 Favored Glycine 0 C--O 1.241 0.54 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -67.75 78.81 0.52 Allowed 'Trans proline' 0 N--CA 1.476 0.494 0 C-N-CA 123.697 2.931 . . . . 0.0 111.96 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.5 p -82.3 -16.66 48.57 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.55 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.8 t -89.14 133.0 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.1 m -87.39 159.1 18.84 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.12 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.63 160.61 8.89 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.931 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 m -62.82 128.9 38.07 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.625 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.17 5.41 59.43 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.492 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.4 p -128.55 164.88 21.85 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 117.33 0.565 . . . . 0.0 109.885 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.3 p -130.94 138.64 49.83 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 122.182 0.193 . . . . 0.0 110.845 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.464 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.2 t -78.23 114.38 17.06 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 36' ' ' LEU . 40.0 mt-30 -115.94 115.81 26.84 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.922 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.1 t -77.7 99.79 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.2 mt -78.31 -50.6 11.5 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 122.042 0.925 . . . . 0.0 108.843 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -120.26 161.75 37.33 Favored Pre-proline 0 C--N 1.289 -2.057 0 N-CA-C 103.941 -2.615 . . . . 0.0 103.941 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.43 -28.66 88.12 Favored 'Trans proline' 0 N--CA 1.474 0.345 0 CA-C-N 120.896 1.356 . . . . 0.0 112.093 -175.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -105.01 -25.18 12.66 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.835 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -104.01 113.04 26.29 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.562 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -125.35 140.03 53.17 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -130.95 149.43 52.58 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.921 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.4 m -87.68 106.07 17.79 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.42 ' HB2' ' OE1' ' A' ' 26' ' ' GLN . 2.7 mm? . . . . . 0 C--N 1.289 -2.022 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 . . . . . 0 C--O 1.243 0.754 0 CA-C-O 121.518 0.675 . . . . 0.0 111.831 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 p -80.91 161.7 24.25 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 124.357 1.063 . . . . 0.0 111.426 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -62.06 131.59 50.09 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 77.69 9.68 2.37 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.717 1.207 . . . . 0.0 112.752 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.67 170.01 25.03 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.424 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.6 tt0 -81.56 109.18 15.76 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.659 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -71.44 -54.04 11.98 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 121.266 0.555 . . . . 0.0 111.353 177.597 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.408 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 163.12 116.47 0.38 Allowed Glycine 1 N--CA 1.394 -4.111 0 C-N-CA 118.101 -1.999 . . . . 0.0 113.835 -177.503 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.25 -158.2 18.19 Favored Glycine 0 N--CA 1.409 -3.149 0 N-CA-C 105.485 -3.046 . . . . 0.0 105.485 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.2 mt -66.38 121.05 14.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 117.891 0.845 . . . . 0.0 110.049 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.09 -20.06 29.08 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.295 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -80.03 129.32 34.4 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.7 p -135.4 18.53 3.37 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.56 -125.85 5.52 Favored Glycine 0 C--N 1.311 -0.807 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.513 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.79 85.78 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.242 2.628 . . . . 0.0 111.925 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 10.2 p -88.94 -8.04 54.92 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.573 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.91 137.05 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 90.6 m -87.71 163.14 16.68 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.147 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.87 153.43 10.98 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.967 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.7 m -57.71 114.57 2.34 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.506 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.53 4.43 56.04 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.814 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 81.3 p -113.83 143.82 44.04 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 117.486 0.643 . . . . 0.0 109.882 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.3 p -103.55 132.65 49.62 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.515 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 45.9 t -79.16 106.73 11.4 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -104.61 114.76 29.19 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.4 t -77.83 101.65 3.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.9 mt -81.53 -39.45 24.66 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.738 0.78 . . . . 0.0 109.503 -173.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -132.97 163.06 53.77 Favored Pre-proline 0 C--N 1.289 -2.058 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -60.88 -28.35 86.23 Favored 'Trans proline' 0 C--N 1.345 0.367 0 CA-C-N 120.986 1.388 . . . . 0.0 112.618 -175.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -108.84 -24.07 11.45 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.407 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -103.11 114.51 28.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.292 0.568 . . . . 0.0 111.442 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.612 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.3 m -124.62 146.91 48.82 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -131.44 147.19 52.53 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.079 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.659 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.3 m -89.57 106.47 18.48 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 C--N 1.297 -1.678 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.615 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 . . . . . 0 N--CA 1.438 -1.062 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 p -76.81 171.24 15.05 Favored 'General case' 0 C--O 1.251 1.151 0 CA-C-O 121.179 0.514 . . . . 0.0 111.952 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -63.46 129.74 41.46 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 75.19 9.43 3.84 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.62 1.568 . . . . 0.0 111.508 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.76 165.84 32.35 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -86.56 106.55 17.62 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.517 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.5 p -70.01 -27.09 64.4 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.834 0.825 . . . . 0.0 109.067 174.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.25 129.43 6.0 Favored Glycine 1 N--CA 1.394 -4.165 0 C-N-CA 119.245 -1.455 . . . . 0.0 115.41 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.8 -156.65 30.91 Favored Glycine 0 N--CA 1.407 -3.272 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 171.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.9 mt -59.78 125.43 15.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.54 -1.07 32.47 Favored Glycine 0 C--N 1.317 -0.525 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.386 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -113.62 119.94 39.2 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.4 p -115.81 9.52 15.1 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.76 -139.78 7.68 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.353 -0.693 . . . . 0.0 111.809 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.34 94.58 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.23 2.62 . . . . 0.0 112.083 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.0 p -92.76 -7.46 46.5 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.479 0.657 . . . . 0.0 111.378 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.5 t -100.77 135.58 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.495 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.9 m -90.71 161.8 15.19 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 120.719 0.295 . . . . 0.0 111.69 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.18 164.73 10.41 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.61 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.6 m -54.12 111.52 0.78 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 124.354 1.062 . . . . 0.0 112.764 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.07 -13.48 57.37 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.243 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 82.2 p -100.18 141.03 33.57 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 122.17 -0.606 . . . . 0.0 109.889 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 27.4 p -106.08 136.78 45.15 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.792 -0.186 . . . . 0.0 111.36 -177.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.4 t -80.73 106.15 12.51 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -107.97 115.42 30.1 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.703 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.25 96.17 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.6 mt -77.55 -39.1 47.0 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.057 -173.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -133.55 163.74 48.99 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -61.55 -29.31 84.35 Favored 'Trans proline' 0 C--O 1.235 0.373 0 CA-C-N 121.549 1.589 . . . . 0.0 112.941 -173.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -107.72 -23.5 12.08 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.85 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -103.15 113.83 27.63 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.054 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 m -125.34 141.27 52.17 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -131.75 150.38 52.17 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.018 -174.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.517 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.0 m -89.29 105.89 18.09 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.99 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--N 1.29 -1.984 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.413 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.47 ' NE2' ' HA3' ' A' ' 6' ' ' GLY . 26.0 tp60 . . . . . 0 N--CA 1.443 -0.777 0 CA-C-O 121.254 0.55 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 m -66.75 166.75 12.53 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.48 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -62.28 131.33 49.02 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.652 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 77.25 8.87 2.73 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.705 1.602 . . . . 0.0 112.482 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.47 ' HA3' ' NE2' ' A' ' 2' ' ' GLN . . . -91.85 170.59 33.56 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.5 tt0 -88.49 107.48 18.9 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.68 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.6 p -62.73 -56.91 13.26 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 121.016 0.436 . . . . 0.0 111.664 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.436 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 164.5 112.66 0.27 Allowed Glycine 0 N--CA 1.4 -3.725 0 C-N-CA 118.278 -1.915 . . . . 0.0 113.671 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.59 -167.28 20.13 Favored Glycine 0 N--CA 1.41 -3.038 0 N-CA-C 106.4 -2.68 . . . . 0.0 106.4 171.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.8 mt -59.76 111.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 117.823 0.812 . . . . 0.0 110.926 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.33 -5.02 26.69 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.753 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -98.49 127.94 44.63 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.0 p -124.59 -1.8 7.97 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.73 -135.64 2.81 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.042 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 39.5 Cg_exo -63.99 80.44 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.056 3.171 . . . . 0.0 112.386 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.671 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 9.2 p -76.8 -22.06 54.22 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.721 0.772 . . . . 0.0 110.726 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.08 129.15 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 87.6 m -87.13 161.5 18.06 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.889 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.76 157.79 14.16 Favored 'General case' 0 C--O 1.256 1.396 0 C-N-CA 123.765 0.826 . . . . 0.0 110.808 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.5 m -64.03 111.21 2.42 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.142 0.496 . . . . 0.0 110.406 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.31 0.32 33.14 Favored Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.903 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 79.2 p -116.81 139.48 50.55 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.283 -0.54 . . . . 0.0 109.605 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 24.8 p -102.04 136.04 42.57 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.056 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.448 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.5 t -81.89 109.95 16.72 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -109.89 114.6 28.28 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.41 98.88 3.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.9 mt -78.93 -53.27 7.22 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.855 0.836 . . . . 0.0 109.369 -173.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -115.77 167.04 10.86 Favored Pre-proline 0 C--N 1.283 -2.299 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -61.04 -32.14 91.72 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 CA-C-N 121.001 1.393 . . . . 0.0 112.278 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -105.68 -23.96 12.64 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.23 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -102.36 113.89 27.59 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.344 0.592 . . . . 0.0 111.477 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.6 m -124.64 153.0 42.92 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 176.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -140.83 149.4 41.96 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.536 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.601 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 68.9 m -91.67 106.07 18.2 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--N 1.3 -1.549 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.628 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.369 0.604 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 p -75.08 169.38 18.14 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.188 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -61.82 132.49 53.27 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.373 1.069 . . . . 0.0 109.244 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 74.52 8.84 4.38 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 125.077 1.351 . . . . 0.0 112.565 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.05 164.89 26.36 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.4 tt0 -84.58 101.13 11.88 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.6 p -63.23 -42.49 99.25 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.23 0.538 . . . . 0.0 111.053 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.422 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 139.59 123.61 2.08 Favored Glycine 1 N--CA 1.393 -4.199 0 C-N-CA 118.048 -2.025 . . . . 0.0 114.247 177.053 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.38 -157.81 17.75 Favored Glycine 0 N--CA 1.403 -3.565 0 N-CA-C 105.432 -3.067 . . . . 0.0 105.432 171.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.3 mt -62.67 130.92 27.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.88 -7.96 61.08 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.837 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -109.91 136.56 49.01 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.2 p -141.39 21.23 2.22 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.1 -126.38 5.07 Favored Glycine 0 C--N 1.307 -1.039 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.469 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -70.1 86.7 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.29 2.66 . . . . 0.0 111.537 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.9 p -82.54 -16.81 47.24 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.889 0.852 . . . . 0.0 110.917 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.78 135.36 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 67.3 m -93.07 162.17 14.14 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.62 138.97 51.52 Favored 'General case' 0 C--O 1.25 1.109 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.6 m -57.61 127.16 30.6 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.411 0.444 . . . . 0.0 110.731 -175.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.05 -16.54 27.66 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.214 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.6 p -115.91 144.89 43.43 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.8 p -103.66 136.86 42.58 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -175.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 38.4 t -81.1 107.1 13.62 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -104.42 114.51 28.79 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.554 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.0 t -80.01 100.59 4.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.5 mt -82.91 -51.33 7.71 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.254 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.483 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 1.7 m-20 -112.35 161.64 25.2 Favored Pre-proline 0 C--N 1.292 -1.922 0 N-CA-C 102.102 -3.295 . . . . 0.0 102.102 174.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.02 -25.73 77.89 Favored 'Trans proline' 0 C--O 1.22 -0.412 0 CA-C-N 121.667 1.631 . . . . 0.0 111.326 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -104.26 -23.77 13.2 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.16 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.483 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 61.0 t80 -103.82 114.11 28.12 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.53 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.2 m -125.47 142.24 51.61 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -133.68 147.98 51.44 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.894 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.1 m -88.55 106.5 18.33 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.23 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.294 -1.826 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.519 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.463 ' NE2' ' HA3' ' A' ' 6' ' ' GLY . 28.0 tp60 . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 121.242 0.544 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 p -72.96 172.82 10.25 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 124.169 0.988 . . . . 0.0 112.655 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -67.52 130.41 42.95 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 77.13 9.18 2.74 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.37 1.468 . . . . 0.0 112.351 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.463 ' HA3' ' NE2' ' A' ' 2' ' ' GLN . . . -90.95 164.31 29.87 Favored Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 175.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -82.55 104.61 12.95 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.694 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.7 p -62.53 -55.18 29.84 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-O 121.099 0.476 . . . . 0.0 111.305 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 159.83 112.89 0.32 Allowed Glycine 1 N--CA 1.392 -4.285 0 C-N-CA 117.685 -2.198 . . . . 0.0 114.123 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.35 -158.14 22.91 Favored Glycine 0 N--CA 1.402 -3.604 0 N-CA-C 105.313 -3.115 . . . . 0.0 105.313 170.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.24 128.89 31.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 118.044 0.922 . . . . 0.0 108.628 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.91 -8.98 50.89 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.687 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.461 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 3.4 t80 -113.66 118.03 33.21 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 p -124.54 3.05 8.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.51 -119.69 0.84 Allowed Glycine 0 C--O 1.243 0.658 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.964 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 25.2 Cg_exo -67.96 78.5 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.662 2.908 . . . . 0.0 111.836 175.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.654 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.7 p -85.83 -22.66 27.5 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.455 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.89 131.94 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -85.68 153.11 22.57 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.291 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.94 148.64 20.6 Favored 'General case' 0 C--O 1.244 0.791 0 O-C-N 123.932 0.77 . . . . 0.0 110.717 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 m -55.11 116.82 3.0 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 122.979 0.512 . . . . 0.0 111.508 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.93 -5.7 29.08 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.287 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.2 p -119.27 154.52 33.33 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.6 p -116.73 142.09 47.36 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.977 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.5 t -83.06 112.04 19.43 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.528 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.5 mt-30 -109.74 114.37 27.89 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.7 t -81.93 105.83 12.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.8 mt -83.38 -53.89 5.39 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.943 -175.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -116.21 163.29 22.2 Favored Pre-proline 0 C--N 1.296 -1.737 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -58.37 -31.86 94.88 Favored 'Trans proline' 0 C--O 1.218 -0.503 0 C-N-CA 121.279 1.319 . . . . 0.0 112.04 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -102.69 -24.12 13.78 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.865 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -103.7 114.18 28.25 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 120.934 0.397 . . . . 0.0 111.904 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.8 m -129.22 147.52 51.07 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -136.62 147.65 47.04 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.14 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.694 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.6 m -87.25 106.74 18.12 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.197 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.528 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.6 mm? . . . . . 0 C--N 1.294 -1.816 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.494 HE21 ' HA3' ' A' ' 6' ' ' GLY . 59.0 tp60 . . . . . 0 C--O 1.245 0.826 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -73.76 166.17 23.79 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.953 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -60.41 133.81 56.46 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.74 0.816 . . . . 0.0 108.95 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 74.87 9.25 4.08 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.201 1.4 . . . . 0.0 112.04 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.494 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.17 170.43 28.81 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.175 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 33' ' ' SER . 8.2 tt0 -88.43 107.82 19.06 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.523 0.161 . . . . 0.0 110.574 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.622 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -69.08 -29.74 67.91 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 121.973 0.892 . . . . 0.0 109.024 173.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.23 126.97 4.19 Favored Glycine 1 N--CA 1.391 -4.36 0 C-N-CA 118.771 -1.681 . . . . 0.0 114.566 174.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.44 -156.25 32.13 Favored Glycine 0 N--CA 1.41 -3.037 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 171.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -58.08 129.75 20.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 117.566 0.683 . . . . 0.0 109.347 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.21 -22.34 31.38 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.687 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -103.05 112.02 24.65 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -118.58 11.41 12.86 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -175.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.23 -122.16 1.12 Allowed Glycine 0 C--O 1.245 0.804 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.849 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.8 78.65 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.051 3.167 . . . . 0.0 113.003 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.7 p -86.13 -16.81 36.78 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.081 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -90.58 133.8 31.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 86.1 m -92.97 157.55 16.27 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.388 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.13 158.9 18.62 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.784 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.5 m -55.1 121.11 8.05 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.303 0.641 . . . . 0.0 111.644 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.01 -16.96 45.67 Favored Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.427 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 59.2 p -106.88 143.11 35.44 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 122.248 -0.56 . . . . 0.0 110.976 -177.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.2 p -109.36 136.8 48.2 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.498 0.319 . . . . 0.0 111.567 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.43 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.0 t -79.93 108.68 13.7 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -113.19 117.36 31.69 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.338 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.76 106.91 7.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.2 mt -88.38 -41.73 12.64 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.193 0.997 . . . . 0.0 108.949 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -127.71 161.16 56.92 Favored Pre-proline 0 C--N 1.286 -2.166 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 178.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -60.2 -31.63 93.36 Favored 'Trans proline' 0 CA--C 1.52 -0.217 0 CA-C-N 121.027 1.402 . . . . 0.0 112.051 -174.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -105.04 -23.46 12.95 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.295 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -103.29 114.04 28.01 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.176 0.512 . . . . 0.0 111.421 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.2 m -125.57 138.82 53.96 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -124.01 149.96 45.43 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.315 -174.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.4 m -91.91 106.07 18.18 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.287 -2.134 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.638 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 . . . . . 0 N--CA 1.442 -0.87 0 CA-C-O 120.74 0.305 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 p -86.97 177.41 7.25 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 121.148 0.499 . . . . 0.0 111.596 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -62.92 132.41 51.99 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.048 0.539 . . . . 0.0 110.024 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 78.92 8.69 1.93 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.624 1.569 . . . . 0.0 113.218 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.47 173.54 32.67 Favored Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.877 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.0 tt0 -91.4 110.77 22.07 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.8 p -70.84 -33.28 70.5 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-O 121.76 0.79 . . . . 0.0 109.184 174.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.05 133.61 4.58 Favored Glycine 0 N--CA 1.398 -3.897 0 C-N-CA 118.469 -1.824 . . . . 0.0 115.397 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.31 -156.23 20.09 Favored Glycine 0 N--CA 1.402 -3.599 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.93 129.59 20.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.58 -6.72 55.35 Favored Glycine 0 C--N 1.307 -1.031 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.959 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -114.01 132.88 55.83 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.0 p -135.19 6.98 3.36 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.49 -123.14 2.03 Favored Glycine 0 C--O 1.246 0.865 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.273 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -65.27 79.21 0.22 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.709 2.94 . . . . 0.0 113.333 176.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.5 p -89.08 7.01 37.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 122.359 1.076 . . . . 0.0 109.384 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.9 t -106.24 116.92 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.112 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.444 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.1 m -83.44 149.69 26.51 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.14 151.25 12.63 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 123.932 0.77 . . . . 0.0 110.854 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -59.91 119.74 8.3 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.128 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.25 -9.98 28.87 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.784 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.7 p -118.49 146.18 44.71 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 122.197 -0.59 . . . . 0.0 110.491 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 34.4 p -107.08 140.94 39.1 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.135 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.0 t -85.42 107.26 17.32 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -107.89 114.64 28.73 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.49 96.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.421 HD12 ' CE1' ' A' ' 32' ' ' TYR . 87.6 mt -75.68 -53.22 8.9 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.468 0.707 . . . . 0.0 109.831 -174.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -112.06 162.66 20.28 Favored Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 172.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.67 -23.43 75.99 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 CA-C-N 120.935 1.37 . . . . 0.0 111.67 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -106.85 -24.72 11.96 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.979 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.421 ' CE1' HD12 ' A' ' 28' ' ' LEU . 74.7 t80 -103.67 113.8 27.59 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.971 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.9 m -126.68 135.35 51.04 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -124.76 150.34 46.36 Favored 'General case' 0 C--N 1.286 -2.169 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.199 -175.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 79.3 m -90.37 106.27 18.38 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.302 -1.494 0 CA-C-O 118.646 -0.692 . . . . 0.0 109.835 -178.867 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 121.15 0.5 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 p -79.56 170.85 15.96 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.857 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -62.84 134.88 56.92 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.116 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 74.16 9.31 4.58 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.28 1.432 . . . . 0.0 112.3 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.78 170.65 30.94 Favored Glycine 0 N--CA 1.431 -1.653 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.398 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.1 tt0 -87.18 107.25 18.39 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.596 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.5 p -68.26 -51.46 44.9 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 121.195 0.521 . . . . 0.0 110.814 177.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 156.48 121.2 0.69 Allowed Glycine 1 N--CA 1.393 -4.184 0 C-N-CA 118.203 -1.951 . . . . 0.0 114.061 178.34 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.9 -157.26 19.66 Favored Glycine 0 N--CA 1.408 -3.171 0 N-CA-C 106.183 -2.767 . . . . 0.0 106.183 171.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.5 mt -62.48 129.63 25.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 117.812 0.806 . . . . 0.0 108.938 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.53 -20.34 44.73 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.932 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -95.25 124.86 39.51 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.1 p -128.47 9.67 6.08 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.67 -124.06 3.75 Favored Glycine 0 C--O 1.248 0.993 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.945 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.95 75.44 0.43 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 124.054 3.169 . . . . 0.0 112.418 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.1 p -80.36 -11.87 59.65 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.99 0.9 . . . . 0.0 110.598 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.7 t -90.2 133.05 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.9 m -93.09 160.09 15.01 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 123.332 0.395 . . . . 0.0 110.503 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.67 147.13 28.47 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.259 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 m -53.39 117.01 2.75 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.581 0.752 . . . . 0.0 111.346 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.7 -8.15 34.17 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.234 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.3 p -113.59 146.87 39.04 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.228 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 32.6 p -106.58 137.24 44.94 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.557 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.7 t -83.8 113.08 20.67 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -116.59 116.05 26.87 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.261 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.38 99.44 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.7 mt -81.71 -48.05 12.17 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.667 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 49.9 m-20 -122.24 166.84 15.63 Favored Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.16 -32.69 82.97 Favored 'Trans proline' 0 C--N 1.346 0.415 0 CA-C-N 121.495 1.57 . . . . 0.0 112.729 -175.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -105.62 -23.31 12.79 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.294 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 80.0 t80 -102.24 113.81 27.42 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.462 0.649 . . . . 0.0 111.412 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -126.49 140.7 52.26 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 177.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -128.43 147.33 50.65 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.769 -0.773 . . . . 0.0 110.535 -174.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.596 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 65.7 m -89.02 106.51 18.48 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.412 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.293 -1.869 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.646 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 . . . . . 0 N--CA 1.446 -0.656 0 CA-C-O 121.132 0.491 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -64.1 165.76 8.68 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 124.307 1.043 . . . . 0.0 111.985 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -61.58 131.01 48.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 74.76 9.27 4.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.93 1.292 . . . . 0.0 112.833 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.64 169.35 32.62 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -88.05 103.33 15.61 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.681 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.6 p -64.37 -26.06 68.3 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 121.806 0.813 . . . . 0.0 109.228 175.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.421 ' HA3' ' CG ' ' A' ' 13' ' ' TYR . . . 103.31 132.46 7.62 Favored Glycine 1 N--CA 1.39 -4.403 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.697 172.677 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.75 -155.84 29.97 Favored Glycine 0 N--CA 1.403 -3.508 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 172.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 66.0 mt -57.32 123.44 8.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.39 -12.14 26.01 Favored Glycine 0 C--N 1.302 -1.317 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.872 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.421 ' CG ' ' HA3' ' A' ' 9' ' ' GLY . 12.4 t80 -109.83 114.34 27.82 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 p -110.49 0.23 17.67 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.83 -134.67 1.5 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.732 -0.482 . . . . 0.0 112.869 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -63.55 79.19 0.14 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 123.401 2.734 . . . . 0.0 113.65 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 9.6 p -80.49 -14.28 58.4 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.202 1.001 . . . . 0.0 109.905 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.0 t -92.66 128.73 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.8 m -87.34 167.24 14.23 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.445 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.38 152.88 44.4 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.846 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.9 m -58.48 123.44 16.22 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.813 0.339 . . . . 0.0 110.561 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.09 -7.77 29.09 Favored Glycine 0 N--CA 1.433 -1.561 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.975 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 82.1 p -123.06 154.45 38.52 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.7 p -117.02 135.74 53.47 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.0 t -78.52 114.82 17.78 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -116.12 114.94 25.19 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.75 96.36 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 mt -78.31 -38.9 41.24 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.773 -173.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -134.46 167.85 20.75 Favored Pre-proline 0 C--N 1.291 -1.954 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -64.23 -32.96 61.7 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 CA-C-N 121.306 1.502 . . . . 0.0 112.435 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.407 ' HD1' ' O ' ' A' ' 11' ' ' ILE . 42.8 m-85 -106.5 -24.4 12.21 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.762 -176.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -102.02 117.42 34.76 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.43 0.633 . . . . 0.0 110.885 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.8 m -134.2 140.74 46.72 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -127.1 152.41 47.35 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.215 -173.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.681 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 84.6 m -92.55 106.36 18.36 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.292 -1.926 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.459 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 121.358 0.599 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 p -88.88 177.84 6.59 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 124.664 1.185 . . . . 0.0 110.855 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -72.06 133.8 45.46 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 74.76 9.43 4.13 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.439 1.096 . . . . 0.0 112.702 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.0 170.12 31.54 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -90.9 113.19 25.33 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.936 0.368 . . . . 0.0 110.056 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.607 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.8 p -72.56 -33.7 66.99 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.758 0.79 . . . . 0.0 109.166 174.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.6 130.38 4.03 Favored Glycine 0 N--CA 1.398 -3.859 0 C-N-CA 118.58 -1.771 . . . . 0.0 115.311 174.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.42 -155.73 25.6 Favored Glycine 0 N--CA 1.406 -3.323 0 N-CA-C 106.179 -2.768 . . . . 0.0 106.179 172.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.35 129.42 21.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.24 9.11 52.19 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.269 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -114.43 138.49 50.51 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.6 p -138.38 14.15 2.79 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.27 0.557 . . . . 0.0 112.478 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.91 -132.72 7.2 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -69.98 94.02 0.55 Allowed 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.01 2.473 . . . . 0.0 112.307 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.6 p -86.98 -13.96 43.06 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.49 0.662 . . . . 0.0 111.026 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.66 133.11 31.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.106 177.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.5 m -92.75 168.82 10.94 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.059 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.28 156.44 39.26 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.878 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 m -60.89 121.19 11.73 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.317 0.58 . . . . 0.0 110.738 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.32 -15.5 42.68 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 68.8 p -107.15 145.07 32.98 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 p -110.95 135.2 51.83 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 123.555 0.535 . . . . 0.0 110.572 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 47.9 t -80.11 108.01 13.36 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -110.28 117.76 34.5 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.649 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.1 t -77.78 96.09 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.3 mt -79.93 -36.57 36.13 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.316 1.055 . . . . 0.0 109.661 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -135.8 162.4 57.14 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -60.39 -32.18 93.6 Favored 'Trans proline' 0 C--O 1.223 -0.26 0 CA-C-N 121.22 1.471 . . . . 0.0 112.966 -174.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -105.58 -24.02 12.66 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 120.975 0.417 . . . . 0.0 110.383 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -103.24 113.82 27.61 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.613 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.2 m -124.31 134.7 53.12 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -122.08 150.19 42.49 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.977 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.8 m -91.43 105.84 18.06 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.294 -1.835 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.493 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 . . . . . 0 N--CA 1.431 -1.397 0 CA-C-O 121.173 0.511 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 p -74.75 167.86 20.99 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 124.378 1.071 . . . . 0.0 112.068 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -65.3 130.98 45.3 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 77.16 9.16 2.73 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.196 1.398 . . . . 0.0 112.36 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.29 169.21 26.16 Favored Glycine 0 N--CA 1.431 -1.659 0 C-N-CA 119.85 -1.167 . . . . 0.0 110.449 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 33' ' ' SER . 8.0 tt0 -86.85 109.46 19.31 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 116.911 0.355 . . . . 0.0 110.368 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -71.45 -34.82 70.57 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-O 121.578 0.704 . . . . 0.0 109.57 174.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.32 133.75 4.44 Favored Glycine 0 N--CA 1.396 -3.976 0 C-N-CA 118.16 -1.972 . . . . 0.0 115.146 174.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.37 -156.26 23.59 Favored Glycine 0 N--CA 1.401 -3.671 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 173.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -56.97 131.7 20.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.92 -11.19 62.39 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.421 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -113.73 117.2 30.85 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 p -126.53 19.63 7.36 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.02 -128.49 1.88 Allowed Glycine 0 C--O 1.243 0.715 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -65.61 79.41 0.25 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.18 2.586 . . . . 0.0 112.867 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -85.3 -18.01 35.18 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.85 0.833 . . . . 0.0 109.907 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.92 129.4 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.3 m -91.66 168.47 11.46 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 120.762 0.315 . . . . 0.0 110.469 -178.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.79 145.46 52.48 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.2 t -52.26 124.66 13.73 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 123.716 0.635 . . . . 0.0 110.507 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.06 -26.66 16.48 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.858 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.2 p -97.61 140.73 31.59 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.994 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.4 p -100.52 133.8 44.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.278 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.2 t -81.01 107.01 13.46 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -108.77 116.98 33.01 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.8 t -75.02 103.26 2.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.41 HD12 ' CE1' ' A' ' 32' ' ' TYR . 86.0 mt -86.5 -48.07 8.71 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.666 -174.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -118.58 165.02 17.76 Favored Pre-proline 0 C--N 1.288 -2.099 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -60.97 -29.4 87.92 Favored 'Trans proline' 0 C--O 1.218 -0.476 0 CA-C-N 121.421 1.543 . . . . 0.0 111.646 -175.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -105.7 -23.93 12.64 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.964 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.41 ' CE1' HD12 ' A' ' 28' ' ' LEU . 85.8 t80 -103.1 113.97 27.88 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.16 0.505 . . . . 0.0 111.16 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.1 m -125.11 137.97 54.17 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 176.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -122.98 149.07 44.78 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.948 -175.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.2 m -89.36 106.07 18.21 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.297 -1.715 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.32 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 . . . . . 0 N--CA 1.436 -1.162 0 CA-C-O 120.999 0.428 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -70.3 165.64 21.88 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.374 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.403 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 16.2 t-160 -66.07 131.13 45.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 75.94 8.88 3.49 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.126 1.37 . . . . 0.0 111.631 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.68 170.76 31.18 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.0 tt0 -88.71 106.81 18.59 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.616 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.9 p -65.38 -40.97 94.16 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-O 121.594 0.711 . . . . 0.0 109.44 174.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.2 119.91 2.35 Favored Glycine 1 N--CA 1.396 -4.032 0 C-N-CA 118.449 -1.834 . . . . 0.0 114.667 174.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.95 -156.76 33.04 Favored Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 106.39 -2.684 . . . . 0.0 106.39 170.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -58.06 132.81 22.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 117.244 0.522 . . . . 0.0 109.908 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.21 -17.62 55.51 Favored Glycine 0 C--O 1.245 0.798 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.462 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -93.43 127.81 39.22 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.6 p -129.29 15.35 6.14 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.037 0.446 . . . . 0.0 111.465 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.61 -137.57 5.47 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.76 91.54 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.915 2.41 . . . . 0.0 111.351 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 2.4 p -89.67 0.24 57.09 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.73 0.776 . . . . 0.0 111.293 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -106.45 128.81 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.589 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.5 m -79.82 155.74 27.72 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.515 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.5 159.43 18.59 Favored 'General case' 0 C--O 1.254 1.297 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.883 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 m -49.86 118.24 2.75 Favored 'General case' 0 C--O 1.247 0.933 0 C-N-CA 124.041 0.936 . . . . 0.0 112.157 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.32 -12.1 43.75 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.52 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 75.6 p -110.51 153.51 24.98 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 117.59 0.695 . . . . 0.0 111.846 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.9 p -112.02 139.88 47.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.35 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.415 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.8 t -84.41 107.06 16.46 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.508 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 75.6 mt-30 -103.67 115.01 29.7 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.1 t -81.35 101.28 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.536 HD12 ' CE1' ' A' ' 32' ' ' TYR . 86.2 mt -80.03 -52.31 7.98 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.822 0.82 . . . . 0.0 109.37 -176.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -118.94 167.7 11.28 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.72 -32.52 86.56 Favored 'Trans proline' 0 C--N 1.347 0.489 0 CA-C-N 120.92 1.364 . . . . 0.0 112.384 -176.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -105.66 -23.55 12.73 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 120.777 0.322 . . . . 0.0 110.76 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.536 ' CE1' HD12 ' A' ' 28' ' ' LEU . 63.3 t80 -101.51 114.21 28.02 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.546 0.689 . . . . 0.0 110.801 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.7 m -129.37 143.74 50.96 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -130.97 148.93 52.79 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.512 -174.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 81.7 m -88.86 106.67 18.54 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.876 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.508 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.8 mm? . . . . . 0 C--N 1.298 -1.653 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 . . . . . 0 N--CA 1.445 -0.688 0 CA-C-O 121.372 0.606 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 p -75.31 176.26 7.59 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.193 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -63.51 134.1 55.0 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.831 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 73.91 9.22 4.77 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 124.58 1.152 . . . . 0.0 112.503 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.97 170.16 31.62 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.4 tt0 -90.81 105.79 18.07 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 122.439 0.296 . . . . 0.0 110.548 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.2 p -64.7 -56.76 11.69 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 170.61 106.46 0.19 Allowed Glycine 0 N--CA 1.407 -3.269 0 C-N-CA 117.958 -2.068 . . . . 0.0 113.34 -175.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.21 -165.07 20.34 Favored Glycine 0 N--CA 1.417 -2.606 0 N-CA-C 105.963 -2.855 . . . . 0.0 105.963 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.4 mt -65.11 112.66 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 118.22 1.01 . . . . 0.0 110.337 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.5 -9.09 28.39 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.026 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.46 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 2.8 t80 -113.52 113.22 24.82 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.8 p -125.46 14.77 8.24 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.124 0.487 . . . . 0.0 112.095 -176.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.65 -124.18 0.7 Allowed Glycine 0 C--N 1.318 -0.452 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -66.19 80.98 0.29 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.59 2.86 . . . . 0.0 111.812 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.2 p -84.04 -12.53 55.02 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-O 121.892 0.854 . . . . 0.0 111.182 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.9 132.87 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.6 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.8 m -90.75 163.14 14.58 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.395 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.43 141.43 54.67 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.585 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -53.68 114.58 1.6 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 123.748 0.819 . . . . 0.0 110.732 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.15 -9.95 29.09 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.595 -0.73 . . . . 0.0 113.06 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.7 p -111.52 135.64 51.81 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.1 p -96.17 132.77 41.25 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.736 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.581 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.0 t -77.01 113.06 14.31 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -114.73 116.95 29.48 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.5 t -79.72 103.15 6.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.3 mt -81.75 -48.44 11.64 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.142 0.972 . . . . 0.0 109.472 -173.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -122.44 167.24 14.63 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 103.734 -2.691 . . . . 0.0 103.734 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.37 -34.69 53.83 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 CA-C-N 121.18 1.457 . . . . 0.0 111.94 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -100.51 -24.81 14.38 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.699 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -104.0 114.39 28.6 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.9 m -118.88 153.32 34.74 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 174.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -140.33 148.24 41.05 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 118.798 0.726 . . . . 0.0 110.55 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.493 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.3 m -91.81 106.62 18.61 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.385 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 . . . . . 0 N--CA 1.424 -1.754 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 p -72.62 166.67 22.29 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 123.558 0.743 . . . . 0.0 111.29 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.401 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 15.0 t-160 -63.03 132.93 53.63 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 76.56 9.39 3.03 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.74 1.216 . . . . 0.0 112.462 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.2 170.63 28.94 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.6 tt0 -85.8 114.1 22.48 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.878 0.339 . . . . 0.0 110.337 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.634 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.4 p -71.47 -54.29 11.11 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 123.618 0.574 . . . . 0.0 110.3 176.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.5 122.46 0.83 Allowed Glycine 1 N--CA 1.396 -4.029 0 C-N-CA 118.228 -1.939 . . . . 0.0 113.902 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.13 -157.71 19.53 Favored Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 105.572 -3.011 . . . . 0.0 105.572 173.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.13 126.03 20.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 118.009 0.904 . . . . 0.0 108.92 175.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.6 -17.13 39.92 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.582 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -89.41 127.41 35.82 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -124.18 -3.43 8.01 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.37 -135.24 2.16 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.1 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.35 92.62 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.373 2.715 . . . . 0.0 113.348 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.5 p -91.72 -5.97 52.74 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.284 0.564 . . . . 0.0 111.624 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.8 t -96.18 130.11 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.9 m -87.56 161.72 17.59 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.182 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.14 153.03 5.43 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 124.206 1.002 . . . . 0.0 110.684 176.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.2 m -51.23 111.19 0.53 Allowed 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 123.936 0.895 . . . . 0.0 111.741 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.49 -14.95 57.76 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.247 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 70.4 p -92.74 139.76 30.22 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.0 p -101.97 136.83 41.13 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -176.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.426 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.6 t -80.89 117.63 21.69 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -116.96 117.93 31.02 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.67 96.29 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.2 mt -76.76 -38.98 53.16 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.094 -175.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -131.27 160.56 66.55 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -59.62 -27.63 85.43 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 121.548 1.499 . . . . 0.0 111.332 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -106.55 -24.38 12.2 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.453 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -103.32 114.37 28.59 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.051 -0.659 . . . . 0.0 110.463 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.7 m -127.76 136.06 50.99 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -123.03 149.93 43.71 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.388 -173.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 79.2 m -90.05 106.79 18.71 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.578 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.298 -1.638 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.507 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.439 -0.997 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -86.45 123.65 31.91 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 118.514 0.597 . . . . 0.0 111.073 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.7 p -65.65 163.27 16.68 Favored 'General case' 0 C--O 1.254 1.34 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.375 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -60.59 130.71 47.89 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.297 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 75.61 9.13 3.64 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.232 1.413 . . . . 0.0 112.331 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.95 172.05 32.0 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 33' ' ' SER . 7.7 tt0 -86.47 103.78 15.33 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.873 0.336 . . . . 0.0 110.702 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.574 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 3.6 p -67.12 -28.17 67.93 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.841 0.829 . . . . 0.0 109.428 174.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.463 ' HA3' ' CG ' ' A' ' 13' ' ' TYR . . . 108.98 134.22 7.04 Favored Glycine 0 N--CA 1.396 -3.991 0 C-N-CA 118.85 -1.643 . . . . 0.0 115.254 172.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.99 -155.94 29.04 Favored Glycine 0 N--CA 1.403 -3.506 0 N-CA-C 107.614 -2.195 . . . . 0.0 107.614 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.7 mt -57.11 128.03 17.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.71 -19.02 36.75 Favored Glycine 0 C--N 1.311 -0.844 0 C-N-CA 120.044 -1.074 . . . . 0.0 112.644 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.463 ' CG ' ' HA3' ' A' ' 9' ' ' GLY . 9.3 t80 -90.88 125.45 35.75 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -118.63 2.99 11.75 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -174.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.03 -128.68 5.97 Favored Glycine 0 C--N 1.311 -0.835 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.976 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -64.67 85.67 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.572 2.848 . . . . 0.0 113.027 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -90.12 -7.55 53.47 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 122.042 0.925 . . . . 0.0 109.72 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.14 131.28 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.574 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.2 m -92.85 158.05 16.06 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.086 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.52 141.19 32.08 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 123.801 0.688 . . . . 0.0 109.75 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 m -51.31 117.92 2.92 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.628 0.771 . . . . 0.0 111.859 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.92 -18.15 26.72 Favored Glycine 0 N--CA 1.431 -1.689 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.231 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 61.2 p -102.57 144.68 30.67 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.0 p -100.94 132.7 46.23 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.486 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.2 t -79.49 106.47 11.55 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.419 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.6 mt-30 -106.08 114.79 29.14 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.664 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.9 t -78.93 96.3 2.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.454 HD12 ' CE2' ' A' ' 32' ' ' TYR . 80.9 mt -77.15 -52.12 9.82 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.947 -175.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -115.79 162.31 26.05 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.57 -24.44 78.01 Favored 'Trans proline' 0 C--O 1.212 -0.791 0 CA-C-N 121.375 1.527 . . . . 0.0 112.099 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -108.87 -23.38 11.76 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.752 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.454 ' CE2' HD12 ' A' ' 28' ' ' LEU . 69.3 t80 -103.01 114.09 28.1 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.167 0.508 . . . . 0.0 111.457 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -126.88 134.26 50.53 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -120.24 151.25 39.43 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -176.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.1 m -92.76 106.17 18.19 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.419 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.9 mm? . . . . . 0 C--N 1.297 -1.681 0 CA-C-O 118.462 -0.78 . . . . 0.0 109.233 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 N--CA 1.442 -0.874 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -90.62 128.03 36.47 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.356 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 t -73.47 177.09 5.51 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-O 121.809 0.814 . . . . 0.0 110.947 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -64.12 131.8 48.55 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.374 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 76.06 9.79 3.25 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.916 1.286 . . . . 0.0 113.386 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.3 168.0 25.3 Favored Glycine 0 C--N 1.312 -0.786 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.573 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.0 tt0 -81.54 112.72 19.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 117.026 0.413 . . . . 0.0 110.353 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.699 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.3 p -72.87 -58.07 3.6 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.783 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.418 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 171.71 109.42 0.22 Allowed Glycine 0 N--CA 1.396 -3.98 0 C-N-CA 118.134 -1.984 . . . . 0.0 113.363 -176.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.56 -157.53 17.31 Favored Glycine 0 N--CA 1.405 -3.406 0 N-CA-C 105.974 -2.851 . . . . 0.0 105.974 171.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.418 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 77.2 mt -65.67 126.1 24.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 117.665 0.732 . . . . 0.0 109.604 174.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.96 -13.16 60.69 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.907 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -90.37 111.96 23.38 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.8 p -109.98 6.83 23.44 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.97 -136.97 9.29 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.872 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -64.13 88.29 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.682 2.922 . . . . 0.0 112.996 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 24.4 p -84.21 -16.09 44.59 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.787 0.803 . . . . 0.0 110.5 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.3 t -82.4 129.84 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.74 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.0 m -88.18 168.92 12.34 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.002 0.43 . . . . 0.0 110.954 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.62 155.04 16.33 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.758 0.823 . . . . 0.0 110.709 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -64.52 111.53 2.74 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.245 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.51 6.47 27.08 Favored Glycine 0 N--CA 1.432 -1.578 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.056 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 59.7 p -125.1 152.19 44.71 Favored 'General case' 0 C--O 1.244 0.788 0 O-C-N 122.411 -0.464 . . . . 0.0 110.394 177.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.1 p -115.23 139.85 49.6 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.881 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.3 t -83.92 110.12 18.15 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -110.68 114.91 28.66 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -79.56 98.2 2.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.117 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.1 mt -78.52 -43.86 25.78 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.48 -174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -126.73 160.46 58.6 Favored Pre-proline 0 C--N 1.289 -2.033 0 N-CA-C 103.655 -2.72 . . . . 0.0 103.655 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.41 -29.43 84.37 Favored 'Trans proline' 0 C--O 1.225 -0.153 0 C-N-CA 121.752 1.635 . . . . 0.0 112.005 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 53.6 m-85 -104.36 -25.5 12.82 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.851 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -104.28 113.56 27.2 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 119.551 -0.859 . . . . 0.0 110.434 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 13.7 m -125.53 135.74 52.59 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 177.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -121.35 147.61 45.47 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.411 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.699 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.7 m -87.62 106.64 18.16 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.29 -2.003 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.98 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.439 -1.014 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -93.57 117.91 30.69 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 121.796 -0.565 . . . . 0.0 110.451 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 m -69.15 169.11 12.61 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.555 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.424 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 17.7 t-160 -59.62 132.25 53.39 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.509 0.723 . . . . 0.0 109.27 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 77.4 8.87 2.66 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.564 1.546 . . . . 0.0 112.247 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.87 169.0 29.33 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.562 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.0 tt0 -88.31 103.77 16.12 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.604 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.5 p -62.51 -47.86 82.09 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.246 0.546 . . . . 0.0 111.68 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 151.07 117.18 0.77 Allowed Glycine 0 N--CA 1.397 -3.904 0 C-N-CA 118.189 -1.958 . . . . 0.0 113.773 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.56 -157.39 18.78 Favored Glycine 0 N--CA 1.413 -2.873 0 N-CA-C 106.376 -2.69 . . . . 0.0 106.376 172.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.84 121.68 14.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 117.963 0.881 . . . . 0.0 109.597 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.96 -9.17 46.72 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.386 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.445 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 2.7 t80 -113.79 112.01 22.71 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.0 p -120.98 14.99 11.6 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 120.866 0.365 . . . . 0.0 111.877 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.41 -126.49 0.97 Allowed Glycine 0 C--O 1.241 0.588 0 C-N-CA 121.261 -0.495 . . . . 0.0 111.878 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.2 79.95 0.56 Allowed 'Trans proline' 0 C--O 1.217 -0.547 0 C-N-CA 122.939 2.426 . . . . 0.0 112.01 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 23.0 p -83.45 2.18 37.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 122.269 1.033 . . . . 0.0 110.787 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.2 t -101.42 131.86 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.8 m -90.31 162.08 15.34 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 123.358 0.411 . . . . 0.0 110.591 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.75 144.64 37.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.841 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.1 p -56.17 118.2 4.48 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 124.069 0.856 . . . . 0.0 111.416 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.03 -3.19 28.56 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.983 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.2 p -120.51 166.15 14.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 117.388 0.594 . . . . 0.0 110.281 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 34.4 p -120.89 146.04 47.02 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 122.202 0.201 . . . . 0.0 111.152 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.5 t -90.08 111.54 22.69 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -111.81 114.82 28.03 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -76.96 99.85 2.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 mt -82.53 -53.98 5.54 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.298 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -110.29 165.57 12.43 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.27 -26.23 64.2 Favored 'Trans proline' 0 C--O 1.221 -0.35 0 CA-C-N 121.445 1.552 . . . . 0.0 111.14 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -106.53 -25.29 11.9 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.432 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -103.62 113.26 26.64 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.631 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.4 m -123.54 139.31 54.14 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 176.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -127.61 150.57 49.67 Favored 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.597 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.7 m -90.01 106.42 18.46 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.299 -1.588 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.433 -1.302 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -78.68 123.9 27.63 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.246 0.546 . . . . 0.0 111.7 -170.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -74.22 171.95 12.67 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.459 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -62.32 132.86 54.05 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.365 0.666 . . . . 0.0 109.719 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 74.74 8.99 4.21 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.282 1.433 . . . . 0.0 112.406 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.25 169.56 33.36 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -89.09 105.61 17.9 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 117.134 0.467 . . . . 0.0 110.792 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 2.5 p -67.26 -31.5 71.87 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 121.587 0.708 . . . . 0.0 109.934 175.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.53 131.35 5.13 Favored Glycine 0 N--CA 1.396 -3.987 0 C-N-CA 118.922 -1.608 . . . . 0.0 115.866 172.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.6 -156.06 25.47 Favored Glycine 0 N--CA 1.408 -3.225 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.2 mt -56.31 127.4 15.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.17 -23.36 29.09 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.055 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -89.04 130.94 35.41 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.2 p -137.86 14.91 2.89 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.656 0.741 . . . . 0.0 111.234 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.8 -130.23 5.3 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.41 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.45 84.26 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.314 2.676 . . . . 0.0 112.267 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.3 p -88.25 2.32 52.59 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 122.252 1.025 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -105.88 127.25 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.9 m -87.76 153.02 21.68 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.84 154.4 15.09 Favored 'General case' 0 C--O 1.252 1.216 0 O-C-N 123.596 0.56 . . . . 0.0 111.236 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.2 m -49.4 116.39 1.71 Allowed 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.556 1.142 . . . . 0.0 112.035 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.89 -1.8 48.28 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.557 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.5 p -117.7 145.67 44.26 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 117.649 0.725 . . . . 0.0 110.212 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.5 p -106.25 138.64 42.07 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -79.4 113.81 17.83 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.427 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.6 mt-30 -113.73 114.76 26.81 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.49 100.14 2.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.3 mt -79.26 -53.2 7.18 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -175.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -116.85 160.3 37.32 Favored Pre-proline 0 C--N 1.29 -1.995 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.27 -29.89 91.48 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 121.484 1.456 . . . . 0.0 113.261 -174.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -106.58 -23.81 12.35 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 120.959 0.409 . . . . 0.0 110.488 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -103.12 113.49 27.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.217 0.532 . . . . 0.0 111.352 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.7 m -124.99 142.74 51.29 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -129.84 149.14 51.71 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.238 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 67.5 m -88.67 107.63 19.03 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.939 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.427 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.8 mm? . . . . . 0 C--N 1.303 -1.419 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.438 -1.072 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -80.15 135.63 36.34 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.555 -175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -81.77 169.85 16.42 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 124.088 0.955 . . . . 0.0 111.877 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -64.63 131.57 47.33 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 75.61 9.51 3.57 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.718 1.207 . . . . 0.0 112.741 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.03 167.57 26.7 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.429 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.9 tt0 -84.96 116.08 23.17 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.617 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.6 p -73.56 -55.2 6.61 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 123.8 0.688 . . . . 0.0 110.973 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.411 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 161.65 108.65 0.23 Allowed Glycine 0 N--CA 1.401 -3.673 0 C-N-CA 118.114 -1.993 . . . . 0.0 114.528 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.33 -158.33 29.0 Favored Glycine 0 N--CA 1.41 -3.043 0 N-CA-C 106.36 -2.696 . . . . 0.0 106.36 171.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.495 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 72.6 mt -65.3 117.07 5.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 118.074 0.937 . . . . 0.0 110.901 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.25 -14.79 23.16 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.573 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -92.27 125.57 36.99 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.6 p -119.76 -6.39 10.12 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.42 -131.2 1.81 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.762 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.53 79.98 0.1 Allowed 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 123.963 3.109 . . . . 0.0 112.669 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 5.2 p -85.35 -5.94 59.27 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.86 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.0 t -99.43 131.96 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 82.6 m -92.54 146.95 23.28 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 123.364 0.415 . . . . 0.0 110.092 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.53 154.05 6.95 Favored 'General case' 0 C--O 1.251 1.17 0 O-C-N 124.007 0.817 . . . . 0.0 110.865 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 m -50.82 126.86 16.97 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.865 0.866 . . . . 0.0 111.417 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.93 -16.54 57.29 Favored Glycine 0 N--CA 1.432 -1.585 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.565 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.8 p -110.22 142.41 41.83 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.432 0.616 . . . . 0.0 110.289 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.3 p -109.29 133.6 52.83 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.507 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.6 t -75.31 107.15 7.22 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -109.37 114.73 28.65 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.3 t -78.55 96.63 2.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.0 mt -75.7 -51.5 12.59 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.371 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -120.34 166.99 13.66 Favored Pre-proline 0 C--N 1.284 -2.258 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.57 -33.5 86.98 Favored 'Trans proline' 0 C--N 1.343 0.261 0 CA-C-N 121.399 1.535 . . . . 0.0 112.323 -175.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.495 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 21.9 m-85 -104.94 -23.78 12.93 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.44 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -102.23 113.5 26.85 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.376 0.607 . . . . 0.0 110.761 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.0 m -127.0 137.46 53.1 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -128.37 150.78 49.95 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.304 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.556 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 67.1 m -90.15 105.68 17.97 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.294 -1.833 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.945 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.444 -0.747 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -81.79 128.07 33.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.195 0.522 . . . . 0.0 111.721 -172.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 p -70.39 169.81 13.19 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.004 0.922 . . . . 0.0 112.907 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -61.74 129.5 41.33 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.904 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 76.75 9.25 2.94 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.766 1.226 . . . . 0.0 112.765 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.05 164.21 28.46 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.3 tt0 -83.49 107.47 15.99 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.627 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.6 p -67.27 -51.04 57.82 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-O 121.183 0.516 . . . . 0.0 111.421 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.59 118.69 0.71 Allowed Glycine 0 N--CA 1.399 -3.794 0 C-N-CA 118.266 -1.921 . . . . 0.0 113.651 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.12 -158.09 18.34 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 105.691 -2.964 . . . . 0.0 105.691 171.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.63 119.97 15.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 117.919 0.86 . . . . 0.0 109.042 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.38 -6.27 28.39 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.014 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -113.9 132.27 55.98 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 p -141.33 20.82 2.23 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.88 -121.6 3.33 Favored Glycine 0 C--O 1.241 0.54 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -67.75 78.81 0.52 Allowed 'Trans proline' 0 N--CA 1.476 0.494 0 C-N-CA 123.697 2.931 . . . . 0.0 111.96 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.5 p -82.3 -16.66 48.57 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.55 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.8 t -89.14 133.0 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.1 m -87.39 159.1 18.84 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.12 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.63 160.61 8.89 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.931 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 m -62.82 128.9 38.07 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.625 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.17 5.41 59.43 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.492 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.4 p -128.55 164.88 21.85 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 117.33 0.565 . . . . 0.0 109.885 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.3 p -130.94 138.64 49.83 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 122.182 0.193 . . . . 0.0 110.845 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.464 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.2 t -78.23 114.38 17.06 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 36' ' ' LEU . 40.0 mt-30 -115.94 115.81 26.84 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.922 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.1 t -77.7 99.79 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.2 mt -78.31 -50.6 11.5 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 122.042 0.925 . . . . 0.0 108.843 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -120.26 161.75 37.33 Favored Pre-proline 0 C--N 1.289 -2.057 0 N-CA-C 103.941 -2.615 . . . . 0.0 103.941 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.43 -28.66 88.12 Favored 'Trans proline' 0 N--CA 1.474 0.345 0 CA-C-N 120.896 1.356 . . . . 0.0 112.093 -175.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -105.01 -25.18 12.66 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.835 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -104.01 113.04 26.29 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.562 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -125.35 140.03 53.17 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -130.95 149.43 52.58 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.921 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.4 m -87.68 106.07 17.79 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.42 ' HB2' ' OE1' ' A' ' 26' ' ' GLN . 2.7 mm? . . . . . 0 C--N 1.289 -2.022 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -83.14 146.15 28.82 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.518 0.675 . . . . 0.0 111.831 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 p -80.91 161.7 24.25 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 124.357 1.063 . . . . 0.0 111.426 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -62.06 131.59 50.09 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 77.69 9.68 2.37 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.717 1.207 . . . . 0.0 112.752 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.67 170.01 25.03 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.424 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.6 tt0 -81.56 109.18 15.76 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.659 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -71.44 -54.04 11.98 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 121.266 0.555 . . . . 0.0 111.353 177.597 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.408 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 163.12 116.47 0.38 Allowed Glycine 1 N--CA 1.394 -4.111 0 C-N-CA 118.101 -1.999 . . . . 0.0 113.835 -177.503 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.25 -158.2 18.19 Favored Glycine 0 N--CA 1.409 -3.149 0 N-CA-C 105.485 -3.046 . . . . 0.0 105.485 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.2 mt -66.38 121.05 14.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 117.891 0.845 . . . . 0.0 110.049 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.09 -20.06 29.08 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.295 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -80.03 129.32 34.4 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.7 p -135.4 18.53 3.37 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.56 -125.85 5.52 Favored Glycine 0 C--N 1.311 -0.807 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.513 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.79 85.78 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.242 2.628 . . . . 0.0 111.925 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 10.2 p -88.94 -8.04 54.92 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.573 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.91 137.05 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 90.6 m -87.71 163.14 16.68 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.147 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.87 153.43 10.98 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.967 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.7 m -57.71 114.57 2.34 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.506 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.53 4.43 56.04 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.814 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 81.3 p -113.83 143.82 44.04 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 117.486 0.643 . . . . 0.0 109.882 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.3 p -103.55 132.65 49.62 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.515 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 45.9 t -79.16 106.73 11.4 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -104.61 114.76 29.19 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.4 t -77.83 101.65 3.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.9 mt -81.53 -39.45 24.66 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.738 0.78 . . . . 0.0 109.503 -173.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -132.97 163.06 53.77 Favored Pre-proline 0 C--N 1.289 -2.058 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -60.88 -28.35 86.23 Favored 'Trans proline' 0 C--N 1.345 0.367 0 CA-C-N 120.986 1.388 . . . . 0.0 112.618 -175.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -108.84 -24.07 11.45 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.407 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -103.11 114.51 28.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.292 0.568 . . . . 0.0 111.442 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.612 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.3 m -124.62 146.91 48.82 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -131.44 147.19 52.53 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.079 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.659 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.3 m -89.57 106.47 18.48 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 C--N 1.297 -1.678 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.615 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.424 HG22 ' HB ' ' A' ' 18' ' ' VAL . 11.6 p . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -99.11 143.38 29.44 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 p -76.81 171.24 15.05 Favored 'General case' 0 C--O 1.251 1.151 0 CA-C-O 121.179 0.514 . . . . 0.0 111.952 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -63.46 129.74 41.46 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 75.19 9.43 3.84 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.62 1.568 . . . . 0.0 111.508 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.76 165.84 32.35 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -86.56 106.55 17.62 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.517 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.5 p -70.01 -27.09 64.4 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.834 0.825 . . . . 0.0 109.067 174.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.25 129.43 6.0 Favored Glycine 1 N--CA 1.394 -4.165 0 C-N-CA 119.245 -1.455 . . . . 0.0 115.41 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.8 -156.65 30.91 Favored Glycine 0 N--CA 1.407 -3.272 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 171.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.9 mt -59.78 125.43 15.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.54 -1.07 32.47 Favored Glycine 0 C--N 1.317 -0.525 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.386 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -113.62 119.94 39.2 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.4 p -115.81 9.52 15.1 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.76 -139.78 7.68 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.353 -0.693 . . . . 0.0 111.809 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.34 94.58 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.23 2.62 . . . . 0.0 112.083 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.0 p -92.76 -7.46 46.5 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.479 0.657 . . . . 0.0 111.378 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 1' ' ' THR . 48.5 t -100.77 135.58 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.495 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.9 m -90.71 161.8 15.19 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 120.719 0.295 . . . . 0.0 111.69 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.18 164.73 10.41 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.61 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.6 m -54.12 111.52 0.78 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 124.354 1.062 . . . . 0.0 112.764 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.07 -13.48 57.37 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.243 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 82.2 p -100.18 141.03 33.57 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 122.17 -0.606 . . . . 0.0 109.889 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 27.4 p -106.08 136.78 45.15 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.792 -0.186 . . . . 0.0 111.36 -177.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.4 t -80.73 106.15 12.51 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -107.97 115.42 30.1 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.703 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.25 96.17 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.6 mt -77.55 -39.1 47.0 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.057 -173.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -133.55 163.74 48.99 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -61.55 -29.31 84.35 Favored 'Trans proline' 0 C--O 1.235 0.373 0 CA-C-N 121.549 1.589 . . . . 0.0 112.941 -173.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -107.72 -23.5 12.08 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.85 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -103.15 113.83 27.63 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.054 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 m -125.34 141.27 52.17 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -131.75 150.38 52.17 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.018 -174.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.517 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.0 m -89.29 105.89 18.09 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.99 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--N 1.29 -1.984 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.413 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' NE2' ' HA3' ' A' ' 6' ' ' GLY . 26.0 tp60 -81.39 121.76 26.64 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.254 0.55 . . . . 0.0 111.106 -175.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 m -66.75 166.75 12.53 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.48 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -62.28 131.33 49.02 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.652 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 77.25 8.87 2.73 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.705 1.602 . . . . 0.0 112.482 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.47 ' HA3' ' NE2' ' A' ' 2' ' ' GLN . . . -91.85 170.59 33.56 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.5 tt0 -88.49 107.48 18.9 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.68 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.6 p -62.73 -56.91 13.26 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 121.016 0.436 . . . . 0.0 111.664 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.436 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 164.5 112.66 0.27 Allowed Glycine 0 N--CA 1.4 -3.725 0 C-N-CA 118.278 -1.915 . . . . 0.0 113.671 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.59 -167.28 20.13 Favored Glycine 0 N--CA 1.41 -3.038 0 N-CA-C 106.4 -2.68 . . . . 0.0 106.4 171.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.8 mt -59.76 111.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 117.823 0.812 . . . . 0.0 110.926 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.33 -5.02 26.69 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.753 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -98.49 127.94 44.63 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.0 p -124.59 -1.8 7.97 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.73 -135.64 2.81 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.042 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 39.5 Cg_exo -63.99 80.44 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.056 3.171 . . . . 0.0 112.386 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.671 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 9.2 p -76.8 -22.06 54.22 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.721 0.772 . . . . 0.0 110.726 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.08 129.15 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 87.6 m -87.13 161.5 18.06 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.889 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.76 157.79 14.16 Favored 'General case' 0 C--O 1.256 1.396 0 C-N-CA 123.765 0.826 . . . . 0.0 110.808 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.5 m -64.03 111.21 2.42 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.142 0.496 . . . . 0.0 110.406 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.31 0.32 33.14 Favored Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.903 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 79.2 p -116.81 139.48 50.55 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.283 -0.54 . . . . 0.0 109.605 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 24.8 p -102.04 136.04 42.57 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.056 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.448 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.5 t -81.89 109.95 16.72 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -109.89 114.6 28.28 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.41 98.88 3.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.9 mt -78.93 -53.27 7.22 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.855 0.836 . . . . 0.0 109.369 -173.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -115.77 167.04 10.86 Favored Pre-proline 0 C--N 1.283 -2.299 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -61.04 -32.14 91.72 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 CA-C-N 121.001 1.393 . . . . 0.0 112.278 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -105.68 -23.96 12.64 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.23 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -102.36 113.89 27.59 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.344 0.592 . . . . 0.0 111.477 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.6 m -124.64 153.0 42.92 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 176.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -140.83 149.4 41.96 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.536 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.601 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 68.9 m -91.67 106.07 18.2 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--N 1.3 -1.549 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.628 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.436 -1.162 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -86.35 130.29 34.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.369 0.604 . . . . 0.0 110.93 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 p -75.08 169.38 18.14 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.188 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -61.82 132.49 53.27 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.373 1.069 . . . . 0.0 109.244 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 74.52 8.84 4.38 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 125.077 1.351 . . . . 0.0 112.565 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.05 164.89 26.36 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.4 tt0 -84.58 101.13 11.88 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.6 p -63.23 -42.49 99.25 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.23 0.538 . . . . 0.0 111.053 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.422 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 139.59 123.61 2.08 Favored Glycine 1 N--CA 1.393 -4.199 0 C-N-CA 118.048 -2.025 . . . . 0.0 114.247 177.053 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.38 -157.81 17.75 Favored Glycine 0 N--CA 1.403 -3.565 0 N-CA-C 105.432 -3.067 . . . . 0.0 105.432 171.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.3 mt -62.67 130.92 27.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.88 -7.96 61.08 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.837 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -109.91 136.56 49.01 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.2 p -141.39 21.23 2.22 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.1 -126.38 5.07 Favored Glycine 0 C--N 1.307 -1.039 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.469 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -70.1 86.7 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.29 2.66 . . . . 0.0 111.537 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.9 p -82.54 -16.81 47.24 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.889 0.852 . . . . 0.0 110.917 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.78 135.36 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 67.3 m -93.07 162.17 14.14 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.62 138.97 51.52 Favored 'General case' 0 C--O 1.25 1.109 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.6 m -57.61 127.16 30.6 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.411 0.444 . . . . 0.0 110.731 -175.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.05 -16.54 27.66 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.214 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.6 p -115.91 144.89 43.43 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.8 p -103.66 136.86 42.58 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -175.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 38.4 t -81.1 107.1 13.62 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -104.42 114.51 28.79 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.554 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.0 t -80.01 100.59 4.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.5 mt -82.91 -51.33 7.71 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.254 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.483 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 1.7 m-20 -112.35 161.64 25.2 Favored Pre-proline 0 C--N 1.292 -1.922 0 N-CA-C 102.102 -3.295 . . . . 0.0 102.102 174.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.02 -25.73 77.89 Favored 'Trans proline' 0 C--O 1.22 -0.412 0 CA-C-N 121.667 1.631 . . . . 0.0 111.326 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -104.26 -23.77 13.2 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.16 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.483 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 61.0 t80 -103.82 114.11 28.12 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.53 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.2 m -125.47 142.24 51.61 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -133.68 147.98 51.44 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.894 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.1 m -88.55 106.5 18.33 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.23 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.294 -1.826 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.519 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.435 -1.197 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.463 ' NE2' ' HA3' ' A' ' 6' ' ' GLY . 28.0 tp60 -89.8 129.55 36.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.242 0.544 . . . . 0.0 111.145 -174.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 p -72.96 172.82 10.25 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 124.169 0.988 . . . . 0.0 112.655 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -67.52 130.41 42.95 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 77.13 9.18 2.74 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.37 1.468 . . . . 0.0 112.351 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.463 ' HA3' ' NE2' ' A' ' 2' ' ' GLN . . . -90.95 164.31 29.87 Favored Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 175.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -82.55 104.61 12.95 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.694 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.7 p -62.53 -55.18 29.84 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-O 121.099 0.476 . . . . 0.0 111.305 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 159.83 112.89 0.32 Allowed Glycine 1 N--CA 1.392 -4.285 0 C-N-CA 117.685 -2.198 . . . . 0.0 114.123 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.35 -158.14 22.91 Favored Glycine 0 N--CA 1.402 -3.604 0 N-CA-C 105.313 -3.115 . . . . 0.0 105.313 170.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.24 128.89 31.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 118.044 0.922 . . . . 0.0 108.628 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.91 -8.98 50.89 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.687 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.461 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 3.4 t80 -113.66 118.03 33.21 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 p -124.54 3.05 8.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.51 -119.69 0.84 Allowed Glycine 0 C--O 1.243 0.658 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.964 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 25.2 Cg_exo -67.96 78.5 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.662 2.908 . . . . 0.0 111.836 175.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.654 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.7 p -85.83 -22.66 27.5 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.455 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.89 131.94 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -85.68 153.11 22.57 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.291 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.94 148.64 20.6 Favored 'General case' 0 C--O 1.244 0.791 0 O-C-N 123.932 0.77 . . . . 0.0 110.717 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 m -55.11 116.82 3.0 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 122.979 0.512 . . . . 0.0 111.508 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.93 -5.7 29.08 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.287 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.2 p -119.27 154.52 33.33 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.6 p -116.73 142.09 47.36 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.977 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.5 t -83.06 112.04 19.43 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.528 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.5 mt-30 -109.74 114.37 27.89 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.7 t -81.93 105.83 12.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.8 mt -83.38 -53.89 5.39 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.943 -175.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -116.21 163.29 22.2 Favored Pre-proline 0 C--N 1.296 -1.737 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -58.37 -31.86 94.88 Favored 'Trans proline' 0 C--O 1.218 -0.503 0 C-N-CA 121.279 1.319 . . . . 0.0 112.04 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -102.69 -24.12 13.78 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.865 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -103.7 114.18 28.25 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 120.934 0.397 . . . . 0.0 111.904 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.8 m -129.22 147.52 51.07 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -136.62 147.65 47.04 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.14 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.694 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.6 m -87.25 106.74 18.12 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.197 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.528 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.6 mm? . . . . . 0 C--N 1.294 -1.816 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.494 HE21 ' HA3' ' A' ' 6' ' ' GLY . 59.0 tp60 -103.75 134.36 47.19 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 118.656 0.662 . . . . 0.0 110.157 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -73.76 166.17 23.79 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.953 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -60.41 133.81 56.46 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.74 0.816 . . . . 0.0 108.95 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 74.87 9.25 4.08 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.201 1.4 . . . . 0.0 112.04 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.494 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.17 170.43 28.81 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.175 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 33' ' ' SER . 8.2 tt0 -88.43 107.82 19.06 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.523 0.161 . . . . 0.0 110.574 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.622 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -69.08 -29.74 67.91 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 121.973 0.892 . . . . 0.0 109.024 173.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.23 126.97 4.19 Favored Glycine 1 N--CA 1.391 -4.36 0 C-N-CA 118.771 -1.681 . . . . 0.0 114.566 174.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.44 -156.25 32.13 Favored Glycine 0 N--CA 1.41 -3.037 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 171.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -58.08 129.75 20.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 117.566 0.683 . . . . 0.0 109.347 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.21 -22.34 31.38 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.687 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -103.05 112.02 24.65 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -118.58 11.41 12.86 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -175.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.23 -122.16 1.12 Allowed Glycine 0 C--O 1.245 0.804 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.849 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.8 78.65 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.051 3.167 . . . . 0.0 113.003 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.7 p -86.13 -16.81 36.78 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.081 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -90.58 133.8 31.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 86.1 m -92.97 157.55 16.27 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.388 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.13 158.9 18.62 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.784 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.5 m -55.1 121.11 8.05 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.303 0.641 . . . . 0.0 111.644 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.01 -16.96 45.67 Favored Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.427 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 59.2 p -106.88 143.11 35.44 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 122.248 -0.56 . . . . 0.0 110.976 -177.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.2 p -109.36 136.8 48.2 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.498 0.319 . . . . 0.0 111.567 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.43 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.0 t -79.93 108.68 13.7 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -113.19 117.36 31.69 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.338 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.76 106.91 7.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.2 mt -88.38 -41.73 12.64 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.193 0.997 . . . . 0.0 108.949 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -127.71 161.16 56.92 Favored Pre-proline 0 C--N 1.286 -2.166 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 178.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -60.2 -31.63 93.36 Favored 'Trans proline' 0 CA--C 1.52 -0.217 0 CA-C-N 121.027 1.402 . . . . 0.0 112.051 -174.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -105.04 -23.46 12.95 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.295 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -103.29 114.04 28.01 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.176 0.512 . . . . 0.0 111.421 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.2 m -125.57 138.82 53.96 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -124.01 149.96 45.43 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.315 -174.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.4 m -91.91 106.07 18.18 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.287 -2.134 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.638 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.5 m . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -96.46 134.84 39.15 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 118.948 0.795 . . . . 0.0 110.786 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 p -86.97 177.41 7.25 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 121.148 0.499 . . . . 0.0 111.596 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -62.92 132.41 51.99 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.048 0.539 . . . . 0.0 110.024 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 78.92 8.69 1.93 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.624 1.569 . . . . 0.0 113.218 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.47 173.54 32.67 Favored Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.877 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.0 tt0 -91.4 110.77 22.07 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.8 p -70.84 -33.28 70.5 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-O 121.76 0.79 . . . . 0.0 109.184 174.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.05 133.61 4.58 Favored Glycine 0 N--CA 1.398 -3.897 0 C-N-CA 118.469 -1.824 . . . . 0.0 115.397 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.31 -156.23 20.09 Favored Glycine 0 N--CA 1.402 -3.599 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.93 129.59 20.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.58 -6.72 55.35 Favored Glycine 0 C--N 1.307 -1.031 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.959 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -114.01 132.88 55.83 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.0 p -135.19 6.98 3.36 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.49 -123.14 2.03 Favored Glycine 0 C--O 1.246 0.865 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.273 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -65.27 79.21 0.22 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.709 2.94 . . . . 0.0 113.333 176.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.5 p -89.08 7.01 37.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 122.359 1.076 . . . . 0.0 109.384 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.9 t -106.24 116.92 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.112 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.444 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.1 m -83.44 149.69 26.51 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.14 151.25 12.63 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 123.932 0.77 . . . . 0.0 110.854 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -59.91 119.74 8.3 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.128 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.25 -9.98 28.87 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.784 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.7 p -118.49 146.18 44.71 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 122.197 -0.59 . . . . 0.0 110.491 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 34.4 p -107.08 140.94 39.1 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.135 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.0 t -85.42 107.26 17.32 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -107.89 114.64 28.73 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.49 96.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.421 HD12 ' CE1' ' A' ' 32' ' ' TYR . 87.6 mt -75.68 -53.22 8.9 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.468 0.707 . . . . 0.0 109.831 -174.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -112.06 162.66 20.28 Favored Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 172.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.67 -23.43 75.99 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 CA-C-N 120.935 1.37 . . . . 0.0 111.67 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -106.85 -24.72 11.96 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.979 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.421 ' CE1' HD12 ' A' ' 28' ' ' LEU . 74.7 t80 -103.67 113.8 27.59 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.971 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.9 m -126.68 135.35 51.04 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -124.76 150.34 46.36 Favored 'General case' 0 C--N 1.286 -2.169 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.199 -175.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 79.3 m -90.37 106.27 18.38 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.302 -1.494 0 CA-C-O 118.646 -0.692 . . . . 0.0 109.835 -178.867 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.437 -1.09 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -84.34 138.36 32.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.15 0.5 . . . . 0.0 111.654 -175.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 p -79.56 170.85 15.96 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.857 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -62.84 134.88 56.92 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.116 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 74.16 9.31 4.58 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.28 1.432 . . . . 0.0 112.3 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.78 170.65 30.94 Favored Glycine 0 N--CA 1.431 -1.653 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.398 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.1 tt0 -87.18 107.25 18.39 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.596 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.5 p -68.26 -51.46 44.9 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 121.195 0.521 . . . . 0.0 110.814 177.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 156.48 121.2 0.69 Allowed Glycine 1 N--CA 1.393 -4.184 0 C-N-CA 118.203 -1.951 . . . . 0.0 114.061 178.34 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.9 -157.26 19.66 Favored Glycine 0 N--CA 1.408 -3.171 0 N-CA-C 106.183 -2.767 . . . . 0.0 106.183 171.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.5 mt -62.48 129.63 25.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 117.812 0.806 . . . . 0.0 108.938 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.53 -20.34 44.73 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.932 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -95.25 124.86 39.51 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.1 p -128.47 9.67 6.08 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.67 -124.06 3.75 Favored Glycine 0 C--O 1.248 0.993 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.945 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.95 75.44 0.43 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 124.054 3.169 . . . . 0.0 112.418 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.1 p -80.36 -11.87 59.65 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.99 0.9 . . . . 0.0 110.598 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.7 t -90.2 133.05 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.9 m -93.09 160.09 15.01 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 123.332 0.395 . . . . 0.0 110.503 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.67 147.13 28.47 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.259 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 m -53.39 117.01 2.75 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.581 0.752 . . . . 0.0 111.346 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.7 -8.15 34.17 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.234 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.3 p -113.59 146.87 39.04 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.228 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 32.6 p -106.58 137.24 44.94 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.557 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.7 t -83.8 113.08 20.67 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -116.59 116.05 26.87 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.261 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.38 99.44 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.7 mt -81.71 -48.05 12.17 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.667 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 49.9 m-20 -122.24 166.84 15.63 Favored Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.16 -32.69 82.97 Favored 'Trans proline' 0 C--N 1.346 0.415 0 CA-C-N 121.495 1.57 . . . . 0.0 112.729 -175.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -105.62 -23.31 12.79 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.294 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 80.0 t80 -102.24 113.81 27.42 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.462 0.649 . . . . 0.0 111.412 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -126.49 140.7 52.26 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 177.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -128.43 147.33 50.65 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.769 -0.773 . . . . 0.0 110.535 -174.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.596 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 65.7 m -89.02 106.51 18.48 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.412 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.293 -1.869 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.646 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 N--CA 1.442 -0.843 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -74.89 130.1 38.82 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.132 0.491 . . . . 0.0 110.582 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -64.1 165.76 8.68 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 124.307 1.043 . . . . 0.0 111.985 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -61.58 131.01 48.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 74.76 9.27 4.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.93 1.292 . . . . 0.0 112.833 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.64 169.35 32.62 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -88.05 103.33 15.61 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.681 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.6 p -64.37 -26.06 68.3 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 121.806 0.813 . . . . 0.0 109.228 175.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.421 ' HA3' ' CG ' ' A' ' 13' ' ' TYR . . . 103.31 132.46 7.62 Favored Glycine 1 N--CA 1.39 -4.403 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.697 172.677 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.75 -155.84 29.97 Favored Glycine 0 N--CA 1.403 -3.508 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 172.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 66.0 mt -57.32 123.44 8.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.39 -12.14 26.01 Favored Glycine 0 C--N 1.302 -1.317 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.872 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.421 ' CG ' ' HA3' ' A' ' 9' ' ' GLY . 12.4 t80 -109.83 114.34 27.82 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 p -110.49 0.23 17.67 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.83 -134.67 1.5 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.732 -0.482 . . . . 0.0 112.869 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -63.55 79.19 0.14 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 123.401 2.734 . . . . 0.0 113.65 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 9.6 p -80.49 -14.28 58.4 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.202 1.001 . . . . 0.0 109.905 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.0 t -92.66 128.73 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.8 m -87.34 167.24 14.23 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.445 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.38 152.88 44.4 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.846 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.9 m -58.48 123.44 16.22 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.813 0.339 . . . . 0.0 110.561 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.09 -7.77 29.09 Favored Glycine 0 N--CA 1.433 -1.561 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.975 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 82.1 p -123.06 154.45 38.52 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.7 p -117.02 135.74 53.47 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.0 t -78.52 114.82 17.78 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -116.12 114.94 25.19 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.75 96.36 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 mt -78.31 -38.9 41.24 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.773 -173.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -134.46 167.85 20.75 Favored Pre-proline 0 C--N 1.291 -1.954 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -64.23 -32.96 61.7 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 CA-C-N 121.306 1.502 . . . . 0.0 112.435 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.407 ' HD1' ' O ' ' A' ' 11' ' ' ILE . 42.8 m-85 -106.5 -24.4 12.21 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.762 -176.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -102.02 117.42 34.76 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.43 0.633 . . . . 0.0 110.885 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.8 m -134.2 140.74 46.72 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -127.1 152.41 47.35 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.215 -173.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.681 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 84.6 m -92.55 106.36 18.36 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.292 -1.926 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.459 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.429 -1.494 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -81.76 147.43 29.44 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.358 0.599 . . . . 0.0 112.158 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 p -88.88 177.84 6.59 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 124.664 1.185 . . . . 0.0 110.855 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -72.06 133.8 45.46 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 74.76 9.43 4.13 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.439 1.096 . . . . 0.0 112.702 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.0 170.12 31.54 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -90.9 113.19 25.33 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.936 0.368 . . . . 0.0 110.056 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.607 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.8 p -72.56 -33.7 66.99 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.758 0.79 . . . . 0.0 109.166 174.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.6 130.38 4.03 Favored Glycine 0 N--CA 1.398 -3.859 0 C-N-CA 118.58 -1.771 . . . . 0.0 115.311 174.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.42 -155.73 25.6 Favored Glycine 0 N--CA 1.406 -3.323 0 N-CA-C 106.179 -2.768 . . . . 0.0 106.179 172.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.35 129.42 21.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.24 9.11 52.19 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.269 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -114.43 138.49 50.51 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.6 p -138.38 14.15 2.79 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.27 0.557 . . . . 0.0 112.478 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.91 -132.72 7.2 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -69.98 94.02 0.55 Allowed 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.01 2.473 . . . . 0.0 112.307 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.6 p -86.98 -13.96 43.06 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.49 0.662 . . . . 0.0 111.026 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.66 133.11 31.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.106 177.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.5 m -92.75 168.82 10.94 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.059 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.28 156.44 39.26 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.878 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 m -60.89 121.19 11.73 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.317 0.58 . . . . 0.0 110.738 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.32 -15.5 42.68 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 68.8 p -107.15 145.07 32.98 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 p -110.95 135.2 51.83 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 123.555 0.535 . . . . 0.0 110.572 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 47.9 t -80.11 108.01 13.36 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -110.28 117.76 34.5 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.649 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.1 t -77.78 96.09 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.3 mt -79.93 -36.57 36.13 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.316 1.055 . . . . 0.0 109.661 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -135.8 162.4 57.14 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -60.39 -32.18 93.6 Favored 'Trans proline' 0 C--O 1.223 -0.26 0 CA-C-N 121.22 1.471 . . . . 0.0 112.966 -174.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -105.58 -24.02 12.66 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 120.975 0.417 . . . . 0.0 110.383 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -103.24 113.82 27.61 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.613 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.2 m -124.31 134.7 53.12 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -122.08 150.19 42.49 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.977 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.8 m -91.43 105.84 18.06 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.294 -1.835 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.493 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.446 -0.625 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -88.98 139.31 30.58 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.173 0.511 . . . . 0.0 110.559 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 p -74.75 167.86 20.99 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 124.378 1.071 . . . . 0.0 112.068 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -65.3 130.98 45.3 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 77.16 9.16 2.73 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.196 1.398 . . . . 0.0 112.36 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.29 169.21 26.16 Favored Glycine 0 N--CA 1.431 -1.659 0 C-N-CA 119.85 -1.167 . . . . 0.0 110.449 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 33' ' ' SER . 8.0 tt0 -86.85 109.46 19.31 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 116.911 0.355 . . . . 0.0 110.368 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -71.45 -34.82 70.57 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-O 121.578 0.704 . . . . 0.0 109.57 174.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.32 133.75 4.44 Favored Glycine 0 N--CA 1.396 -3.976 0 C-N-CA 118.16 -1.972 . . . . 0.0 115.146 174.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.37 -156.26 23.59 Favored Glycine 0 N--CA 1.401 -3.671 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 173.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -56.97 131.7 20.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.92 -11.19 62.39 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.421 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -113.73 117.2 30.85 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 p -126.53 19.63 7.36 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.02 -128.49 1.88 Allowed Glycine 0 C--O 1.243 0.715 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -65.61 79.41 0.25 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.18 2.586 . . . . 0.0 112.867 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -85.3 -18.01 35.18 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.85 0.833 . . . . 0.0 109.907 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.92 129.4 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.3 m -91.66 168.47 11.46 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 120.762 0.315 . . . . 0.0 110.469 -178.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.79 145.46 52.48 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.2 t -52.26 124.66 13.73 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 123.716 0.635 . . . . 0.0 110.507 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.06 -26.66 16.48 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.858 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.2 p -97.61 140.73 31.59 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.994 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.4 p -100.52 133.8 44.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.278 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.2 t -81.01 107.01 13.46 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -108.77 116.98 33.01 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.8 t -75.02 103.26 2.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.41 HD12 ' CE1' ' A' ' 32' ' ' TYR . 86.0 mt -86.5 -48.07 8.71 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.666 -174.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -118.58 165.02 17.76 Favored Pre-proline 0 C--N 1.288 -2.099 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -60.97 -29.4 87.92 Favored 'Trans proline' 0 C--O 1.218 -0.476 0 CA-C-N 121.421 1.543 . . . . 0.0 111.646 -175.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -105.7 -23.93 12.64 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.964 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.41 ' CE1' HD12 ' A' ' 28' ' ' LEU . 85.8 t80 -103.1 113.97 27.88 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.16 0.505 . . . . 0.0 111.16 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.1 m -125.11 137.97 54.17 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 176.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -122.98 149.07 44.78 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.948 -175.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.2 m -89.36 106.07 18.21 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.297 -1.715 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.32 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.436 -1.139 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -93.87 135.82 34.79 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 120.999 0.428 . . . . 0.0 110.551 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -70.3 165.64 21.88 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.374 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.403 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 16.2 t-160 -66.07 131.13 45.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 75.94 8.88 3.49 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.126 1.37 . . . . 0.0 111.631 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.68 170.76 31.18 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.0 tt0 -88.71 106.81 18.59 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.616 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.9 p -65.38 -40.97 94.16 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-O 121.594 0.711 . . . . 0.0 109.44 174.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.2 119.91 2.35 Favored Glycine 1 N--CA 1.396 -4.032 0 C-N-CA 118.449 -1.834 . . . . 0.0 114.667 174.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.95 -156.76 33.04 Favored Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 106.39 -2.684 . . . . 0.0 106.39 170.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -58.06 132.81 22.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 117.244 0.522 . . . . 0.0 109.908 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.21 -17.62 55.51 Favored Glycine 0 C--O 1.245 0.798 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.462 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -93.43 127.81 39.22 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.6 p -129.29 15.35 6.14 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.037 0.446 . . . . 0.0 111.465 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.61 -137.57 5.47 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.76 91.54 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.915 2.41 . . . . 0.0 111.351 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 2.4 p -89.67 0.24 57.09 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.73 0.776 . . . . 0.0 111.293 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -106.45 128.81 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.589 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.5 m -79.82 155.74 27.72 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.515 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.5 159.43 18.59 Favored 'General case' 0 C--O 1.254 1.297 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.883 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 m -49.86 118.24 2.75 Favored 'General case' 0 C--O 1.247 0.933 0 C-N-CA 124.041 0.936 . . . . 0.0 112.157 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.32 -12.1 43.75 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.52 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 75.6 p -110.51 153.51 24.98 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 117.59 0.695 . . . . 0.0 111.846 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.9 p -112.02 139.88 47.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.35 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.415 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.8 t -84.41 107.06 16.46 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.508 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 75.6 mt-30 -103.67 115.01 29.7 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.1 t -81.35 101.28 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.536 HD12 ' CE1' ' A' ' 32' ' ' TYR . 86.2 mt -80.03 -52.31 7.98 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.822 0.82 . . . . 0.0 109.37 -176.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -118.94 167.7 11.28 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.72 -32.52 86.56 Favored 'Trans proline' 0 C--N 1.347 0.489 0 CA-C-N 120.92 1.364 . . . . 0.0 112.384 -176.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -105.66 -23.55 12.73 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 120.777 0.322 . . . . 0.0 110.76 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.536 ' CE1' HD12 ' A' ' 28' ' ' LEU . 63.3 t80 -101.51 114.21 28.02 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.546 0.689 . . . . 0.0 110.801 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.7 m -129.37 143.74 50.96 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -130.97 148.93 52.79 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.512 -174.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 81.7 m -88.86 106.67 18.54 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.876 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.508 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.8 mm? . . . . . 0 C--N 1.298 -1.653 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.441 -0.904 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -74.26 126.73 31.26 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.372 0.606 . . . . 0.0 111.694 -170.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 p -75.31 176.26 7.59 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.193 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -63.51 134.1 55.0 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.831 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 73.91 9.22 4.77 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 124.58 1.152 . . . . 0.0 112.503 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.97 170.16 31.62 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.4 tt0 -90.81 105.79 18.07 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 122.439 0.296 . . . . 0.0 110.548 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.2 p -64.7 -56.76 11.69 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 170.61 106.46 0.19 Allowed Glycine 0 N--CA 1.407 -3.269 0 C-N-CA 117.958 -2.068 . . . . 0.0 113.34 -175.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.21 -165.07 20.34 Favored Glycine 0 N--CA 1.417 -2.606 0 N-CA-C 105.963 -2.855 . . . . 0.0 105.963 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.4 mt -65.11 112.66 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 118.22 1.01 . . . . 0.0 110.337 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.5 -9.09 28.39 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.026 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.46 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 2.8 t80 -113.52 113.22 24.82 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.8 p -125.46 14.77 8.24 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.124 0.487 . . . . 0.0 112.095 -176.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.65 -124.18 0.7 Allowed Glycine 0 C--N 1.318 -0.452 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -66.19 80.98 0.29 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.59 2.86 . . . . 0.0 111.812 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.2 p -84.04 -12.53 55.02 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-O 121.892 0.854 . . . . 0.0 111.182 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.9 132.87 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.6 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.8 m -90.75 163.14 14.58 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.395 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.43 141.43 54.67 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.585 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -53.68 114.58 1.6 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 123.748 0.819 . . . . 0.0 110.732 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.15 -9.95 29.09 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.595 -0.73 . . . . 0.0 113.06 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.7 p -111.52 135.64 51.81 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.1 p -96.17 132.77 41.25 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.736 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.581 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.0 t -77.01 113.06 14.31 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -114.73 116.95 29.48 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.5 t -79.72 103.15 6.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.3 mt -81.75 -48.44 11.64 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.142 0.972 . . . . 0.0 109.472 -173.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -122.44 167.24 14.63 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 103.734 -2.691 . . . . 0.0 103.734 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.37 -34.69 53.83 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 CA-C-N 121.18 1.457 . . . . 0.0 111.94 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -100.51 -24.81 14.38 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.699 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -104.0 114.39 28.6 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.9 m -118.88 153.32 34.74 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 174.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -140.33 148.24 41.05 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 118.798 0.726 . . . . 0.0 110.55 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.493 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.3 m -91.81 106.62 18.61 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.385 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.458 HG22 ' HB ' ' A' ' 18' ' ' VAL . 28.0 p . . . . . 0 N--CA 1.437 -1.096 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -105.28 141.52 36.65 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 p -72.62 166.67 22.29 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 123.558 0.743 . . . . 0.0 111.29 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.401 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 15.0 t-160 -63.03 132.93 53.63 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 76.56 9.39 3.03 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.74 1.216 . . . . 0.0 112.462 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.2 170.63 28.94 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.6 tt0 -85.8 114.1 22.48 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.878 0.339 . . . . 0.0 110.337 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.634 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.4 p -71.47 -54.29 11.11 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 123.618 0.574 . . . . 0.0 110.3 176.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.5 122.46 0.83 Allowed Glycine 1 N--CA 1.396 -4.029 0 C-N-CA 118.228 -1.939 . . . . 0.0 113.902 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.13 -157.71 19.53 Favored Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 105.572 -3.011 . . . . 0.0 105.572 173.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.13 126.03 20.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 118.009 0.904 . . . . 0.0 108.92 175.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.6 -17.13 39.92 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.582 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -89.41 127.41 35.82 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -124.18 -3.43 8.01 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.37 -135.24 2.16 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.1 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.35 92.62 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.373 2.715 . . . . 0.0 113.348 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.5 p -91.72 -5.97 52.74 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.284 0.564 . . . . 0.0 111.624 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.458 ' HB ' HG22 ' A' ' 1' ' ' THR . 90.8 t -96.18 130.11 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.9 m -87.56 161.72 17.59 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.182 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.14 153.03 5.43 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 124.206 1.002 . . . . 0.0 110.684 176.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.2 m -51.23 111.19 0.53 Allowed 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 123.936 0.895 . . . . 0.0 111.741 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.49 -14.95 57.76 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.247 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 70.4 p -92.74 139.76 30.22 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.0 p -101.97 136.83 41.13 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -176.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.426 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.6 t -80.89 117.63 21.69 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -116.96 117.93 31.02 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.67 96.29 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.2 mt -76.76 -38.98 53.16 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.094 -175.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -131.27 160.56 66.55 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -59.62 -27.63 85.43 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 121.548 1.499 . . . . 0.0 111.332 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -106.55 -24.38 12.2 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.453 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -103.32 114.37 28.59 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.051 -0.659 . . . . 0.0 110.463 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.7 m -127.76 136.06 50.99 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -123.03 149.93 43.71 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.388 -173.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 79.2 m -90.05 106.79 18.71 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.578 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.298 -1.638 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.507 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 . . . . . 0 N--CA 1.44 -0.936 0 CA-C-O 121.085 0.469 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.7 p -65.65 163.27 16.68 Favored 'General case' 0 C--O 1.254 1.34 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.375 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -60.59 130.71 47.89 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.297 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 75.61 9.13 3.64 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.232 1.413 . . . . 0.0 112.331 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.95 172.05 32.0 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.519 HE21 ' HA2' ' A' ' 9' ' ' GLY . 48.8 tt0 -86.47 103.78 15.33 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.873 0.336 . . . . 0.0 110.702 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.574 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 3.6 p -67.12 -28.17 67.93 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.841 0.829 . . . . 0.0 109.428 174.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.519 ' HA2' HE21 ' A' ' 7' ' ' GLN . . . 108.98 134.22 7.04 Favored Glycine 0 N--CA 1.396 -3.991 0 C-N-CA 118.85 -1.643 . . . . 0.0 115.254 172.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.99 -155.94 29.04 Favored Glycine 0 N--CA 1.403 -3.506 0 N-CA-C 107.614 -2.195 . . . . 0.0 107.614 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.7 mt -57.11 128.03 17.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.71 -19.02 36.75 Favored Glycine 0 C--N 1.311 -0.844 0 C-N-CA 120.044 -1.074 . . . . 0.0 112.644 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.463 ' CG ' ' HA3' ' A' ' 9' ' ' GLY . 9.3 t80 -90.88 125.45 35.75 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -118.63 2.99 11.75 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -174.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.03 -128.68 5.97 Favored Glycine 0 C--N 1.311 -0.835 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.976 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -64.67 85.67 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.572 2.848 . . . . 0.0 113.027 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -90.12 -7.55 53.47 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 122.042 0.925 . . . . 0.0 109.72 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.14 131.28 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.574 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.2 m -92.85 158.05 16.06 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.086 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.52 141.19 32.08 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 123.801 0.688 . . . . 0.0 109.75 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 m -51.31 117.92 2.92 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.628 0.771 . . . . 0.0 111.859 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.92 -18.15 26.72 Favored Glycine 0 N--CA 1.431 -1.689 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.231 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 61.2 p -102.57 144.68 30.67 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.0 p -100.94 132.7 46.23 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.486 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.2 t -79.49 106.47 11.55 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.419 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.6 mt-30 -106.08 114.79 29.14 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.664 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.9 t -78.93 96.3 2.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.454 HD12 ' CE2' ' A' ' 32' ' ' TYR . 80.9 mt -77.15 -52.12 9.82 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.947 -175.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -115.79 162.31 26.05 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.57 -24.44 78.01 Favored 'Trans proline' 0 C--O 1.212 -0.791 0 CA-C-N 121.375 1.527 . . . . 0.0 112.099 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -108.87 -23.38 11.76 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.752 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.454 ' CE2' HD12 ' A' ' 28' ' ' LEU . 69.3 t80 -103.01 114.09 28.1 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.167 0.508 . . . . 0.0 111.457 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -126.88 134.26 50.53 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -120.24 151.25 39.43 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -176.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.1 m -92.76 106.17 18.19 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.419 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.9 mm? . . . . . 0 C--N 1.297 -1.681 0 CA-C-O 118.462 -0.78 . . . . 0.0 109.233 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 . . . . . 0 N--CA 1.43 -1.427 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 t -73.47 177.09 5.51 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-O 121.809 0.814 . . . . 0.0 110.947 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -64.12 131.8 48.55 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.374 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 76.06 9.79 3.25 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.916 1.286 . . . . 0.0 113.386 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.3 168.0 25.3 Favored Glycine 0 C--N 1.312 -0.786 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.573 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.0 tt0 -81.54 112.72 19.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 117.026 0.413 . . . . 0.0 110.353 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.699 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.3 p -72.87 -58.07 3.6 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.783 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.418 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 171.71 109.42 0.22 Allowed Glycine 0 N--CA 1.396 -3.98 0 C-N-CA 118.134 -1.984 . . . . 0.0 113.363 -176.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.56 -157.53 17.31 Favored Glycine 0 N--CA 1.405 -3.406 0 N-CA-C 105.974 -2.851 . . . . 0.0 105.974 171.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.418 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 77.2 mt -65.67 126.1 24.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 117.665 0.732 . . . . 0.0 109.604 174.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.96 -13.16 60.69 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.907 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -90.37 111.96 23.38 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.8 p -109.98 6.83 23.44 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.97 -136.97 9.29 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.872 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -64.13 88.29 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.682 2.922 . . . . 0.0 112.996 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 24.4 p -84.21 -16.09 44.59 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.787 0.803 . . . . 0.0 110.5 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.3 t -82.4 129.84 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.74 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.0 m -88.18 168.92 12.34 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.002 0.43 . . . . 0.0 110.954 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.62 155.04 16.33 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.758 0.823 . . . . 0.0 110.709 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -64.52 111.53 2.74 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.245 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.51 6.47 27.08 Favored Glycine 0 N--CA 1.432 -1.578 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.056 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 59.7 p -125.1 152.19 44.71 Favored 'General case' 0 C--O 1.244 0.788 0 O-C-N 122.411 -0.464 . . . . 0.0 110.394 177.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.1 p -115.23 139.85 49.6 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.881 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.3 t -83.92 110.12 18.15 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -110.68 114.91 28.66 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -79.56 98.2 2.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.117 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.1 mt -78.52 -43.86 25.78 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.48 -174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -126.73 160.46 58.6 Favored Pre-proline 0 C--N 1.289 -2.033 0 N-CA-C 103.655 -2.72 . . . . 0.0 103.655 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.41 -29.43 84.37 Favored 'Trans proline' 0 C--O 1.225 -0.153 0 C-N-CA 121.752 1.635 . . . . 0.0 112.005 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 53.6 m-85 -104.36 -25.5 12.82 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.851 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -104.28 113.56 27.2 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 119.551 -0.859 . . . . 0.0 110.434 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 13.7 m -125.53 135.74 52.59 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 177.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -121.35 147.61 45.47 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.411 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.699 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.7 m -87.62 106.64 18.16 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.29 -2.003 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.98 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 . . . . . 0 N--CA 1.442 -0.847 0 CA-C-O 121.093 0.473 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 m -69.15 169.11 12.61 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.555 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.424 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 17.7 t-160 -59.62 132.25 53.39 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.509 0.723 . . . . 0.0 109.27 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 77.4 8.87 2.66 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.564 1.546 . . . . 0.0 112.247 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.87 169.0 29.33 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.562 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.0 tt0 -88.31 103.77 16.12 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.604 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.5 p -62.51 -47.86 82.09 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.246 0.546 . . . . 0.0 111.68 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 151.07 117.18 0.77 Allowed Glycine 0 N--CA 1.397 -3.904 0 C-N-CA 118.189 -1.958 . . . . 0.0 113.773 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.56 -157.39 18.78 Favored Glycine 0 N--CA 1.413 -2.873 0 N-CA-C 106.376 -2.69 . . . . 0.0 106.376 172.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.84 121.68 14.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 117.963 0.881 . . . . 0.0 109.597 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.96 -9.17 46.72 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.386 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.445 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 2.7 t80 -113.79 112.01 22.71 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.0 p -120.98 14.99 11.6 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 120.866 0.365 . . . . 0.0 111.877 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.41 -126.49 0.97 Allowed Glycine 0 C--O 1.241 0.588 0 C-N-CA 121.261 -0.495 . . . . 0.0 111.878 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.2 79.95 0.56 Allowed 'Trans proline' 0 C--O 1.217 -0.547 0 C-N-CA 122.939 2.426 . . . . 0.0 112.01 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 23.0 p -83.45 2.18 37.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 122.269 1.033 . . . . 0.0 110.787 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.2 t -101.42 131.86 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.8 m -90.31 162.08 15.34 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 123.358 0.411 . . . . 0.0 110.591 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.75 144.64 37.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.841 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.1 p -56.17 118.2 4.48 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 124.069 0.856 . . . . 0.0 111.416 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.03 -3.19 28.56 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.983 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.2 p -120.51 166.15 14.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 117.388 0.594 . . . . 0.0 110.281 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 34.4 p -120.89 146.04 47.02 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 122.202 0.201 . . . . 0.0 111.152 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.5 t -90.08 111.54 22.69 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -111.81 114.82 28.03 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -76.96 99.85 2.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 mt -82.53 -53.98 5.54 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.298 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -110.29 165.57 12.43 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.27 -26.23 64.2 Favored 'Trans proline' 0 C--O 1.221 -0.35 0 CA-C-N 121.445 1.552 . . . . 0.0 111.14 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -106.53 -25.29 11.9 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.432 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -103.62 113.26 26.64 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.631 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.4 m -123.54 139.31 54.14 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 176.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -127.61 150.57 49.67 Favored 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.597 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.7 m -90.01 106.42 18.46 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.299 -1.588 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 . . . . . 0 N--CA 1.445 -0.716 0 CA-C-O 121.246 0.546 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -74.22 171.95 12.67 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.459 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -62.32 132.86 54.05 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.365 0.666 . . . . 0.0 109.719 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 74.74 8.99 4.21 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.282 1.433 . . . . 0.0 112.406 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.25 169.56 33.36 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -89.09 105.61 17.9 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 117.134 0.467 . . . . 0.0 110.792 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 2.5 p -67.26 -31.5 71.87 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 121.587 0.708 . . . . 0.0 109.934 175.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.53 131.35 5.13 Favored Glycine 0 N--CA 1.396 -3.987 0 C-N-CA 118.922 -1.608 . . . . 0.0 115.866 172.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.6 -156.06 25.47 Favored Glycine 0 N--CA 1.408 -3.225 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.2 mt -56.31 127.4 15.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.17 -23.36 29.09 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.055 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -89.04 130.94 35.41 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.2 p -137.86 14.91 2.89 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.656 0.741 . . . . 0.0 111.234 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.8 -130.23 5.3 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.41 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.45 84.26 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.314 2.676 . . . . 0.0 112.267 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.3 p -88.25 2.32 52.59 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 122.252 1.025 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -105.88 127.25 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.9 m -87.76 153.02 21.68 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.84 154.4 15.09 Favored 'General case' 0 C--O 1.252 1.216 0 O-C-N 123.596 0.56 . . . . 0.0 111.236 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.2 m -49.4 116.39 1.71 Allowed 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.556 1.142 . . . . 0.0 112.035 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.89 -1.8 48.28 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.557 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.5 p -117.7 145.67 44.26 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 117.649 0.725 . . . . 0.0 110.212 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.5 p -106.25 138.64 42.07 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -79.4 113.81 17.83 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.427 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.6 mt-30 -113.73 114.76 26.81 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.49 100.14 2.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.3 mt -79.26 -53.2 7.18 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -175.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -116.85 160.3 37.32 Favored Pre-proline 0 C--N 1.29 -1.995 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.27 -29.89 91.48 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 121.484 1.456 . . . . 0.0 113.261 -174.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -106.58 -23.81 12.35 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 120.959 0.409 . . . . 0.0 110.488 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -103.12 113.49 27.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.217 0.532 . . . . 0.0 111.352 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.7 m -124.99 142.74 51.29 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -129.84 149.14 51.71 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.238 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 67.5 m -88.67 107.63 19.03 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.939 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.427 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.8 mm? . . . . . 0 C--N 1.303 -1.419 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.519 HE21 ' HA3' ' A' ' 6' ' ' GLY . 62.1 tp60 . . . . . 0 N--CA 1.436 -1.156 0 CA-C-O 121.144 0.497 . . . . 0.0 111.555 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -81.77 169.85 16.42 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 124.088 0.955 . . . . 0.0 111.877 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -64.63 131.57 47.33 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 75.61 9.51 3.57 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.718 1.207 . . . . 0.0 112.741 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.519 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.03 167.57 26.7 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.429 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.9 tt0 -84.96 116.08 23.17 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.617 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.6 p -73.56 -55.2 6.61 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 123.8 0.688 . . . . 0.0 110.973 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.411 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 161.65 108.65 0.23 Allowed Glycine 0 N--CA 1.401 -3.673 0 C-N-CA 118.114 -1.993 . . . . 0.0 114.528 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.33 -158.33 29.0 Favored Glycine 0 N--CA 1.41 -3.043 0 N-CA-C 106.36 -2.696 . . . . 0.0 106.36 171.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.495 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 72.6 mt -65.3 117.07 5.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 118.074 0.937 . . . . 0.0 110.901 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.25 -14.79 23.16 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.573 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -92.27 125.57 36.99 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.6 p -119.76 -6.39 10.12 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.42 -131.2 1.81 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.762 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.53 79.98 0.1 Allowed 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 123.963 3.109 . . . . 0.0 112.669 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 5.2 p -85.35 -5.94 59.27 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.86 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.0 t -99.43 131.96 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 82.6 m -92.54 146.95 23.28 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 123.364 0.415 . . . . 0.0 110.092 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.53 154.05 6.95 Favored 'General case' 0 C--O 1.251 1.17 0 O-C-N 124.007 0.817 . . . . 0.0 110.865 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 m -50.82 126.86 16.97 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.865 0.866 . . . . 0.0 111.417 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.93 -16.54 57.29 Favored Glycine 0 N--CA 1.432 -1.585 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.565 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.8 p -110.22 142.41 41.83 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.432 0.616 . . . . 0.0 110.289 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.3 p -109.29 133.6 52.83 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.507 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.6 t -75.31 107.15 7.22 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -109.37 114.73 28.65 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.3 t -78.55 96.63 2.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.0 mt -75.7 -51.5 12.59 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.371 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -120.34 166.99 13.66 Favored Pre-proline 0 C--N 1.284 -2.258 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.57 -33.5 86.98 Favored 'Trans proline' 0 C--N 1.343 0.261 0 CA-C-N 121.399 1.535 . . . . 0.0 112.323 -175.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.495 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 21.9 m-85 -104.94 -23.78 12.93 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.44 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -102.23 113.5 26.85 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.376 0.607 . . . . 0.0 110.761 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.0 m -127.0 137.46 53.1 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -128.37 150.78 49.95 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.304 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.556 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 67.1 m -90.15 105.68 17.97 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.294 -1.833 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.945 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.195 0.522 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 p -70.39 169.81 13.19 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.004 0.922 . . . . 0.0 112.907 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -61.74 129.5 41.33 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.904 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 76.75 9.25 2.94 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.766 1.226 . . . . 0.0 112.765 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.05 164.21 28.46 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.3 tt0 -83.49 107.47 15.99 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.627 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.6 p -67.27 -51.04 57.82 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-O 121.183 0.516 . . . . 0.0 111.421 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.59 118.69 0.71 Allowed Glycine 0 N--CA 1.399 -3.794 0 C-N-CA 118.266 -1.921 . . . . 0.0 113.651 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.12 -158.09 18.34 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 105.691 -2.964 . . . . 0.0 105.691 171.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.63 119.97 15.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 117.919 0.86 . . . . 0.0 109.042 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.38 -6.27 28.39 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.014 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -113.9 132.27 55.98 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 p -141.33 20.82 2.23 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.88 -121.6 3.33 Favored Glycine 0 C--O 1.241 0.54 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -67.75 78.81 0.52 Allowed 'Trans proline' 0 N--CA 1.476 0.494 0 C-N-CA 123.697 2.931 . . . . 0.0 111.96 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.5 p -82.3 -16.66 48.57 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.55 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.8 t -89.14 133.0 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.1 m -87.39 159.1 18.84 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.12 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.63 160.61 8.89 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.931 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 m -62.82 128.9 38.07 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.625 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.17 5.41 59.43 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.492 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.4 p -128.55 164.88 21.85 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 117.33 0.565 . . . . 0.0 109.885 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.3 p -130.94 138.64 49.83 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 122.182 0.193 . . . . 0.0 110.845 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.464 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.2 t -78.23 114.38 17.06 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 40.4 mt-30 -115.94 115.81 26.84 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.922 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.1 t -77.7 99.79 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.2 mt -78.31 -50.6 11.5 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 122.042 0.925 . . . . 0.0 108.843 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -120.26 161.75 37.33 Favored Pre-proline 0 C--N 1.289 -2.057 0 N-CA-C 103.941 -2.615 . . . . 0.0 103.941 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.43 -28.66 88.12 Favored 'Trans proline' 0 N--CA 1.474 0.345 0 CA-C-N 120.896 1.356 . . . . 0.0 112.093 -175.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -105.01 -25.18 12.66 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.835 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -104.01 113.04 26.29 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.562 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -125.35 140.03 53.17 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -130.95 149.43 52.58 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.921 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.4 m -87.68 106.07 17.79 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.57 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.7 mm? . . . . . 0 C--N 1.289 -2.022 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.478 HE21 ' HA3' ' A' ' 6' ' ' GLY . 54.1 tp60 . . . . . 0 C--O 1.243 0.754 0 CA-C-O 121.518 0.675 . . . . 0.0 111.831 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 p -80.91 161.7 24.25 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 124.357 1.063 . . . . 0.0 111.426 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -62.06 131.59 50.09 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 77.69 9.68 2.37 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.717 1.207 . . . . 0.0 112.752 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.478 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -97.67 170.01 25.03 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.424 177.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.6 tt0 -81.56 109.18 15.76 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.659 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -71.44 -54.04 11.98 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 121.266 0.555 . . . . 0.0 111.353 177.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.408 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 163.12 116.47 0.38 Allowed Glycine 1 N--CA 1.394 -4.111 0 C-N-CA 118.101 -1.999 . . . . 0.0 113.835 -177.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.25 -158.2 18.19 Favored Glycine 0 N--CA 1.409 -3.149 0 N-CA-C 105.485 -3.046 . . . . 0.0 105.485 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.2 mt -66.38 121.05 14.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 117.891 0.845 . . . . 0.0 110.049 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.09 -20.06 29.08 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.295 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -80.03 129.32 34.4 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.7 p -135.4 18.53 3.37 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.56 -125.85 5.52 Favored Glycine 0 C--N 1.311 -0.807 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.513 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.79 85.78 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.242 2.628 . . . . 0.0 111.925 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 10.2 p -88.94 -8.04 54.92 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.573 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.91 137.05 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 90.6 m -87.71 163.14 16.68 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.147 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.87 153.43 10.98 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.967 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.7 m -57.71 114.57 2.34 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.506 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.53 4.43 56.04 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.814 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 81.3 p -113.83 143.82 44.04 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 117.486 0.643 . . . . 0.0 109.882 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.3 p -103.55 132.65 49.62 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.515 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 45.9 t -79.16 106.73 11.4 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -104.61 114.76 29.19 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.4 t -77.83 101.65 3.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.9 mt -81.53 -39.45 24.66 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.738 0.78 . . . . 0.0 109.503 -173.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -132.97 163.06 53.77 Favored Pre-proline 0 C--N 1.289 -2.058 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -60.88 -28.35 86.23 Favored 'Trans proline' 0 C--N 1.345 0.367 0 CA-C-N 120.986 1.388 . . . . 0.0 112.618 -175.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -108.84 -24.07 11.45 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.407 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -103.11 114.51 28.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.292 0.568 . . . . 0.0 111.442 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.612 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.3 m -124.62 146.91 48.82 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -131.44 147.19 52.53 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.079 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.659 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.3 m -89.57 106.47 18.48 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 C--N 1.297 -1.678 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.615 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 . . . . . 0 N--CA 1.438 -1.062 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 p -76.81 171.24 15.05 Favored 'General case' 0 C--O 1.251 1.151 0 CA-C-O 121.179 0.514 . . . . 0.0 111.952 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -63.46 129.74 41.46 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 75.19 9.43 3.84 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.62 1.568 . . . . 0.0 111.508 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.76 165.84 32.35 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -86.56 106.55 17.62 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.517 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.5 p -70.01 -27.09 64.4 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.834 0.825 . . . . 0.0 109.067 174.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.25 129.43 6.0 Favored Glycine 1 N--CA 1.394 -4.165 0 C-N-CA 119.245 -1.455 . . . . 0.0 115.41 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.8 -156.65 30.91 Favored Glycine 0 N--CA 1.407 -3.272 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 171.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.9 mt -59.78 125.43 15.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.54 -1.07 32.47 Favored Glycine 0 C--N 1.317 -0.525 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.386 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -113.62 119.94 39.2 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.4 p -115.81 9.52 15.1 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.76 -139.78 7.68 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.353 -0.693 . . . . 0.0 111.809 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.34 94.58 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.23 2.62 . . . . 0.0 112.083 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.0 p -92.76 -7.46 46.5 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.479 0.657 . . . . 0.0 111.378 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.5 t -100.77 135.58 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.495 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.9 m -90.71 161.8 15.19 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 120.719 0.295 . . . . 0.0 111.69 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.18 164.73 10.41 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.61 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.6 m -54.12 111.52 0.78 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 124.354 1.062 . . . . 0.0 112.764 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.07 -13.48 57.37 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.243 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 82.2 p -100.18 141.03 33.57 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 122.17 -0.606 . . . . 0.0 109.889 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 27.4 p -106.08 136.78 45.15 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.792 -0.186 . . . . 0.0 111.36 -177.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.4 t -80.73 106.15 12.51 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -107.97 115.42 30.1 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.703 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.25 96.17 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.6 mt -77.55 -39.1 47.0 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.057 -173.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.419 HD22 ' HB3' ' A' ' 32' ' ' TYR . 29.7 m-80 -133.55 163.74 48.99 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -61.55 -29.31 84.35 Favored 'Trans proline' 0 C--O 1.235 0.373 0 CA-C-N 121.549 1.589 . . . . 0.0 112.941 -173.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -107.72 -23.5 12.08 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.85 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HB3' HD22 ' A' ' 29' ' ' ASN . 70.3 t80 -103.15 113.83 27.63 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.054 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 m -125.34 141.27 52.17 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -131.75 150.38 52.17 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.018 -174.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.517 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.0 m -89.29 105.89 18.09 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.99 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--N 1.29 -1.984 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.413 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.47 ' NE2' ' HA3' ' A' ' 6' ' ' GLY . 26.0 tp60 . . . . . 0 N--CA 1.443 -0.777 0 CA-C-O 121.254 0.55 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 m -66.75 166.75 12.53 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.48 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -62.28 131.33 49.02 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.652 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 77.25 8.87 2.73 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.705 1.602 . . . . 0.0 112.482 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.47 ' HA3' ' NE2' ' A' ' 2' ' ' GLN . . . -91.85 170.59 33.56 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.5 tt0 -88.49 107.48 18.9 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.68 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.6 p -62.73 -56.91 13.26 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 121.016 0.436 . . . . 0.0 111.664 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.436 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 164.5 112.66 0.27 Allowed Glycine 0 N--CA 1.4 -3.725 0 C-N-CA 118.278 -1.915 . . . . 0.0 113.671 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.59 -167.28 20.13 Favored Glycine 0 N--CA 1.41 -3.038 0 N-CA-C 106.4 -2.68 . . . . 0.0 106.4 171.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.8 mt -59.76 111.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 117.823 0.812 . . . . 0.0 110.926 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.33 -5.02 26.69 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.753 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -98.49 127.94 44.63 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.0 p -124.59 -1.8 7.97 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.73 -135.64 2.81 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.042 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 39.5 Cg_exo -63.99 80.44 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.056 3.171 . . . . 0.0 112.386 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.671 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 9.2 p -76.8 -22.06 54.22 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.721 0.772 . . . . 0.0 110.726 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.08 129.15 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 87.6 m -87.13 161.5 18.06 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.889 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.76 157.79 14.16 Favored 'General case' 0 C--O 1.256 1.396 0 C-N-CA 123.765 0.826 . . . . 0.0 110.808 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.5 m -64.03 111.21 2.42 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.142 0.496 . . . . 0.0 110.406 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.31 0.32 33.14 Favored Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.903 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 79.2 p -116.81 139.48 50.55 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.283 -0.54 . . . . 0.0 109.605 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 24.8 p -102.04 136.04 42.57 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.056 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.448 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.5 t -81.89 109.95 16.72 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -109.89 114.6 28.28 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.41 98.88 3.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.9 mt -78.93 -53.27 7.22 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.855 0.836 . . . . 0.0 109.369 -173.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -115.77 167.04 10.86 Favored Pre-proline 0 C--N 1.283 -2.299 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -61.04 -32.14 91.72 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 CA-C-N 121.001 1.393 . . . . 0.0 112.278 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -105.68 -23.96 12.64 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.23 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -102.36 113.89 27.59 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.344 0.592 . . . . 0.0 111.477 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.6 m -124.64 153.0 42.92 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 176.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -140.83 149.4 41.96 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.536 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.601 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 68.9 m -91.67 106.07 18.2 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--N 1.3 -1.549 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.628 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.451 ' NE2' ' HA3' ' A' ' 6' ' ' GLY . 28.2 tp60 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.369 0.604 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 p -75.08 169.38 18.14 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.188 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -61.82 132.49 53.27 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.373 1.069 . . . . 0.0 109.244 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 74.52 8.84 4.38 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 125.077 1.351 . . . . 0.0 112.565 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.451 ' HA3' ' NE2' ' A' ' 2' ' ' GLN . . . -94.05 164.89 26.36 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 176.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.4 tt0 -84.58 101.13 11.88 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.6 p -63.23 -42.49 99.25 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.23 0.538 . . . . 0.0 111.053 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.422 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 139.59 123.61 2.08 Favored Glycine 1 N--CA 1.393 -4.199 0 C-N-CA 118.048 -2.025 . . . . 0.0 114.247 177.053 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.38 -157.81 17.75 Favored Glycine 0 N--CA 1.403 -3.565 0 N-CA-C 105.432 -3.067 . . . . 0.0 105.432 171.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.3 mt -62.67 130.92 27.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.88 -7.96 61.08 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.837 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -109.91 136.56 49.01 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.2 p -141.39 21.23 2.22 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.1 -126.38 5.07 Favored Glycine 0 C--N 1.307 -1.039 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.469 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -70.1 86.7 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.29 2.66 . . . . 0.0 111.537 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.9 p -82.54 -16.81 47.24 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.889 0.852 . . . . 0.0 110.917 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.78 135.36 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 67.3 m -93.07 162.17 14.14 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.62 138.97 51.52 Favored 'General case' 0 C--O 1.25 1.109 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.6 m -57.61 127.16 30.6 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.411 0.444 . . . . 0.0 110.731 -175.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.05 -16.54 27.66 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.214 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.6 p -115.91 144.89 43.43 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.8 p -103.66 136.86 42.58 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -175.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 38.4 t -81.1 107.1 13.62 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -104.42 114.51 28.79 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.554 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.0 t -80.01 100.59 4.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.5 mt -82.91 -51.33 7.71 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.254 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.503 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -112.35 161.64 25.2 Favored Pre-proline 0 C--N 1.292 -1.922 0 N-CA-C 102.102 -3.295 . . . . 0.0 102.102 174.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.02 -25.73 77.89 Favored 'Trans proline' 0 C--O 1.22 -0.412 0 CA-C-N 121.667 1.631 . . . . 0.0 111.326 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -104.26 -23.77 13.2 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.16 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.483 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 61.0 t80 -103.82 114.11 28.12 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.53 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.2 m -125.47 142.24 51.61 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -133.68 147.98 51.44 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.894 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.1 m -88.55 106.5 18.33 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.23 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.294 -1.826 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.519 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.463 ' NE2' ' HA3' ' A' ' 6' ' ' GLY . 28.0 tp60 . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 121.242 0.544 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 p -72.96 172.82 10.25 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 124.169 0.988 . . . . 0.0 112.655 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -67.52 130.41 42.95 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 77.13 9.18 2.74 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.37 1.468 . . . . 0.0 112.351 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.463 ' HA3' ' NE2' ' A' ' 2' ' ' GLN . . . -90.95 164.31 29.87 Favored Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 175.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -82.55 104.61 12.95 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.694 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.7 p -62.53 -55.18 29.84 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-O 121.099 0.476 . . . . 0.0 111.305 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 159.83 112.89 0.32 Allowed Glycine 1 N--CA 1.392 -4.285 0 C-N-CA 117.685 -2.198 . . . . 0.0 114.123 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.35 -158.14 22.91 Favored Glycine 0 N--CA 1.402 -3.604 0 N-CA-C 105.313 -3.115 . . . . 0.0 105.313 170.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.24 128.89 31.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 118.044 0.922 . . . . 0.0 108.628 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.91 -8.98 50.89 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.687 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.461 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 3.4 t80 -113.66 118.03 33.21 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 p -124.54 3.05 8.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.51 -119.69 0.84 Allowed Glycine 0 C--O 1.243 0.658 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.964 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 25.2 Cg_exo -67.96 78.5 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.662 2.908 . . . . 0.0 111.836 175.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.654 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.7 p -85.83 -22.66 27.5 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.455 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.89 131.94 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -85.68 153.11 22.57 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.291 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.94 148.64 20.6 Favored 'General case' 0 C--O 1.244 0.791 0 O-C-N 123.932 0.77 . . . . 0.0 110.717 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 m -55.11 116.82 3.0 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 122.979 0.512 . . . . 0.0 111.508 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.93 -5.7 29.08 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.287 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.2 p -119.27 154.52 33.33 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.6 p -116.73 142.09 47.36 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.977 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.5 t -83.06 112.04 19.43 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.528 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.5 mt-30 -109.74 114.37 27.89 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.7 t -81.93 105.83 12.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.8 mt -83.38 -53.89 5.39 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.943 -175.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -116.21 163.29 22.2 Favored Pre-proline 0 C--N 1.296 -1.737 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -58.37 -31.86 94.88 Favored 'Trans proline' 0 C--O 1.218 -0.503 0 C-N-CA 121.279 1.319 . . . . 0.0 112.04 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -102.69 -24.12 13.78 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.865 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -103.7 114.18 28.25 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 120.934 0.397 . . . . 0.0 111.904 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.8 m -129.22 147.52 51.07 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -136.62 147.65 47.04 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.14 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.694 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.6 m -87.25 106.74 18.12 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.197 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.528 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.6 mm? . . . . . 0 C--N 1.294 -1.816 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.494 HE21 ' HA3' ' A' ' 6' ' ' GLY . 59.0 tp60 . . . . . 0 C--O 1.245 0.826 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -73.76 166.17 23.79 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.953 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -60.41 133.81 56.46 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.74 0.816 . . . . 0.0 108.95 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 74.87 9.25 4.08 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.201 1.4 . . . . 0.0 112.04 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.494 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.17 170.43 28.81 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.175 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.7 tt0 -88.43 107.82 19.06 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.523 0.161 . . . . 0.0 110.574 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.622 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -69.08 -29.74 67.91 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 121.973 0.892 . . . . 0.0 109.024 173.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.413 ' HA2' HE21 ' A' ' 7' ' ' GLN . . . 115.23 126.97 4.19 Favored Glycine 1 N--CA 1.391 -4.36 0 C-N-CA 118.771 -1.681 . . . . 0.0 114.566 174.358 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.44 -156.25 32.13 Favored Glycine 0 N--CA 1.41 -3.037 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 171.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -58.08 129.75 20.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 117.566 0.683 . . . . 0.0 109.347 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.21 -22.34 31.38 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.687 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -103.05 112.02 24.65 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -118.58 11.41 12.86 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -175.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.23 -122.16 1.12 Allowed Glycine 0 C--O 1.245 0.804 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.849 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.8 78.65 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.051 3.167 . . . . 0.0 113.003 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.7 p -86.13 -16.81 36.78 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.081 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -90.58 133.8 31.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 86.1 m -92.97 157.55 16.27 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.388 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.13 158.9 18.62 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.784 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.5 m -55.1 121.11 8.05 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.303 0.641 . . . . 0.0 111.644 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.01 -16.96 45.67 Favored Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.427 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 59.2 p -106.88 143.11 35.44 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 122.248 -0.56 . . . . 0.0 110.976 -177.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.2 p -109.36 136.8 48.2 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.498 0.319 . . . . 0.0 111.567 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.43 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.0 t -79.93 108.68 13.7 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -113.19 117.36 31.69 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.338 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.76 106.91 7.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.2 mt -88.38 -41.73 12.64 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.193 0.997 . . . . 0.0 108.949 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.415 HD22 ' HB3' ' A' ' 32' ' ' TYR . 37.9 m-80 -127.71 161.16 56.92 Favored Pre-proline 0 C--N 1.286 -2.166 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 178.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -60.2 -31.63 93.36 Favored 'Trans proline' 0 CA--C 1.52 -0.217 0 CA-C-N 121.027 1.402 . . . . 0.0 112.051 -174.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -105.04 -23.46 12.95 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.295 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.415 ' HB3' HD22 ' A' ' 29' ' ' ASN . 76.7 t80 -103.29 114.04 28.01 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.176 0.512 . . . . 0.0 111.421 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.2 m -125.57 138.82 53.96 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -124.01 149.96 45.43 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.315 -174.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.4 m -91.91 106.07 18.18 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.287 -2.134 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.638 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.515 HE21 ' HA3' ' A' ' 6' ' ' GLY . 55.6 tp60 . . . . . 0 N--CA 1.442 -0.87 0 CA-C-O 120.74 0.305 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 p -86.97 177.41 7.25 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 121.148 0.499 . . . . 0.0 111.596 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -62.92 132.41 51.99 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.048 0.539 . . . . 0.0 110.024 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 78.92 8.69 1.93 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.624 1.569 . . . . 0.0 113.218 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.515 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -94.47 173.54 32.67 Favored Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.877 176.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.0 tt0 -91.4 110.77 22.07 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.8 p -70.84 -33.28 70.5 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-O 121.76 0.79 . . . . 0.0 109.184 174.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.05 133.61 4.58 Favored Glycine 0 N--CA 1.398 -3.897 0 C-N-CA 118.469 -1.824 . . . . 0.0 115.397 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.31 -156.23 20.09 Favored Glycine 0 N--CA 1.402 -3.599 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.93 129.59 20.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.58 -6.72 55.35 Favored Glycine 0 C--N 1.307 -1.031 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.959 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -114.01 132.88 55.83 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.0 p -135.19 6.98 3.36 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.49 -123.14 2.03 Favored Glycine 0 C--O 1.246 0.865 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.273 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -65.27 79.21 0.22 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.709 2.94 . . . . 0.0 113.333 176.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.5 p -89.08 7.01 37.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 122.359 1.076 . . . . 0.0 109.384 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.9 t -106.24 116.92 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.112 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.444 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.1 m -83.44 149.69 26.51 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.14 151.25 12.63 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 123.932 0.77 . . . . 0.0 110.854 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -59.91 119.74 8.3 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.128 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.25 -9.98 28.87 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.784 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.7 p -118.49 146.18 44.71 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 122.197 -0.59 . . . . 0.0 110.491 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 34.4 p -107.08 140.94 39.1 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.135 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.0 t -85.42 107.26 17.32 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -107.89 114.64 28.73 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.49 96.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.421 HD12 ' CE1' ' A' ' 32' ' ' TYR . 87.6 mt -75.68 -53.22 8.9 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.468 0.707 . . . . 0.0 109.831 -174.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -112.06 162.66 20.28 Favored Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 172.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.67 -23.43 75.99 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 CA-C-N 120.935 1.37 . . . . 0.0 111.67 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -106.85 -24.72 11.96 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.979 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.421 ' CE1' HD12 ' A' ' 28' ' ' LEU . 74.7 t80 -103.67 113.8 27.59 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.971 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.9 m -126.68 135.35 51.04 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -124.76 150.34 46.36 Favored 'General case' 0 C--N 1.286 -2.169 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.199 -175.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 79.3 m -90.37 106.27 18.38 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.302 -1.494 0 CA-C-O 118.646 -0.692 . . . . 0.0 109.835 -178.867 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.514 HE21 ' HA3' ' A' ' 6' ' ' GLY . 61.1 tp60 . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 121.15 0.5 . . . . 0.0 111.654 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 p -79.56 170.85 15.96 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.857 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -62.84 134.88 56.92 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.116 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 74.16 9.31 4.58 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.28 1.432 . . . . 0.0 112.3 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.514 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -93.78 170.65 30.94 Favored Glycine 0 N--CA 1.431 -1.653 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.398 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.1 tt0 -87.18 107.25 18.39 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.596 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.5 p -68.26 -51.46 44.9 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 121.195 0.521 . . . . 0.0 110.814 177.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 156.48 121.2 0.69 Allowed Glycine 1 N--CA 1.393 -4.184 0 C-N-CA 118.203 -1.951 . . . . 0.0 114.061 178.34 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.9 -157.26 19.66 Favored Glycine 0 N--CA 1.408 -3.171 0 N-CA-C 106.183 -2.767 . . . . 0.0 106.183 171.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.5 mt -62.48 129.63 25.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 117.812 0.806 . . . . 0.0 108.938 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.53 -20.34 44.73 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.932 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -95.25 124.86 39.51 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.1 p -128.47 9.67 6.08 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.67 -124.06 3.75 Favored Glycine 0 C--O 1.248 0.993 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.945 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.95 75.44 0.43 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 124.054 3.169 . . . . 0.0 112.418 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.1 p -80.36 -11.87 59.65 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.99 0.9 . . . . 0.0 110.598 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.7 t -90.2 133.05 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.9 m -93.09 160.09 15.01 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 123.332 0.395 . . . . 0.0 110.503 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.67 147.13 28.47 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.259 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 m -53.39 117.01 2.75 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.581 0.752 . . . . 0.0 111.346 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.7 -8.15 34.17 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.234 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.3 p -113.59 146.87 39.04 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.228 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 32.6 p -106.58 137.24 44.94 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.557 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.7 t -83.8 113.08 20.67 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -116.59 116.05 26.87 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.261 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.38 99.44 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.7 mt -81.71 -48.05 12.17 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.667 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 49.9 m-20 -122.24 166.84 15.63 Favored Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.16 -32.69 82.97 Favored 'Trans proline' 0 C--N 1.346 0.415 0 CA-C-N 121.495 1.57 . . . . 0.0 112.729 -175.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -105.62 -23.31 12.79 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.294 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 80.0 t80 -102.24 113.81 27.42 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.462 0.649 . . . . 0.0 111.412 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -126.49 140.7 52.26 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 177.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -128.43 147.33 50.65 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.769 -0.773 . . . . 0.0 110.535 -174.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.596 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 65.7 m -89.02 106.51 18.48 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.412 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.293 -1.869 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.646 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 . . . . . 0 N--CA 1.446 -0.656 0 CA-C-O 121.132 0.491 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -64.1 165.76 8.68 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 124.307 1.043 . . . . 0.0 111.985 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -61.58 131.01 48.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 74.76 9.27 4.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.93 1.292 . . . . 0.0 112.833 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.64 169.35 32.62 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.406 HE21 ' HA2' ' A' ' 9' ' ' GLY . 44.3 tt0 -88.05 103.33 15.61 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.681 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.6 p -64.37 -26.06 68.3 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 121.806 0.813 . . . . 0.0 109.228 175.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.421 ' HA3' ' CG ' ' A' ' 13' ' ' TYR . . . 103.31 132.46 7.62 Favored Glycine 1 N--CA 1.39 -4.403 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.697 172.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.75 -155.84 29.97 Favored Glycine 0 N--CA 1.403 -3.508 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 172.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 66.0 mt -57.32 123.44 8.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.39 -12.14 26.01 Favored Glycine 0 C--N 1.302 -1.317 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.872 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.421 ' CG ' ' HA3' ' A' ' 9' ' ' GLY . 12.4 t80 -109.83 114.34 27.82 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 p -110.49 0.23 17.67 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.83 -134.67 1.5 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.732 -0.482 . . . . 0.0 112.869 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -63.55 79.19 0.14 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 123.401 2.734 . . . . 0.0 113.65 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 9.6 p -80.49 -14.28 58.4 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.202 1.001 . . . . 0.0 109.905 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.0 t -92.66 128.73 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.8 m -87.34 167.24 14.23 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.445 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.38 152.88 44.4 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.846 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.9 m -58.48 123.44 16.22 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.813 0.339 . . . . 0.0 110.561 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.09 -7.77 29.09 Favored Glycine 0 N--CA 1.433 -1.561 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.975 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 82.1 p -123.06 154.45 38.52 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.7 p -117.02 135.74 53.47 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.0 t -78.52 114.82 17.78 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -116.12 114.94 25.19 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.75 96.36 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 mt -78.31 -38.9 41.24 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.773 -173.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -134.46 167.85 20.75 Favored Pre-proline 0 C--N 1.291 -1.954 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -64.23 -32.96 61.7 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 CA-C-N 121.306 1.502 . . . . 0.0 112.435 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.407 ' HD1' ' O ' ' A' ' 11' ' ' ILE . 42.8 m-85 -106.5 -24.4 12.21 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.762 -176.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -102.02 117.42 34.76 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.43 0.633 . . . . 0.0 110.885 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.8 m -134.2 140.74 46.72 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -127.1 152.41 47.35 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.215 -173.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.681 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 84.6 m -92.55 106.36 18.36 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.292 -1.926 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.459 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.478 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.1 tp60 . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 121.358 0.599 . . . . 0.0 112.158 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 p -88.88 177.84 6.59 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 124.664 1.185 . . . . 0.0 110.855 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -72.06 133.8 45.46 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 74.76 9.43 4.13 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.439 1.096 . . . . 0.0 112.702 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.478 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -93.0 170.12 31.54 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 176.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -90.9 113.19 25.33 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.936 0.368 . . . . 0.0 110.056 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.607 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.8 p -72.56 -33.7 66.99 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.758 0.79 . . . . 0.0 109.166 174.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.6 130.38 4.03 Favored Glycine 0 N--CA 1.398 -3.859 0 C-N-CA 118.58 -1.771 . . . . 0.0 115.311 174.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.42 -155.73 25.6 Favored Glycine 0 N--CA 1.406 -3.323 0 N-CA-C 106.179 -2.768 . . . . 0.0 106.179 172.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.35 129.42 21.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.24 9.11 52.19 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.269 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -114.43 138.49 50.51 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.6 p -138.38 14.15 2.79 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.27 0.557 . . . . 0.0 112.478 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.91 -132.72 7.2 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -69.98 94.02 0.55 Allowed 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.01 2.473 . . . . 0.0 112.307 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.6 p -86.98 -13.96 43.06 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.49 0.662 . . . . 0.0 111.026 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.66 133.11 31.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.106 177.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.5 m -92.75 168.82 10.94 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.059 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.28 156.44 39.26 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.878 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 m -60.89 121.19 11.73 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.317 0.58 . . . . 0.0 110.738 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.32 -15.5 42.68 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 68.8 p -107.15 145.07 32.98 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 p -110.95 135.2 51.83 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 123.555 0.535 . . . . 0.0 110.572 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 47.9 t -80.11 108.01 13.36 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -110.28 117.76 34.5 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.649 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.1 t -77.78 96.09 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.3 mt -79.93 -36.57 36.13 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.316 1.055 . . . . 0.0 109.661 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.408 HD22 ' HB3' ' A' ' 32' ' ' TYR . 23.0 m-80 -135.8 162.4 57.14 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -60.39 -32.18 93.6 Favored 'Trans proline' 0 C--O 1.223 -0.26 0 CA-C-N 121.22 1.471 . . . . 0.0 112.966 -174.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -105.58 -24.02 12.66 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 120.975 0.417 . . . . 0.0 110.383 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' HB3' HD22 ' A' ' 29' ' ' ASN . 71.4 t80 -103.24 113.82 27.61 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.613 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.2 m -124.31 134.7 53.12 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -122.08 150.19 42.49 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.977 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.8 m -91.43 105.84 18.06 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.294 -1.835 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.493 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.516 HE21 ' HA3' ' A' ' 6' ' ' GLY . 64.4 tp60 . . . . . 0 N--CA 1.431 -1.397 0 CA-C-O 121.173 0.511 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 p -74.75 167.86 20.99 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 124.378 1.071 . . . . 0.0 112.068 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -65.3 130.98 45.3 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 77.16 9.16 2.73 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.196 1.398 . . . . 0.0 112.36 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.516 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -96.29 169.21 26.16 Favored Glycine 0 N--CA 1.431 -1.659 0 C-N-CA 119.85 -1.167 . . . . 0.0 110.449 176.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.3 tt0 -86.85 109.46 19.31 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 116.911 0.355 . . . . 0.0 110.368 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -71.45 -34.82 70.57 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-O 121.578 0.704 . . . . 0.0 109.57 174.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.32 133.75 4.44 Favored Glycine 0 N--CA 1.396 -3.976 0 C-N-CA 118.16 -1.972 . . . . 0.0 115.146 174.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.37 -156.26 23.59 Favored Glycine 0 N--CA 1.401 -3.671 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 173.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -56.97 131.7 20.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.92 -11.19 62.39 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.421 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -113.73 117.2 30.85 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 p -126.53 19.63 7.36 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.02 -128.49 1.88 Allowed Glycine 0 C--O 1.243 0.715 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -65.61 79.41 0.25 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.18 2.586 . . . . 0.0 112.867 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -85.3 -18.01 35.18 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.85 0.833 . . . . 0.0 109.907 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.92 129.4 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.3 m -91.66 168.47 11.46 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 120.762 0.315 . . . . 0.0 110.469 -178.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.79 145.46 52.48 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.2 t -52.26 124.66 13.73 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 123.716 0.635 . . . . 0.0 110.507 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.06 -26.66 16.48 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.858 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.2 p -97.61 140.73 31.59 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.994 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.4 p -100.52 133.8 44.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.278 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.2 t -81.01 107.01 13.46 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -108.77 116.98 33.01 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.8 t -75.02 103.26 2.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.41 HD12 ' CE1' ' A' ' 32' ' ' TYR . 86.0 mt -86.5 -48.07 8.71 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.666 -174.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -118.58 165.02 17.76 Favored Pre-proline 0 C--N 1.288 -2.099 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -60.97 -29.4 87.92 Favored 'Trans proline' 0 C--O 1.218 -0.476 0 CA-C-N 121.421 1.543 . . . . 0.0 111.646 -175.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -105.7 -23.93 12.64 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.964 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.41 ' CE1' HD12 ' A' ' 28' ' ' LEU . 85.8 t80 -103.1 113.97 27.88 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.16 0.505 . . . . 0.0 111.16 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.1 m -125.11 137.97 54.17 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 176.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -122.98 149.07 44.78 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.948 -175.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.2 m -89.36 106.07 18.21 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.297 -1.715 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.32 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 . . . . . 0 N--CA 1.436 -1.162 0 CA-C-O 120.999 0.428 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -70.3 165.64 21.88 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.374 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.403 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 16.2 t-160 -66.07 131.13 45.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 75.94 8.88 3.49 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.126 1.37 . . . . 0.0 111.631 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.68 170.76 31.18 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.0 tt0 -88.71 106.81 18.59 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.616 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.9 p -65.38 -40.97 94.16 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-O 121.594 0.711 . . . . 0.0 109.44 174.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.2 119.91 2.35 Favored Glycine 1 N--CA 1.396 -4.032 0 C-N-CA 118.449 -1.834 . . . . 0.0 114.667 174.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.95 -156.76 33.04 Favored Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 106.39 -2.684 . . . . 0.0 106.39 170.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -58.06 132.81 22.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 117.244 0.522 . . . . 0.0 109.908 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.21 -17.62 55.51 Favored Glycine 0 C--O 1.245 0.798 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.462 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -93.43 127.81 39.22 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.6 p -129.29 15.35 6.14 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.037 0.446 . . . . 0.0 111.465 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.61 -137.57 5.47 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.76 91.54 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.915 2.41 . . . . 0.0 111.351 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 2.4 p -89.67 0.24 57.09 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.73 0.776 . . . . 0.0 111.293 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -106.45 128.81 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.589 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.5 m -79.82 155.74 27.72 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.515 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.5 159.43 18.59 Favored 'General case' 0 C--O 1.254 1.297 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.883 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 m -49.86 118.24 2.75 Favored 'General case' 0 C--O 1.247 0.933 0 C-N-CA 124.041 0.936 . . . . 0.0 112.157 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.32 -12.1 43.75 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.52 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 75.6 p -110.51 153.51 24.98 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 117.59 0.695 . . . . 0.0 111.846 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.9 p -112.02 139.88 47.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.35 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.415 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.8 t -84.41 107.06 16.46 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.508 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 75.6 mt-30 -103.67 115.01 29.7 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.1 t -81.35 101.28 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.536 HD12 ' CE1' ' A' ' 32' ' ' TYR . 86.2 mt -80.03 -52.31 7.98 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.822 0.82 . . . . 0.0 109.37 -176.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -118.94 167.7 11.28 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.72 -32.52 86.56 Favored 'Trans proline' 0 C--N 1.347 0.489 0 CA-C-N 120.92 1.364 . . . . 0.0 112.384 -176.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -105.66 -23.55 12.73 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 120.777 0.322 . . . . 0.0 110.76 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.536 ' CE1' HD12 ' A' ' 28' ' ' LEU . 63.3 t80 -101.51 114.21 28.02 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.546 0.689 . . . . 0.0 110.801 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.7 m -129.37 143.74 50.96 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -130.97 148.93 52.79 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.512 -174.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 81.7 m -88.86 106.67 18.54 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.876 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.508 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.8 mm? . . . . . 0 C--N 1.298 -1.653 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 . . . . . 0 N--CA 1.445 -0.688 0 CA-C-O 121.372 0.606 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 p -75.31 176.26 7.59 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.193 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -63.51 134.1 55.0 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.831 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 73.91 9.22 4.77 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 124.58 1.152 . . . . 0.0 112.503 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.97 170.16 31.62 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.4 tt0 -90.81 105.79 18.07 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 122.439 0.296 . . . . 0.0 110.548 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.2 p -64.7 -56.76 11.69 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 170.61 106.46 0.19 Allowed Glycine 0 N--CA 1.407 -3.269 0 C-N-CA 117.958 -2.068 . . . . 0.0 113.34 -175.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.21 -165.07 20.34 Favored Glycine 0 N--CA 1.417 -2.606 0 N-CA-C 105.963 -2.855 . . . . 0.0 105.963 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.4 mt -65.11 112.66 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 118.22 1.01 . . . . 0.0 110.337 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.5 -9.09 28.39 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.026 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.46 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 2.8 t80 -113.52 113.22 24.82 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.8 p -125.46 14.77 8.24 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.124 0.487 . . . . 0.0 112.095 -176.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.65 -124.18 0.7 Allowed Glycine 0 C--N 1.318 -0.452 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -66.19 80.98 0.29 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.59 2.86 . . . . 0.0 111.812 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.2 p -84.04 -12.53 55.02 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-O 121.892 0.854 . . . . 0.0 111.182 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.9 132.87 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.6 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.8 m -90.75 163.14 14.58 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.395 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.43 141.43 54.67 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.585 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -53.68 114.58 1.6 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 123.748 0.819 . . . . 0.0 110.732 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.15 -9.95 29.09 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.595 -0.73 . . . . 0.0 113.06 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.7 p -111.52 135.64 51.81 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.1 p -96.17 132.77 41.25 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.736 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.581 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.0 t -77.01 113.06 14.31 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -114.73 116.95 29.48 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.5 t -79.72 103.15 6.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.3 mt -81.75 -48.44 11.64 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.142 0.972 . . . . 0.0 109.472 -173.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.41 HD22 ' HB3' ' A' ' 32' ' ' TYR . 29.0 m-80 -122.44 167.24 14.63 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 103.734 -2.691 . . . . 0.0 103.734 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.37 -34.69 53.83 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 CA-C-N 121.18 1.457 . . . . 0.0 111.94 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -100.51 -24.81 14.38 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.699 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HB3' HD22 ' A' ' 29' ' ' ASN . 64.5 t80 -104.0 114.39 28.6 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.9 m -118.88 153.32 34.74 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 174.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -140.33 148.24 41.05 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 118.798 0.726 . . . . 0.0 110.55 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.493 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.3 m -91.81 106.62 18.61 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.385 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 . . . . . 0 N--CA 1.424 -1.754 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 p -72.62 166.67 22.29 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 123.558 0.743 . . . . 0.0 111.29 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.401 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 15.0 t-160 -63.03 132.93 53.63 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 76.56 9.39 3.03 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.74 1.216 . . . . 0.0 112.462 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.2 170.63 28.94 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.6 tt0 -85.8 114.1 22.48 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.878 0.339 . . . . 0.0 110.337 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.634 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.4 p -71.47 -54.29 11.11 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 123.618 0.574 . . . . 0.0 110.3 176.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.5 122.46 0.83 Allowed Glycine 1 N--CA 1.396 -4.029 0 C-N-CA 118.228 -1.939 . . . . 0.0 113.902 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.13 -157.71 19.53 Favored Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 105.572 -3.011 . . . . 0.0 105.572 173.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.13 126.03 20.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 118.009 0.904 . . . . 0.0 108.92 175.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.6 -17.13 39.92 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.582 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -89.41 127.41 35.82 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -124.18 -3.43 8.01 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.37 -135.24 2.16 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.1 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.35 92.62 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.373 2.715 . . . . 0.0 113.348 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.5 p -91.72 -5.97 52.74 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.284 0.564 . . . . 0.0 111.624 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.8 t -96.18 130.11 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.9 m -87.56 161.72 17.59 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.182 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.14 153.03 5.43 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 124.206 1.002 . . . . 0.0 110.684 176.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.2 m -51.23 111.19 0.53 Allowed 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 123.936 0.895 . . . . 0.0 111.741 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.49 -14.95 57.76 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.247 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 70.4 p -92.74 139.76 30.22 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.0 p -101.97 136.83 41.13 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -176.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.426 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.6 t -80.89 117.63 21.69 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -116.96 117.93 31.02 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.67 96.29 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.2 mt -76.76 -38.98 53.16 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.094 -175.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -131.27 160.56 66.55 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -59.62 -27.63 85.43 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 121.548 1.499 . . . . 0.0 111.332 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -106.55 -24.38 12.2 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.453 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -103.32 114.37 28.59 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.051 -0.659 . . . . 0.0 110.463 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.7 m -127.76 136.06 50.99 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -123.03 149.93 43.71 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.388 -173.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 79.2 m -90.05 106.79 18.71 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.578 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.298 -1.638 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.507 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.439 -0.997 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -86.45 123.65 31.91 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 118.514 0.597 . . . . 0.0 111.073 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.7 p -65.65 163.27 16.68 Favored 'General case' 0 C--O 1.254 1.34 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.375 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -60.59 130.71 47.89 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.297 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 75.61 9.13 3.64 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.232 1.413 . . . . 0.0 112.331 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.95 172.05 32.0 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.519 HE21 ' HA2' ' A' ' 9' ' ' GLY . 48.8 tt0 -86.47 103.78 15.33 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.873 0.336 . . . . 0.0 110.702 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.574 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 3.6 p -67.12 -28.17 67.93 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.841 0.829 . . . . 0.0 109.428 174.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.519 ' HA2' HE21 ' A' ' 7' ' ' GLN . . . 108.98 134.22 7.04 Favored Glycine 0 N--CA 1.396 -3.991 0 C-N-CA 118.85 -1.643 . . . . 0.0 115.254 172.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.99 -155.94 29.04 Favored Glycine 0 N--CA 1.403 -3.506 0 N-CA-C 107.614 -2.195 . . . . 0.0 107.614 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.7 mt -57.11 128.03 17.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.71 -19.02 36.75 Favored Glycine 0 C--N 1.311 -0.844 0 C-N-CA 120.044 -1.074 . . . . 0.0 112.644 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.463 ' CG ' ' HA3' ' A' ' 9' ' ' GLY . 9.3 t80 -90.88 125.45 35.75 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -118.63 2.99 11.75 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -174.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.03 -128.68 5.97 Favored Glycine 0 C--N 1.311 -0.835 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.976 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -64.67 85.67 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.572 2.848 . . . . 0.0 113.027 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -90.12 -7.55 53.47 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 122.042 0.925 . . . . 0.0 109.72 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.14 131.28 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.574 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.2 m -92.85 158.05 16.06 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.086 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.52 141.19 32.08 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 123.801 0.688 . . . . 0.0 109.75 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 m -51.31 117.92 2.92 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.628 0.771 . . . . 0.0 111.859 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.92 -18.15 26.72 Favored Glycine 0 N--CA 1.431 -1.689 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.231 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 61.2 p -102.57 144.68 30.67 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.0 p -100.94 132.7 46.23 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.486 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.2 t -79.49 106.47 11.55 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.419 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.6 mt-30 -106.08 114.79 29.14 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.664 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.9 t -78.93 96.3 2.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.454 HD12 ' CE2' ' A' ' 32' ' ' TYR . 80.9 mt -77.15 -52.12 9.82 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.947 -175.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -115.79 162.31 26.05 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.57 -24.44 78.01 Favored 'Trans proline' 0 C--O 1.212 -0.791 0 CA-C-N 121.375 1.527 . . . . 0.0 112.099 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -108.87 -23.38 11.76 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.752 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.454 ' CE2' HD12 ' A' ' 28' ' ' LEU . 69.3 t80 -103.01 114.09 28.1 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.167 0.508 . . . . 0.0 111.457 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.5 m -126.88 134.26 50.53 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -120.24 151.25 39.43 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -176.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.1 m -92.76 106.17 18.19 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.419 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.9 mm? . . . . . 0 C--N 1.297 -1.681 0 CA-C-O 118.462 -0.78 . . . . 0.0 109.233 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 N--CA 1.442 -0.874 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -90.62 128.03 36.47 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.356 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 t -73.47 177.09 5.51 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-O 121.809 0.814 . . . . 0.0 110.947 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -64.12 131.8 48.55 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.374 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 76.06 9.79 3.25 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.916 1.286 . . . . 0.0 113.386 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.3 168.0 25.3 Favored Glycine 0 C--N 1.312 -0.786 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.573 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.0 tt0 -81.54 112.72 19.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 117.026 0.413 . . . . 0.0 110.353 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.699 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.3 p -72.87 -58.07 3.6 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.783 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.418 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 171.71 109.42 0.22 Allowed Glycine 0 N--CA 1.396 -3.98 0 C-N-CA 118.134 -1.984 . . . . 0.0 113.363 -176.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.56 -157.53 17.31 Favored Glycine 0 N--CA 1.405 -3.406 0 N-CA-C 105.974 -2.851 . . . . 0.0 105.974 171.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.418 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 77.2 mt -65.67 126.1 24.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 117.665 0.732 . . . . 0.0 109.604 174.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.96 -13.16 60.69 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.907 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -90.37 111.96 23.38 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.8 p -109.98 6.83 23.44 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.97 -136.97 9.29 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.872 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -64.13 88.29 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.682 2.922 . . . . 0.0 112.996 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 24.4 p -84.21 -16.09 44.59 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.787 0.803 . . . . 0.0 110.5 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.3 t -82.4 129.84 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.74 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.0 m -88.18 168.92 12.34 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.002 0.43 . . . . 0.0 110.954 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.62 155.04 16.33 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.758 0.823 . . . . 0.0 110.709 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -64.52 111.53 2.74 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.245 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.51 6.47 27.08 Favored Glycine 0 N--CA 1.432 -1.578 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.056 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 59.7 p -125.1 152.19 44.71 Favored 'General case' 0 C--O 1.244 0.788 0 O-C-N 122.411 -0.464 . . . . 0.0 110.394 177.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.1 p -115.23 139.85 49.6 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.881 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.3 t -83.92 110.12 18.15 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -110.68 114.91 28.66 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -79.56 98.2 2.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.117 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.1 mt -78.52 -43.86 25.78 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.48 -174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -126.73 160.46 58.6 Favored Pre-proline 0 C--N 1.289 -2.033 0 N-CA-C 103.655 -2.72 . . . . 0.0 103.655 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.41 -29.43 84.37 Favored 'Trans proline' 0 C--O 1.225 -0.153 0 C-N-CA 121.752 1.635 . . . . 0.0 112.005 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 53.6 m-85 -104.36 -25.5 12.82 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.851 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -104.28 113.56 27.2 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 119.551 -0.859 . . . . 0.0 110.434 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 13.7 m -125.53 135.74 52.59 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 177.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -121.35 147.61 45.47 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.411 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.699 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.7 m -87.62 106.64 18.16 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.29 -2.003 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.98 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.439 -1.014 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -93.57 117.91 30.69 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 121.796 -0.565 . . . . 0.0 110.451 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 m -69.15 169.11 12.61 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.555 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.424 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 17.7 t-160 -59.62 132.25 53.39 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.509 0.723 . . . . 0.0 109.27 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 77.4 8.87 2.66 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.564 1.546 . . . . 0.0 112.247 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.87 169.0 29.33 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.562 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.0 tt0 -88.31 103.77 16.12 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.604 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.5 p -62.51 -47.86 82.09 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.246 0.546 . . . . 0.0 111.68 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 151.07 117.18 0.77 Allowed Glycine 0 N--CA 1.397 -3.904 0 C-N-CA 118.189 -1.958 . . . . 0.0 113.773 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.56 -157.39 18.78 Favored Glycine 0 N--CA 1.413 -2.873 0 N-CA-C 106.376 -2.69 . . . . 0.0 106.376 172.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.84 121.68 14.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 117.963 0.881 . . . . 0.0 109.597 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.96 -9.17 46.72 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.386 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.445 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 2.7 t80 -113.79 112.01 22.71 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.0 p -120.98 14.99 11.6 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 120.866 0.365 . . . . 0.0 111.877 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.41 -126.49 0.97 Allowed Glycine 0 C--O 1.241 0.588 0 C-N-CA 121.261 -0.495 . . . . 0.0 111.878 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.2 79.95 0.56 Allowed 'Trans proline' 0 C--O 1.217 -0.547 0 C-N-CA 122.939 2.426 . . . . 0.0 112.01 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 23.0 p -83.45 2.18 37.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 122.269 1.033 . . . . 0.0 110.787 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.2 t -101.42 131.86 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.8 m -90.31 162.08 15.34 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 123.358 0.411 . . . . 0.0 110.591 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.75 144.64 37.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.841 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.1 p -56.17 118.2 4.48 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 124.069 0.856 . . . . 0.0 111.416 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.03 -3.19 28.56 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.983 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.2 p -120.51 166.15 14.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 117.388 0.594 . . . . 0.0 110.281 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 34.4 p -120.89 146.04 47.02 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 122.202 0.201 . . . . 0.0 111.152 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.5 t -90.08 111.54 22.69 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -111.81 114.82 28.03 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -76.96 99.85 2.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 mt -82.53 -53.98 5.54 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.298 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -110.29 165.57 12.43 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.27 -26.23 64.2 Favored 'Trans proline' 0 C--O 1.221 -0.35 0 CA-C-N 121.445 1.552 . . . . 0.0 111.14 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -106.53 -25.29 11.9 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.432 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -103.62 113.26 26.64 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.631 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.4 m -123.54 139.31 54.14 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 176.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -127.61 150.57 49.67 Favored 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.597 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.7 m -90.01 106.42 18.46 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.299 -1.588 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.433 -1.302 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -78.68 123.9 27.63 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.246 0.546 . . . . 0.0 111.7 -170.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -74.22 171.95 12.67 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.459 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -62.32 132.86 54.05 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.365 0.666 . . . . 0.0 109.719 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 74.74 8.99 4.21 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.282 1.433 . . . . 0.0 112.406 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.25 169.56 33.36 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -89.09 105.61 17.9 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 117.134 0.467 . . . . 0.0 110.792 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 2.5 p -67.26 -31.5 71.87 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 121.587 0.708 . . . . 0.0 109.934 175.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.53 131.35 5.13 Favored Glycine 0 N--CA 1.396 -3.987 0 C-N-CA 118.922 -1.608 . . . . 0.0 115.866 172.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.6 -156.06 25.47 Favored Glycine 0 N--CA 1.408 -3.225 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.2 mt -56.31 127.4 15.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.17 -23.36 29.09 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.055 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -89.04 130.94 35.41 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.2 p -137.86 14.91 2.89 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.656 0.741 . . . . 0.0 111.234 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.8 -130.23 5.3 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.41 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.45 84.26 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.314 2.676 . . . . 0.0 112.267 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.3 p -88.25 2.32 52.59 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 122.252 1.025 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -105.88 127.25 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.9 m -87.76 153.02 21.68 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.84 154.4 15.09 Favored 'General case' 0 C--O 1.252 1.216 0 O-C-N 123.596 0.56 . . . . 0.0 111.236 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.2 m -49.4 116.39 1.71 Allowed 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.556 1.142 . . . . 0.0 112.035 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.89 -1.8 48.28 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.557 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.5 p -117.7 145.67 44.26 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 117.649 0.725 . . . . 0.0 110.212 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.5 p -106.25 138.64 42.07 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -79.4 113.81 17.83 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.427 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 77.6 mt-30 -113.73 114.76 26.81 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.49 100.14 2.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.3 mt -79.26 -53.2 7.18 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -175.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -116.85 160.3 37.32 Favored Pre-proline 0 C--N 1.29 -1.995 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.27 -29.89 91.48 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 121.484 1.456 . . . . 0.0 113.261 -174.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -106.58 -23.81 12.35 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 120.959 0.409 . . . . 0.0 110.488 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -103.12 113.49 27.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.217 0.532 . . . . 0.0 111.352 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.7 m -124.99 142.74 51.29 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -129.84 149.14 51.71 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.238 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 67.5 m -88.67 107.63 19.03 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.939 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.427 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.8 mm? . . . . . 0 C--N 1.303 -1.419 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.438 -1.072 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.519 HE21 ' HA3' ' A' ' 6' ' ' GLY . 62.1 tp60 -80.15 135.63 36.34 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.555 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -81.77 169.85 16.42 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 124.088 0.955 . . . . 0.0 111.877 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -64.63 131.57 47.33 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 75.61 9.51 3.57 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.718 1.207 . . . . 0.0 112.741 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.519 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.03 167.57 26.7 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.429 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.9 tt0 -84.96 116.08 23.17 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.617 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.6 p -73.56 -55.2 6.61 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 123.8 0.688 . . . . 0.0 110.973 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.411 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 161.65 108.65 0.23 Allowed Glycine 0 N--CA 1.401 -3.673 0 C-N-CA 118.114 -1.993 . . . . 0.0 114.528 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.33 -158.33 29.0 Favored Glycine 0 N--CA 1.41 -3.043 0 N-CA-C 106.36 -2.696 . . . . 0.0 106.36 171.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.495 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 72.6 mt -65.3 117.07 5.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 118.074 0.937 . . . . 0.0 110.901 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.25 -14.79 23.16 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.573 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -92.27 125.57 36.99 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.6 p -119.76 -6.39 10.12 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.42 -131.2 1.81 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.762 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.53 79.98 0.1 Allowed 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 123.963 3.109 . . . . 0.0 112.669 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 5.2 p -85.35 -5.94 59.27 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.86 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.0 t -99.43 131.96 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 82.6 m -92.54 146.95 23.28 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 123.364 0.415 . . . . 0.0 110.092 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.53 154.05 6.95 Favored 'General case' 0 C--O 1.251 1.17 0 O-C-N 124.007 0.817 . . . . 0.0 110.865 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 m -50.82 126.86 16.97 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.865 0.866 . . . . 0.0 111.417 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.93 -16.54 57.29 Favored Glycine 0 N--CA 1.432 -1.585 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.565 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.8 p -110.22 142.41 41.83 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.432 0.616 . . . . 0.0 110.289 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.3 p -109.29 133.6 52.83 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.507 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.6 t -75.31 107.15 7.22 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -109.37 114.73 28.65 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.3 t -78.55 96.63 2.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.0 mt -75.7 -51.5 12.59 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.371 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -120.34 166.99 13.66 Favored Pre-proline 0 C--N 1.284 -2.258 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.57 -33.5 86.98 Favored 'Trans proline' 0 C--N 1.343 0.261 0 CA-C-N 121.399 1.535 . . . . 0.0 112.323 -175.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.495 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 21.9 m-85 -104.94 -23.78 12.93 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.44 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -102.23 113.5 26.85 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.376 0.607 . . . . 0.0 110.761 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.0 m -127.0 137.46 53.1 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -128.37 150.78 49.95 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.304 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.556 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 67.1 m -90.15 105.68 17.97 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.294 -1.833 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.945 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.444 -0.747 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -81.79 128.07 33.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.195 0.522 . . . . 0.0 111.721 -172.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 p -70.39 169.81 13.19 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.004 0.922 . . . . 0.0 112.907 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -61.74 129.5 41.33 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.904 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 76.75 9.25 2.94 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.766 1.226 . . . . 0.0 112.765 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.05 164.21 28.46 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.3 tt0 -83.49 107.47 15.99 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.627 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.6 p -67.27 -51.04 57.82 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-O 121.183 0.516 . . . . 0.0 111.421 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.59 118.69 0.71 Allowed Glycine 0 N--CA 1.399 -3.794 0 C-N-CA 118.266 -1.921 . . . . 0.0 113.651 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.12 -158.09 18.34 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 105.691 -2.964 . . . . 0.0 105.691 171.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.5 mt -68.63 119.97 15.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 117.919 0.86 . . . . 0.0 109.042 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.38 -6.27 28.39 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.014 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -113.9 132.27 55.98 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 p -141.33 20.82 2.23 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.88 -121.6 3.33 Favored Glycine 0 C--O 1.241 0.54 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -67.75 78.81 0.52 Allowed 'Trans proline' 0 N--CA 1.476 0.494 0 C-N-CA 123.697 2.931 . . . . 0.0 111.96 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.5 p -82.3 -16.66 48.57 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.55 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.8 t -89.14 133.0 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.1 m -87.39 159.1 18.84 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.12 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.63 160.61 8.89 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.931 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 m -62.82 128.9 38.07 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.625 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.17 5.41 59.43 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.492 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.4 p -128.55 164.88 21.85 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 117.33 0.565 . . . . 0.0 109.885 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.3 p -130.94 138.64 49.83 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 122.182 0.193 . . . . 0.0 110.845 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.464 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.2 t -78.23 114.38 17.06 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 40.4 mt-30 -115.94 115.81 26.84 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.922 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.1 t -77.7 99.79 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.2 mt -78.31 -50.6 11.5 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 122.042 0.925 . . . . 0.0 108.843 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -120.26 161.75 37.33 Favored Pre-proline 0 C--N 1.289 -2.057 0 N-CA-C 103.941 -2.615 . . . . 0.0 103.941 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.43 -28.66 88.12 Favored 'Trans proline' 0 N--CA 1.474 0.345 0 CA-C-N 120.896 1.356 . . . . 0.0 112.093 -175.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -105.01 -25.18 12.66 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.835 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -104.01 113.04 26.29 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.562 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -125.35 140.03 53.17 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -130.95 149.43 52.58 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.921 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.4 m -87.68 106.07 17.79 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.57 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.7 mm? . . . . . 0 C--N 1.289 -2.022 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.478 HE21 ' HA3' ' A' ' 6' ' ' GLY . 54.1 tp60 -83.14 146.15 28.82 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.518 0.675 . . . . 0.0 111.831 -173.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 p -80.91 161.7 24.25 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 124.357 1.063 . . . . 0.0 111.426 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -62.06 131.59 50.09 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 77.69 9.68 2.37 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.717 1.207 . . . . 0.0 112.752 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.478 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -97.67 170.01 25.03 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.424 177.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.6 tt0 -81.56 109.18 15.76 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.659 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -71.44 -54.04 11.98 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 121.266 0.555 . . . . 0.0 111.353 177.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.408 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 163.12 116.47 0.38 Allowed Glycine 1 N--CA 1.394 -4.111 0 C-N-CA 118.101 -1.999 . . . . 0.0 113.835 -177.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.25 -158.2 18.19 Favored Glycine 0 N--CA 1.409 -3.149 0 N-CA-C 105.485 -3.046 . . . . 0.0 105.485 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.2 mt -66.38 121.05 14.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 117.891 0.845 . . . . 0.0 110.049 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.09 -20.06 29.08 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.295 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -80.03 129.32 34.4 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.7 p -135.4 18.53 3.37 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.56 -125.85 5.52 Favored Glycine 0 C--N 1.311 -0.807 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.513 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.79 85.78 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.242 2.628 . . . . 0.0 111.925 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 10.2 p -88.94 -8.04 54.92 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.573 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.91 137.05 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 90.6 m -87.71 163.14 16.68 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.147 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.87 153.43 10.98 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.967 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.7 m -57.71 114.57 2.34 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.506 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.53 4.43 56.04 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.814 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 81.3 p -113.83 143.82 44.04 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 117.486 0.643 . . . . 0.0 109.882 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.3 p -103.55 132.65 49.62 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.515 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 45.9 t -79.16 106.73 11.4 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -104.61 114.76 29.19 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.4 t -77.83 101.65 3.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.9 mt -81.53 -39.45 24.66 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.738 0.78 . . . . 0.0 109.503 -173.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -132.97 163.06 53.77 Favored Pre-proline 0 C--N 1.289 -2.058 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -60.88 -28.35 86.23 Favored 'Trans proline' 0 C--N 1.345 0.367 0 CA-C-N 120.986 1.388 . . . . 0.0 112.618 -175.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -108.84 -24.07 11.45 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.407 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -103.11 114.51 28.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.292 0.568 . . . . 0.0 111.442 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.612 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.3 m -124.62 146.91 48.82 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -131.44 147.19 52.53 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.079 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.659 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.3 m -89.57 106.47 18.48 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 C--N 1.297 -1.678 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.615 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.424 HG22 ' HB ' ' A' ' 18' ' ' VAL . 11.6 p . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -99.11 143.38 29.44 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 p -76.81 171.24 15.05 Favored 'General case' 0 C--O 1.251 1.151 0 CA-C-O 121.179 0.514 . . . . 0.0 111.952 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -63.46 129.74 41.46 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 75.19 9.43 3.84 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.62 1.568 . . . . 0.0 111.508 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.76 165.84 32.35 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -86.56 106.55 17.62 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.517 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.5 p -70.01 -27.09 64.4 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.834 0.825 . . . . 0.0 109.067 174.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.25 129.43 6.0 Favored Glycine 1 N--CA 1.394 -4.165 0 C-N-CA 119.245 -1.455 . . . . 0.0 115.41 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.8 -156.65 30.91 Favored Glycine 0 N--CA 1.407 -3.272 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 171.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.9 mt -59.78 125.43 15.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.54 -1.07 32.47 Favored Glycine 0 C--N 1.317 -0.525 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.386 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -113.62 119.94 39.2 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.4 p -115.81 9.52 15.1 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.76 -139.78 7.68 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.353 -0.693 . . . . 0.0 111.809 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.34 94.58 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.23 2.62 . . . . 0.0 112.083 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.0 p -92.76 -7.46 46.5 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.479 0.657 . . . . 0.0 111.378 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 1' ' ' THR . 48.5 t -100.77 135.58 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.495 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.9 m -90.71 161.8 15.19 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 120.719 0.295 . . . . 0.0 111.69 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.18 164.73 10.41 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.61 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.6 m -54.12 111.52 0.78 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 124.354 1.062 . . . . 0.0 112.764 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.07 -13.48 57.37 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.243 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 82.2 p -100.18 141.03 33.57 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 122.17 -0.606 . . . . 0.0 109.889 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 27.4 p -106.08 136.78 45.15 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.792 -0.186 . . . . 0.0 111.36 -177.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.4 t -80.73 106.15 12.51 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -107.97 115.42 30.1 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.703 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.25 96.17 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.6 mt -77.55 -39.1 47.0 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.057 -173.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.419 HD22 ' HB3' ' A' ' 32' ' ' TYR . 29.7 m-80 -133.55 163.74 48.99 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -61.55 -29.31 84.35 Favored 'Trans proline' 0 C--O 1.235 0.373 0 CA-C-N 121.549 1.589 . . . . 0.0 112.941 -173.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -107.72 -23.5 12.08 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.85 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HB3' HD22 ' A' ' 29' ' ' ASN . 70.3 t80 -103.15 113.83 27.63 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.054 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 m -125.34 141.27 52.17 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -131.75 150.38 52.17 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.018 -174.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.517 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.0 m -89.29 105.89 18.09 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.99 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--N 1.29 -1.984 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.413 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' NE2' ' HA3' ' A' ' 6' ' ' GLY . 26.0 tp60 -81.39 121.76 26.64 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.254 0.55 . . . . 0.0 111.106 -175.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 m -66.75 166.75 12.53 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.48 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -62.28 131.33 49.02 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.652 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 77.25 8.87 2.73 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.705 1.602 . . . . 0.0 112.482 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.47 ' HA3' ' NE2' ' A' ' 2' ' ' GLN . . . -91.85 170.59 33.56 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.5 tt0 -88.49 107.48 18.9 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.68 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.6 p -62.73 -56.91 13.26 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 121.016 0.436 . . . . 0.0 111.664 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.436 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 164.5 112.66 0.27 Allowed Glycine 0 N--CA 1.4 -3.725 0 C-N-CA 118.278 -1.915 . . . . 0.0 113.671 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.59 -167.28 20.13 Favored Glycine 0 N--CA 1.41 -3.038 0 N-CA-C 106.4 -2.68 . . . . 0.0 106.4 171.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.8 mt -59.76 111.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 117.823 0.812 . . . . 0.0 110.926 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.33 -5.02 26.69 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.753 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -98.49 127.94 44.63 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.0 p -124.59 -1.8 7.97 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.73 -135.64 2.81 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.042 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 39.5 Cg_exo -63.99 80.44 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.056 3.171 . . . . 0.0 112.386 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.671 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 9.2 p -76.8 -22.06 54.22 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.721 0.772 . . . . 0.0 110.726 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.08 129.15 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 87.6 m -87.13 161.5 18.06 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.889 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.76 157.79 14.16 Favored 'General case' 0 C--O 1.256 1.396 0 C-N-CA 123.765 0.826 . . . . 0.0 110.808 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.5 m -64.03 111.21 2.42 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.142 0.496 . . . . 0.0 110.406 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.31 0.32 33.14 Favored Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.903 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 79.2 p -116.81 139.48 50.55 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.283 -0.54 . . . . 0.0 109.605 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 24.8 p -102.04 136.04 42.57 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.056 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.448 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.5 t -81.89 109.95 16.72 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -109.89 114.6 28.28 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.41 98.88 3.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.9 mt -78.93 -53.27 7.22 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.855 0.836 . . . . 0.0 109.369 -173.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -115.77 167.04 10.86 Favored Pre-proline 0 C--N 1.283 -2.299 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -61.04 -32.14 91.72 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 CA-C-N 121.001 1.393 . . . . 0.0 112.278 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -105.68 -23.96 12.64 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.23 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -102.36 113.89 27.59 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.344 0.592 . . . . 0.0 111.477 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.6 m -124.64 153.0 42.92 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 176.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -140.83 149.4 41.96 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.536 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.601 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 68.9 m -91.67 106.07 18.2 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--N 1.3 -1.549 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.628 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.436 -1.162 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.451 ' NE2' ' HA3' ' A' ' 6' ' ' GLY . 28.2 tp60 -86.35 130.29 34.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.369 0.604 . . . . 0.0 110.93 -176.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 p -75.08 169.38 18.14 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.188 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -61.82 132.49 53.27 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.373 1.069 . . . . 0.0 109.244 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 74.52 8.84 4.38 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 125.077 1.351 . . . . 0.0 112.565 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.451 ' HA3' ' NE2' ' A' ' 2' ' ' GLN . . . -94.05 164.89 26.36 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 176.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.4 tt0 -84.58 101.13 11.88 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.6 p -63.23 -42.49 99.25 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.23 0.538 . . . . 0.0 111.053 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.422 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 139.59 123.61 2.08 Favored Glycine 1 N--CA 1.393 -4.199 0 C-N-CA 118.048 -2.025 . . . . 0.0 114.247 177.053 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.38 -157.81 17.75 Favored Glycine 0 N--CA 1.403 -3.565 0 N-CA-C 105.432 -3.067 . . . . 0.0 105.432 171.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.3 mt -62.67 130.92 27.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.88 -7.96 61.08 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.837 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -109.91 136.56 49.01 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.2 p -141.39 21.23 2.22 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.1 -126.38 5.07 Favored Glycine 0 C--N 1.307 -1.039 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.469 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -70.1 86.7 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.29 2.66 . . . . 0.0 111.537 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.9 p -82.54 -16.81 47.24 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.889 0.852 . . . . 0.0 110.917 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.78 135.36 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 67.3 m -93.07 162.17 14.14 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.62 138.97 51.52 Favored 'General case' 0 C--O 1.25 1.109 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.6 m -57.61 127.16 30.6 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.411 0.444 . . . . 0.0 110.731 -175.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.05 -16.54 27.66 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.214 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.6 p -115.91 144.89 43.43 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.8 p -103.66 136.86 42.58 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -175.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 38.4 t -81.1 107.1 13.62 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -104.42 114.51 28.79 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.554 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.0 t -80.01 100.59 4.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.5 mt -82.91 -51.33 7.71 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.254 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.503 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -112.35 161.64 25.2 Favored Pre-proline 0 C--N 1.292 -1.922 0 N-CA-C 102.102 -3.295 . . . . 0.0 102.102 174.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.02 -25.73 77.89 Favored 'Trans proline' 0 C--O 1.22 -0.412 0 CA-C-N 121.667 1.631 . . . . 0.0 111.326 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -104.26 -23.77 13.2 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.16 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.483 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 61.0 t80 -103.82 114.11 28.12 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.53 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.2 m -125.47 142.24 51.61 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -133.68 147.98 51.44 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.894 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.1 m -88.55 106.5 18.33 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.23 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.294 -1.826 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.519 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.435 -1.197 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.463 ' NE2' ' HA3' ' A' ' 6' ' ' GLY . 28.0 tp60 -89.8 129.55 36.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.242 0.544 . . . . 0.0 111.145 -174.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 p -72.96 172.82 10.25 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 124.169 0.988 . . . . 0.0 112.655 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -67.52 130.41 42.95 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 77.13 9.18 2.74 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.37 1.468 . . . . 0.0 112.351 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.463 ' HA3' ' NE2' ' A' ' 2' ' ' GLN . . . -90.95 164.31 29.87 Favored Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 175.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -82.55 104.61 12.95 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.694 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.7 p -62.53 -55.18 29.84 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-O 121.099 0.476 . . . . 0.0 111.305 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 159.83 112.89 0.32 Allowed Glycine 1 N--CA 1.392 -4.285 0 C-N-CA 117.685 -2.198 . . . . 0.0 114.123 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.35 -158.14 22.91 Favored Glycine 0 N--CA 1.402 -3.604 0 N-CA-C 105.313 -3.115 . . . . 0.0 105.313 170.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.24 128.89 31.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 118.044 0.922 . . . . 0.0 108.628 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.91 -8.98 50.89 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.687 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.461 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 3.4 t80 -113.66 118.03 33.21 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 p -124.54 3.05 8.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.51 -119.69 0.84 Allowed Glycine 0 C--O 1.243 0.658 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.964 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 25.2 Cg_exo -67.96 78.5 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.662 2.908 . . . . 0.0 111.836 175.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.654 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.7 p -85.83 -22.66 27.5 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.455 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.89 131.94 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -85.68 153.11 22.57 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.291 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.94 148.64 20.6 Favored 'General case' 0 C--O 1.244 0.791 0 O-C-N 123.932 0.77 . . . . 0.0 110.717 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 m -55.11 116.82 3.0 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 122.979 0.512 . . . . 0.0 111.508 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.93 -5.7 29.08 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.287 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.2 p -119.27 154.52 33.33 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.6 p -116.73 142.09 47.36 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.977 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.5 t -83.06 112.04 19.43 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.528 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 76.5 mt-30 -109.74 114.37 27.89 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.7 t -81.93 105.83 12.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.8 mt -83.38 -53.89 5.39 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.943 -175.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -116.21 163.29 22.2 Favored Pre-proline 0 C--N 1.296 -1.737 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -58.37 -31.86 94.88 Favored 'Trans proline' 0 C--O 1.218 -0.503 0 C-N-CA 121.279 1.319 . . . . 0.0 112.04 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -102.69 -24.12 13.78 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.865 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -103.7 114.18 28.25 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 120.934 0.397 . . . . 0.0 111.904 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.8 m -129.22 147.52 51.07 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -136.62 147.65 47.04 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.14 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.694 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.6 m -87.25 106.74 18.12 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.197 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.528 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.6 mm? . . . . . 0 C--N 1.294 -1.816 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.494 HE21 ' HA3' ' A' ' 6' ' ' GLY . 59.0 tp60 -103.75 134.36 47.19 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 118.656 0.662 . . . . 0.0 110.157 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -73.76 166.17 23.79 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.953 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -60.41 133.81 56.46 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.74 0.816 . . . . 0.0 108.95 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 74.87 9.25 4.08 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.201 1.4 . . . . 0.0 112.04 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.494 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -95.17 170.43 28.81 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.175 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.7 tt0 -88.43 107.82 19.06 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.523 0.161 . . . . 0.0 110.574 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.622 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -69.08 -29.74 67.91 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 121.973 0.892 . . . . 0.0 109.024 173.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.413 ' HA2' HE21 ' A' ' 7' ' ' GLN . . . 115.23 126.97 4.19 Favored Glycine 1 N--CA 1.391 -4.36 0 C-N-CA 118.771 -1.681 . . . . 0.0 114.566 174.358 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.44 -156.25 32.13 Favored Glycine 0 N--CA 1.41 -3.037 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 171.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -58.08 129.75 20.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 117.566 0.683 . . . . 0.0 109.347 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.21 -22.34 31.38 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.687 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -103.05 112.02 24.65 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -118.58 11.41 12.86 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -175.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.23 -122.16 1.12 Allowed Glycine 0 C--O 1.245 0.804 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.849 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.8 78.65 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.051 3.167 . . . . 0.0 113.003 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.7 p -86.13 -16.81 36.78 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.081 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -90.58 133.8 31.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 86.1 m -92.97 157.55 16.27 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.388 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.13 158.9 18.62 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.784 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.5 m -55.1 121.11 8.05 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.303 0.641 . . . . 0.0 111.644 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.01 -16.96 45.67 Favored Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.427 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 59.2 p -106.88 143.11 35.44 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 122.248 -0.56 . . . . 0.0 110.976 -177.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.2 p -109.36 136.8 48.2 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.498 0.319 . . . . 0.0 111.567 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.43 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.0 t -79.93 108.68 13.7 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -113.19 117.36 31.69 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.338 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.76 106.91 7.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.2 mt -88.38 -41.73 12.64 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.193 0.997 . . . . 0.0 108.949 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.415 HD22 ' HB3' ' A' ' 32' ' ' TYR . 37.9 m-80 -127.71 161.16 56.92 Favored Pre-proline 0 C--N 1.286 -2.166 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 178.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -60.2 -31.63 93.36 Favored 'Trans proline' 0 CA--C 1.52 -0.217 0 CA-C-N 121.027 1.402 . . . . 0.0 112.051 -174.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -105.04 -23.46 12.95 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.295 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.415 ' HB3' HD22 ' A' ' 29' ' ' ASN . 76.7 t80 -103.29 114.04 28.01 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.176 0.512 . . . . 0.0 111.421 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.2 m -125.57 138.82 53.96 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -124.01 149.96 45.43 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.315 -174.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.4 m -91.91 106.07 18.18 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.287 -2.134 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.638 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.5 m . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.515 HE21 ' HA3' ' A' ' 6' ' ' GLY . 55.6 tp60 -96.46 134.84 39.15 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 118.948 0.795 . . . . 0.0 110.786 -177.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 p -86.97 177.41 7.25 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 121.148 0.499 . . . . 0.0 111.596 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -62.92 132.41 51.99 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.048 0.539 . . . . 0.0 110.024 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 78.92 8.69 1.93 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.624 1.569 . . . . 0.0 113.218 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.515 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -94.47 173.54 32.67 Favored Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.877 176.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.0 tt0 -91.4 110.77 22.07 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.8 p -70.84 -33.28 70.5 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-O 121.76 0.79 . . . . 0.0 109.184 174.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.05 133.61 4.58 Favored Glycine 0 N--CA 1.398 -3.897 0 C-N-CA 118.469 -1.824 . . . . 0.0 115.397 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.31 -156.23 20.09 Favored Glycine 0 N--CA 1.402 -3.599 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.93 129.59 20.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.58 -6.72 55.35 Favored Glycine 0 C--N 1.307 -1.031 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.959 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -114.01 132.88 55.83 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.0 p -135.19 6.98 3.36 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.49 -123.14 2.03 Favored Glycine 0 C--O 1.246 0.865 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.273 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -65.27 79.21 0.22 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.709 2.94 . . . . 0.0 113.333 176.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.5 p -89.08 7.01 37.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 122.359 1.076 . . . . 0.0 109.384 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.9 t -106.24 116.92 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.112 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.444 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.1 m -83.44 149.69 26.51 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.14 151.25 12.63 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 123.932 0.77 . . . . 0.0 110.854 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -59.91 119.74 8.3 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.128 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.25 -9.98 28.87 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.784 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.7 p -118.49 146.18 44.71 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 122.197 -0.59 . . . . 0.0 110.491 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 34.4 p -107.08 140.94 39.1 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.135 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.0 t -85.42 107.26 17.32 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -107.89 114.64 28.73 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.49 96.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.421 HD12 ' CE1' ' A' ' 32' ' ' TYR . 87.6 mt -75.68 -53.22 8.9 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.468 0.707 . . . . 0.0 109.831 -174.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -112.06 162.66 20.28 Favored Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 172.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.67 -23.43 75.99 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 CA-C-N 120.935 1.37 . . . . 0.0 111.67 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -106.85 -24.72 11.96 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.979 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.421 ' CE1' HD12 ' A' ' 28' ' ' LEU . 74.7 t80 -103.67 113.8 27.59 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.971 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.9 m -126.68 135.35 51.04 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -124.76 150.34 46.36 Favored 'General case' 0 C--N 1.286 -2.169 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.199 -175.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 79.3 m -90.37 106.27 18.38 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.302 -1.494 0 CA-C-O 118.646 -0.692 . . . . 0.0 109.835 -178.867 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.437 -1.09 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.514 HE21 ' HA3' ' A' ' 6' ' ' GLY . 61.1 tp60 -84.34 138.36 32.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.15 0.5 . . . . 0.0 111.654 -175.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 p -79.56 170.85 15.96 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.857 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -62.84 134.88 56.92 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.116 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 74.16 9.31 4.58 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.28 1.432 . . . . 0.0 112.3 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.514 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -93.78 170.65 30.94 Favored Glycine 0 N--CA 1.431 -1.653 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.398 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.1 tt0 -87.18 107.25 18.39 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.596 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.5 p -68.26 -51.46 44.9 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 121.195 0.521 . . . . 0.0 110.814 177.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 156.48 121.2 0.69 Allowed Glycine 1 N--CA 1.393 -4.184 0 C-N-CA 118.203 -1.951 . . . . 0.0 114.061 178.34 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.9 -157.26 19.66 Favored Glycine 0 N--CA 1.408 -3.171 0 N-CA-C 106.183 -2.767 . . . . 0.0 106.183 171.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.5 mt -62.48 129.63 25.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 117.812 0.806 . . . . 0.0 108.938 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.53 -20.34 44.73 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.932 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -95.25 124.86 39.51 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.1 p -128.47 9.67 6.08 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.67 -124.06 3.75 Favored Glycine 0 C--O 1.248 0.993 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.945 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.95 75.44 0.43 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 124.054 3.169 . . . . 0.0 112.418 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.1 p -80.36 -11.87 59.65 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.99 0.9 . . . . 0.0 110.598 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.7 t -90.2 133.05 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.9 m -93.09 160.09 15.01 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 123.332 0.395 . . . . 0.0 110.503 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.67 147.13 28.47 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.259 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 m -53.39 117.01 2.75 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.581 0.752 . . . . 0.0 111.346 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.7 -8.15 34.17 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.234 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.3 p -113.59 146.87 39.04 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.228 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 32.6 p -106.58 137.24 44.94 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.557 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.7 t -83.8 113.08 20.67 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -116.59 116.05 26.87 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.261 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.38 99.44 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.7 mt -81.71 -48.05 12.17 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.667 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 49.9 m-20 -122.24 166.84 15.63 Favored Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.16 -32.69 82.97 Favored 'Trans proline' 0 C--N 1.346 0.415 0 CA-C-N 121.495 1.57 . . . . 0.0 112.729 -175.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -105.62 -23.31 12.79 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.294 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 80.0 t80 -102.24 113.81 27.42 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.462 0.649 . . . . 0.0 111.412 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -126.49 140.7 52.26 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 177.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -128.43 147.33 50.65 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.769 -0.773 . . . . 0.0 110.535 -174.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.596 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 65.7 m -89.02 106.51 18.48 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.412 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.293 -1.869 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.646 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 N--CA 1.442 -0.843 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -74.89 130.1 38.82 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.132 0.491 . . . . 0.0 110.582 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -64.1 165.76 8.68 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 124.307 1.043 . . . . 0.0 111.985 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -61.58 131.01 48.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 74.76 9.27 4.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.93 1.292 . . . . 0.0 112.833 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.64 169.35 32.62 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.406 HE21 ' HA2' ' A' ' 9' ' ' GLY . 44.3 tt0 -88.05 103.33 15.61 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.681 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.6 p -64.37 -26.06 68.3 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 121.806 0.813 . . . . 0.0 109.228 175.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.421 ' HA3' ' CG ' ' A' ' 13' ' ' TYR . . . 103.31 132.46 7.62 Favored Glycine 1 N--CA 1.39 -4.403 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.697 172.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.75 -155.84 29.97 Favored Glycine 0 N--CA 1.403 -3.508 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 172.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 66.0 mt -57.32 123.44 8.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.39 -12.14 26.01 Favored Glycine 0 C--N 1.302 -1.317 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.872 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.421 ' CG ' ' HA3' ' A' ' 9' ' ' GLY . 12.4 t80 -109.83 114.34 27.82 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 p -110.49 0.23 17.67 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.83 -134.67 1.5 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.732 -0.482 . . . . 0.0 112.869 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -63.55 79.19 0.14 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 123.401 2.734 . . . . 0.0 113.65 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 9.6 p -80.49 -14.28 58.4 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.202 1.001 . . . . 0.0 109.905 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.0 t -92.66 128.73 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.8 m -87.34 167.24 14.23 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.445 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.38 152.88 44.4 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.846 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.9 m -58.48 123.44 16.22 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.813 0.339 . . . . 0.0 110.561 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.09 -7.77 29.09 Favored Glycine 0 N--CA 1.433 -1.561 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.975 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 82.1 p -123.06 154.45 38.52 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.7 p -117.02 135.74 53.47 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.0 t -78.52 114.82 17.78 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -116.12 114.94 25.19 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.75 96.36 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 mt -78.31 -38.9 41.24 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.773 -173.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -134.46 167.85 20.75 Favored Pre-proline 0 C--N 1.291 -1.954 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -64.23 -32.96 61.7 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 CA-C-N 121.306 1.502 . . . . 0.0 112.435 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.407 ' HD1' ' O ' ' A' ' 11' ' ' ILE . 42.8 m-85 -106.5 -24.4 12.21 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.762 -176.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -102.02 117.42 34.76 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.43 0.633 . . . . 0.0 110.885 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.8 m -134.2 140.74 46.72 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -127.1 152.41 47.35 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.215 -173.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.681 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 84.6 m -92.55 106.36 18.36 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.292 -1.926 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.459 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.429 -1.494 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.478 HE21 ' HA3' ' A' ' 6' ' ' GLY . 53.1 tp60 -81.76 147.43 29.44 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.358 0.599 . . . . 0.0 112.158 -172.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 p -88.88 177.84 6.59 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 124.664 1.185 . . . . 0.0 110.855 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -72.06 133.8 45.46 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 74.76 9.43 4.13 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.439 1.096 . . . . 0.0 112.702 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.478 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -93.0 170.12 31.54 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 176.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -90.9 113.19 25.33 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.936 0.368 . . . . 0.0 110.056 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.607 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.8 p -72.56 -33.7 66.99 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.758 0.79 . . . . 0.0 109.166 174.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.6 130.38 4.03 Favored Glycine 0 N--CA 1.398 -3.859 0 C-N-CA 118.58 -1.771 . . . . 0.0 115.311 174.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.42 -155.73 25.6 Favored Glycine 0 N--CA 1.406 -3.323 0 N-CA-C 106.179 -2.768 . . . . 0.0 106.179 172.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.35 129.42 21.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.24 9.11 52.19 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.269 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -114.43 138.49 50.51 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.6 p -138.38 14.15 2.79 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.27 0.557 . . . . 0.0 112.478 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.91 -132.72 7.2 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -69.98 94.02 0.55 Allowed 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.01 2.473 . . . . 0.0 112.307 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.6 p -86.98 -13.96 43.06 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.49 0.662 . . . . 0.0 111.026 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.66 133.11 31.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.106 177.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.5 m -92.75 168.82 10.94 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.059 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.28 156.44 39.26 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.878 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 m -60.89 121.19 11.73 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.317 0.58 . . . . 0.0 110.738 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.32 -15.5 42.68 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 68.8 p -107.15 145.07 32.98 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 p -110.95 135.2 51.83 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 123.555 0.535 . . . . 0.0 110.572 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 47.9 t -80.11 108.01 13.36 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -110.28 117.76 34.5 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.649 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.1 t -77.78 96.09 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.3 mt -79.93 -36.57 36.13 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.316 1.055 . . . . 0.0 109.661 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.408 HD22 ' HB3' ' A' ' 32' ' ' TYR . 23.0 m-80 -135.8 162.4 57.14 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -60.39 -32.18 93.6 Favored 'Trans proline' 0 C--O 1.223 -0.26 0 CA-C-N 121.22 1.471 . . . . 0.0 112.966 -174.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -105.58 -24.02 12.66 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 120.975 0.417 . . . . 0.0 110.383 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' HB3' HD22 ' A' ' 29' ' ' ASN . 71.4 t80 -103.24 113.82 27.61 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.613 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.2 m -124.31 134.7 53.12 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -122.08 150.19 42.49 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.977 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.8 m -91.43 105.84 18.06 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.294 -1.835 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.493 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.446 -0.625 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.516 HE21 ' HA3' ' A' ' 6' ' ' GLY . 64.4 tp60 -88.98 139.31 30.58 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.173 0.511 . . . . 0.0 110.559 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 p -74.75 167.86 20.99 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 124.378 1.071 . . . . 0.0 112.068 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -65.3 130.98 45.3 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 77.16 9.16 2.73 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.196 1.398 . . . . 0.0 112.36 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.516 ' HA3' HE21 ' A' ' 2' ' ' GLN . . . -96.29 169.21 26.16 Favored Glycine 0 N--CA 1.431 -1.659 0 C-N-CA 119.85 -1.167 . . . . 0.0 110.449 176.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.3 tt0 -86.85 109.46 19.31 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 116.911 0.355 . . . . 0.0 110.368 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -71.45 -34.82 70.57 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-O 121.578 0.704 . . . . 0.0 109.57 174.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.32 133.75 4.44 Favored Glycine 0 N--CA 1.396 -3.976 0 C-N-CA 118.16 -1.972 . . . . 0.0 115.146 174.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.37 -156.26 23.59 Favored Glycine 0 N--CA 1.401 -3.671 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 173.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -56.97 131.7 20.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.92 -11.19 62.39 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.421 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -113.73 117.2 30.85 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 p -126.53 19.63 7.36 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.02 -128.49 1.88 Allowed Glycine 0 C--O 1.243 0.715 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -65.61 79.41 0.25 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.18 2.586 . . . . 0.0 112.867 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -85.3 -18.01 35.18 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.85 0.833 . . . . 0.0 109.907 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.92 129.4 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.3 m -91.66 168.47 11.46 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 120.762 0.315 . . . . 0.0 110.469 -178.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.79 145.46 52.48 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.2 t -52.26 124.66 13.73 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 123.716 0.635 . . . . 0.0 110.507 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.06 -26.66 16.48 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.858 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.2 p -97.61 140.73 31.59 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.994 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.4 p -100.52 133.8 44.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.278 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 44.2 t -81.01 107.01 13.46 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -108.77 116.98 33.01 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.8 t -75.02 103.26 2.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.41 HD12 ' CE1' ' A' ' 32' ' ' TYR . 86.0 mt -86.5 -48.07 8.71 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.666 -174.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -118.58 165.02 17.76 Favored Pre-proline 0 C--N 1.288 -2.099 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -60.97 -29.4 87.92 Favored 'Trans proline' 0 C--O 1.218 -0.476 0 CA-C-N 121.421 1.543 . . . . 0.0 111.646 -175.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -105.7 -23.93 12.64 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.964 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.41 ' CE1' HD12 ' A' ' 28' ' ' LEU . 85.8 t80 -103.1 113.97 27.88 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.16 0.505 . . . . 0.0 111.16 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.1 m -125.11 137.97 54.17 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 176.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -122.98 149.07 44.78 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.948 -175.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.2 m -89.36 106.07 18.21 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.297 -1.715 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.32 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.436 -1.139 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -93.87 135.82 34.79 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 120.999 0.428 . . . . 0.0 110.551 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -70.3 165.64 21.88 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.374 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.403 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 16.2 t-160 -66.07 131.13 45.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 75.94 8.88 3.49 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.126 1.37 . . . . 0.0 111.631 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.68 170.76 31.18 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.0 tt0 -88.71 106.81 18.59 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.616 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.9 p -65.38 -40.97 94.16 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-O 121.594 0.711 . . . . 0.0 109.44 174.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.2 119.91 2.35 Favored Glycine 1 N--CA 1.396 -4.032 0 C-N-CA 118.449 -1.834 . . . . 0.0 114.667 174.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.95 -156.76 33.04 Favored Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 106.39 -2.684 . . . . 0.0 106.39 170.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -58.06 132.81 22.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 117.244 0.522 . . . . 0.0 109.908 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.21 -17.62 55.51 Favored Glycine 0 C--O 1.245 0.798 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.462 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -93.43 127.81 39.22 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.6 p -129.29 15.35 6.14 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.037 0.446 . . . . 0.0 111.465 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.61 -137.57 5.47 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.76 91.54 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.915 2.41 . . . . 0.0 111.351 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 2.4 p -89.67 0.24 57.09 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.73 0.776 . . . . 0.0 111.293 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -106.45 128.81 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.589 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.5 m -79.82 155.74 27.72 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.515 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.5 159.43 18.59 Favored 'General case' 0 C--O 1.254 1.297 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.883 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 m -49.86 118.24 2.75 Favored 'General case' 0 C--O 1.247 0.933 0 C-N-CA 124.041 0.936 . . . . 0.0 112.157 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.32 -12.1 43.75 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.52 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 75.6 p -110.51 153.51 24.98 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 117.59 0.695 . . . . 0.0 111.846 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.9 p -112.02 139.88 47.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.35 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.415 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 40.8 t -84.41 107.06 16.46 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.508 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 75.6 mt-30 -103.67 115.01 29.7 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.1 t -81.35 101.28 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.536 HD12 ' CE1' ' A' ' 32' ' ' TYR . 86.2 mt -80.03 -52.31 7.98 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.822 0.82 . . . . 0.0 109.37 -176.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -118.94 167.7 11.28 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.72 -32.52 86.56 Favored 'Trans proline' 0 C--N 1.347 0.489 0 CA-C-N 120.92 1.364 . . . . 0.0 112.384 -176.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -105.66 -23.55 12.73 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 120.777 0.322 . . . . 0.0 110.76 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.536 ' CE1' HD12 ' A' ' 28' ' ' LEU . 63.3 t80 -101.51 114.21 28.02 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.546 0.689 . . . . 0.0 110.801 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.7 m -129.37 143.74 50.96 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -130.97 148.93 52.79 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.512 -174.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 81.7 m -88.86 106.67 18.54 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.876 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.508 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 2.8 mm? . . . . . 0 C--N 1.298 -1.653 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.441 -0.904 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -74.26 126.73 31.26 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.372 0.606 . . . . 0.0 111.694 -170.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 p -75.31 176.26 7.59 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.193 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -63.51 134.1 55.0 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.831 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 73.91 9.22 4.77 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 124.58 1.152 . . . . 0.0 112.503 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.97 170.16 31.62 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.4 tt0 -90.81 105.79 18.07 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 122.439 0.296 . . . . 0.0 110.548 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.2 p -64.7 -56.76 11.69 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 170.61 106.46 0.19 Allowed Glycine 0 N--CA 1.407 -3.269 0 C-N-CA 117.958 -2.068 . . . . 0.0 113.34 -175.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.21 -165.07 20.34 Favored Glycine 0 N--CA 1.417 -2.606 0 N-CA-C 105.963 -2.855 . . . . 0.0 105.963 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.4 mt -65.11 112.66 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 118.22 1.01 . . . . 0.0 110.337 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.5 -9.09 28.39 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.026 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.46 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 2.8 t80 -113.52 113.22 24.82 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.8 p -125.46 14.77 8.24 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.124 0.487 . . . . 0.0 112.095 -176.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.65 -124.18 0.7 Allowed Glycine 0 C--N 1.318 -0.452 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -66.19 80.98 0.29 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.59 2.86 . . . . 0.0 111.812 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.2 p -84.04 -12.53 55.02 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-O 121.892 0.854 . . . . 0.0 111.182 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.9 132.87 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.6 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.8 m -90.75 163.14 14.58 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.395 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.43 141.43 54.67 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.585 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -53.68 114.58 1.6 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 123.748 0.819 . . . . 0.0 110.732 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.15 -9.95 29.09 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.595 -0.73 . . . . 0.0 113.06 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.7 p -111.52 135.64 51.81 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.1 p -96.17 132.77 41.25 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.736 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.581 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.0 t -77.01 113.06 14.31 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -114.73 116.95 29.48 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.5 t -79.72 103.15 6.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.3 mt -81.75 -48.44 11.64 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.142 0.972 . . . . 0.0 109.472 -173.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.41 HD22 ' HB3' ' A' ' 32' ' ' TYR . 29.0 m-80 -122.44 167.24 14.63 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 103.734 -2.691 . . . . 0.0 103.734 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.37 -34.69 53.83 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 CA-C-N 121.18 1.457 . . . . 0.0 111.94 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -100.51 -24.81 14.38 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.699 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HB3' HD22 ' A' ' 29' ' ' ASN . 64.5 t80 -104.0 114.39 28.6 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.9 m -118.88 153.32 34.74 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 174.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -140.33 148.24 41.05 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 118.798 0.726 . . . . 0.0 110.55 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.493 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.3 m -91.81 106.62 18.61 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.385 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.458 HG22 ' HB ' ' A' ' 18' ' ' VAL . 28.0 p . . . . . 0 N--CA 1.437 -1.096 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -105.28 141.52 36.65 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 p -72.62 166.67 22.29 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 123.558 0.743 . . . . 0.0 111.29 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.401 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 15.0 t-160 -63.03 132.93 53.63 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 76.56 9.39 3.03 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.74 1.216 . . . . 0.0 112.462 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.2 170.63 28.94 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.6 tt0 -85.8 114.1 22.48 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.878 0.339 . . . . 0.0 110.337 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.634 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 1.4 p -71.47 -54.29 11.11 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 123.618 0.574 . . . . 0.0 110.3 176.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.5 122.46 0.83 Allowed Glycine 1 N--CA 1.396 -4.029 0 C-N-CA 118.228 -1.939 . . . . 0.0 113.902 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.13 -157.71 19.53 Favored Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 105.572 -3.011 . . . . 0.0 105.572 173.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.13 126.03 20.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 118.009 0.904 . . . . 0.0 108.92 175.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.6 -17.13 39.92 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.582 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -89.41 127.41 35.82 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -124.18 -3.43 8.01 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.37 -135.24 2.16 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.1 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.35 92.62 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.373 2.715 . . . . 0.0 113.348 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.5 p -91.72 -5.97 52.74 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.284 0.564 . . . . 0.0 111.624 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.458 ' HB ' HG22 ' A' ' 1' ' ' THR . 90.8 t -96.18 130.11 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.9 m -87.56 161.72 17.59 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.182 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.14 153.03 5.43 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 124.206 1.002 . . . . 0.0 110.684 176.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.2 m -51.23 111.19 0.53 Allowed 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 123.936 0.895 . . . . 0.0 111.741 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.49 -14.95 57.76 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.247 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 70.4 p -92.74 139.76 30.22 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.0 p -101.97 136.83 41.13 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -176.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.426 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.6 t -80.89 117.63 21.69 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -116.96 117.93 31.02 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.67 96.29 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.2 mt -76.76 -38.98 53.16 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.094 -175.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -131.27 160.56 66.55 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -59.62 -27.63 85.43 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 121.548 1.499 . . . . 0.0 111.332 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -106.55 -24.38 12.2 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.453 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -103.32 114.37 28.59 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.051 -0.659 . . . . 0.0 110.463 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.7 m -127.76 136.06 50.99 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -123.03 149.93 43.71 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.388 -173.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 79.2 m -90.05 106.79 18.71 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.578 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.298 -1.638 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.507 . . . . . . . . 0 0 . 1 stop_ save_